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I N T R O D U C T I O N
I N T R O D U C T I O N
The investigations described in this thesis are 
concerned largely, but not exclusively, with the study of 
primary osteoporosis* This is a condition now laiown to 
affect a large proportion of the population, especially 
elderly women, but in which the aetiological factors are 
poorly understood* Some aspects of osteoporosis secondary 
to knowi predisposing aetiological factors have also been 
considered where they help to throw light on the problems 
of primary osteoporosis.
The problems studied and the present position of 
Imowledge relating to each is outlined below, and examined 
in more detail at the beginning of each Chapter* The extent 
to which answers have been obtained to each of the problems 
posed have been examined at the end of the thesis under the 
general heading 'Conclusions*, and under the same sub-headings 
which introduce the problems below*
Since a large number of Tables and Figures are presented, 
the thesis has been divided into two volumes, the first 
comprising of the text and the other of the Tables,
IllustrationsÇ and Appendices,
1) The problems of definition
Osteoporosis has been Imown to play an important role 
in the problems of advancing age for many years, but it is 
not a condition which can be laid solely at the doorstep of 
advancing mechanisation and modern diet* Fyfe (l958) 
reported osteoporosis affecting the human skeleton from pre­
historic times* In 1885, Pommer was the first to distinguish 
between the histological appearances of osteoporosis and 
osteomalacia, but the clinical entities continued to be 
confused for some time thereafter* Osteoporosis was not in 
fact recognised as a clinical entity until so described by 
Albright, Burnett, Cope and Parsons in 1941* Since that time 
a great deal of attention has been directed to the investigation 
of this condition, but nearly 30 years later, no clear 
quantitative definition of osteoporosis exists*
The difficulties associated with definition are all 
the more surprising in view of the quantitative measurements 
which have been made with increasing frequency over the last 
decade* The problems of definition arise for a number of 
reasons* The definition of any condition which causes disease 
is partly dependent upon the consideration of aetiological
factors* 111 the case of osteoporosis, these are poorly 
understood* It also partly depends upon the development of 
methods which accurately measure the effects of the condition 
on the hone* Definition is also concerned with clinical 
manifestations which, in osteoporosis, are not exclusive to 
the condition*
The qualitative definition of osteoporosis is that it 
is a condition in which the amount of bone present is diminished, 
but the bone remaining is biochemically normal* Even here 
some modification may be necessary for the sake of precision 
as some loss of mineral without loss of matrix has been 
reported by Jowsey and Gershon-Cohen (1964) and Dollerup (l964)@ 
Hoivever, even ignoring this point, examination of this definition 
iiimiediately leads to the discovery of difficulties in quantitative 
definition* Clearly, the definition requires the definition 
of normal limits and though normal surveys have been carried out, 
little use has been made of these for clinical purposes* The 
definition of normal limits does not necessarily help, since any 
subject at the top of the normal scale may lose a significant 
amount of bone without reaching the lower normal limit, yet from 
the dynamic point of view, the subject having lost bone should 
be considered to have developed a degree of osteoporosis*
In other words, the setting of a lower limit of normality 
could be quite artificial and unhelpful when considering 
development of the pathological state,
A further problem arises from the fact that the 
skeletal mass is changing throughout life* Clearly the 
skeleton continues to grow until the epiphyses close in the 
young adult after which no further growth in length has been 
reported to occur® However, recent reports have described 
continued growth in the external diameter of the raetacarpals 
(Garn, Roiuuann, Wagner and Ascoli, 196?), the femur (Smith and 
Bizek, 1966), and the rib (Epker and Frost, I966), At the same 
time the internal diameter continues to increase throughout 
life (Epker and Frost, 1965)* In addition, both the cortical 
and trabecular bones show changes in density, number and 
thickness of trabeculae, and in porosity of the cortical bone 
with time (Rowland, Jowsey and Marshall, 1958; Jowsey, 1963a 
and 1963b; Epker and Frost, I965)#
Further problems have arisen because it is not always 
clear in the literature as to the nature of the physical 
measurements made* For example, the bone mass of a long bone
may be considered as the amount of ash per unit length of 
bone where the volume is the total volume enclosed by the 
periosteum* Alternatively, it could be considered as the 
amount of bone per unit mass of cortex* Because the internal 
and external diameters vary with age, these measurements give 
very different results when considering the relative rates 
of change of bone mass with age*
A further consequence of the failure to define 
osteoporosis quantitatively has been the failure to measure 
and report some parameters of bone mass in the majority of 
publications dealing with various aspects of this condition*
The patients are designated as having osteoporosis, but no 
associated measurements are given to indicate the amount of 
bone present, or how this relates to the normal population*
The first Chapter of this thesis is therefore 
concerned with the definition of what is measured by the 
X-ray methods employed in this study* These measurements 
are used to examine the changes which occur in the normal 
male and female population* The following factors which are 
thought to affect the amount of bone present have been 
considered: first, the effects of age; second, the differences
between the sexes; third, the influence of social class; 
fourth, the effect of the menopause in women*
The study of the normal population cannot of itself, 
lead to a definition of osteoporosis and this is considered 
further in relation to the bone changes occurring in pathological 
states in Chapter ÏI* However, the definition of osteoporosis 
would not be complete without a discussion of the relation 
between the bone mass and the incidence of fractures. This is 
considered in Chapter III* It has been known for some time 
that the incidence of fractures increase with age (Knowelden, Buhr 
and Dunbar, 196k), and that there is a fall in bone mass with 
age (Gitman and Kamlioltz, 1965; Epker, Kelin and Frost, 1965; 
Smith and ïlizek, 1966; Nordin, MacGregor and Smith, 1966;
Morgan, Spiers, Pulvertaft and Fourman, 1967; Smith, Anderson, 
Shimmins, Speirs and Barnett, 1969)0 The relation between bone 
loss and fracture incidence is discussed by Newton-John and 
Morgan (1968)* They were able to demonstrate a relation between 
fracture incidence and the amount of bone in the metacarpal 
in women relating to fractures of the neck of femur and lower 
end of the radius. However, both the incidence of
fracture and the bone loss increases with age, and these 
authors were careful to point out that correlation did not 
imply causation* Surprisingly little attention has been paid to
the relative rates of increase in fracture incidence and 
bone loss in men* The incidence of fracture varies 
between the sexes and if one particular measurement of 
bone mass defines the incidence of fracture in both sexes, 
the case for bone loss being the cause of fracture is 
considerably strengthened* These relations are examined 
in Chapter III*
2) Factors affecting calcium balance
It is self-evident that any subject who is losing 
bone must be in negative calcium balance* It is also 
evident that the negative calcitun balance could be the 
cause or the result of changing bone mass. Clearly, 
therefore, the estimation of calcium balance is theoretically 
a useful technique in the investigation of disorders of 
calcium metabolism*
The state of the calcium balance in any individual 
may be the manifestation of low calcium intake, diminished 
calcium absorption, increased urinary calcitun excretion, 
excessive endogenous faecal calcium loss, or loss associated 
with sweating* However, the measurement of calcium balance 
is both tedious and time consuming.and only measures balance 
over relatively short periods of time* The balance technique 
of itself measures only net faecal loss and excessive loss 
of endogenous calcium can only be inferred if the faecal 
losses exceed the dietary intake* It takes no account of 
sweat losses* The measurements can only be made in relatively 
small numbers of patients* Finally, the balance technique 
is subject to error of between 5 and 10^ and may therefore
be more useful in relative than in absolute measurement*
A further important consideration is that balance may be a 
function of intake, and may not, therefore, give an 
indication of the effect of variations in intake which 
occur over long periods of time*
Chapters IV and V are concerned with the investigation 
of isotopic measurement of calcium absorption, and the 
factors controlling urinary calcium excretion*
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3) Bono formation and destruction rates
Whether negative calcium balance is the cause or 
effect of bone loss, it is evident that the rate of hone 
formation must be lower than the rate of bone destruction if 
the bone mass is diminishing* Albright, Smith and Richardson 
(l941b) and Albright and Reifenstein (l948) concluded that 
osteoporosis resulted from the failure to lay down bone matrix 
and was therefore the result of diminished bone formation* 
However, more recently, this view has been challenged* Jowsey 
(1966) using a quantitative microradiographic technique claimed 
that the rate of bone formation was normal in osteoporosis but 
that the rate of bone destruction was increased* Moreover,
/  c r  I 1 )
with the introduction of Ca, Ga and Sr, a number of authors 
were unable to find any significant difference in the rate 
of bone formation, measured iso.topically, between normal 
subjects and osteoporotic subjects (Fraser, Harrison and Jones, 
I96O; Dymling,. 1964; Nordin, Smith and Glass, 1964;
Lafferty, Spencer and Pearson, I964),
However, there are a nuinber of problems associated 
with the use of isotopes to measure the bone formation rate* 
Quantitatively, the results differ substantially from those 
obtained using the tetracycline labelling technique*
Bauer, Carlsson and Lindquist (1961) give a value of about 
18^ of the skeleton being formed per year in adults using 
isotopes* Frost (1963) measured the rate of bone 
formation in man after tetracycline administration*
This author's measurements were made mainly on rib 
and the values he obtained ranged between 2 and 7^ per 
year* These differences arise from several factors which 
are inherent in the use of isotopes for the measurement, 
of bone formation* Following the injection of an isotope 
the tracer is distributed throughout a rapidly exchanging 
pool of about 5 gm which is partly associated with soft 
tissue calcium, and partly with bone surfaces* With time 
the isotope is steadily lost from this pool, mid has little 
significance after 40 to 50 days (Smith, Speirs mid Shimmins, 
1967), Long-term exchange processes are also responsible 
for isotope uptake (Shimmins and Smith, I966; Smith et al, 
1967)4 By exchange is meant the exchange of isotope for 
stable calcium without any net acquisition of calcium by 
the bone* These processes affect the calculation of bone 
formation which is basically derived by dividing the 
skeletal retention by the integrated plasma specific activity*
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Both retention and plasma specific activity are affected 
by exchange*
The magnitude of these effects have been examined 
by a number of authors (Marshall, White and Cohen, 1959&; 
Marshall, Rowland and Jowsey, 1959b; Marshall, Jowsey and 
Rowland, 1959c; Marshall, Rowland and Jowsey, 1959d;
Lloyd, 1965) using the techniques of quantitative auto-and 
micro-radiography in animals, and by Rowland (1963) who 
studied the retention of radium ingested by human subjects* 
Estimates of the retention of isotope due to exchange 
processes range from 10 to nearly 50^, depending upon the 
time since injection of the isotope and the animal investigated, 
This means that the exchange processes could affect the 
measured rate of bone formation to a considerable and 
varying extent*
85Further problems arise with the use of Sr as a 
tracer for calcium® Discrimination is Imown to occur in 
the transport of these ions across the gut (Bailey, Bryant 
and Loutit, I96O; Spencer, Li, Samachson and Laszlo, I96O; 
Samachson, 1963; Nordin, Smith, MacGregor and Nisbet, 1964b).
There is also discrimination against strontium during 
reahsorption by the renal tubule (MacDonald, Noyes and Lorick, 
1957; Harrison, Lumsden, Raymond and Sutton, 1959; Barnes, 
Bishop, Harrison and Sutton, 196l)* Whether there is 
discrimination at the bone surface during exchange process 
or new bone formation, or the process of bone mineralisation, 
is still controversial*
These problems have been examined in Chapter VI, 
which is in two parts* Part I is concerned with the isotopic 
measurement of mineral into bone; Part IX is concerned with 
the isotopic measurement of bone resorption and the relation 
between this and urinary hydroxyproline excretion* The 
effects of age on these measurements in women have also been 
investigated*
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The role of dietary intake of calcium, phosphorus, protein 
and vitamin D in relation to bone mass and age; the 
absorption of calcium and urinary calcium excretion; the 
role of calcium supplementation of the diet ____ __
The role of calcium in the development and treatment 
of osteoporosis has been a topic of debate for nearly a 
century* Calcium deficient diets were given to animals by 
a number of researchers (Weiske, 1874; Miwa and Stoeltzner,
1898; Gotting, 1909)o These diets were given in an attempt 
to produce rickets, but Pommer (l925) reviewed this work 
and concluded that calcium deficiency produced osteoporosis 
and not rickets* Jaffe, Bodansky and Chandler (l932) 
reported osteoporosis in dogs and Bell, Cuthbertson and Orr, 
(1941) reported it in rats fed low calcium diets; this work 
was confirmed by Crawford, Gribetz, Diner, Hurst and Castleman 
(1957)© Bussaberger, Freeman, Smith and Ivy (l938) reported 
severe osteoporosis produced by gastrectomy in puppies, which 
was presumed to be due to malabsorption of calcium* Melanby 
(19I8 ) reported the development of osteoporosis induced by 
giving large doses of phytate, which decreases calcium absorption, 
but with adequate vitamin D, The osteoporosis so produced
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could be prevented by administering adequate calcium?
Jowsey and Gershon^Cohen (1964) produced osteoporosis in 
cats with low calcium diets, and they were able to improve 
the condition by increasing the dietary calcium intake^
The evidence for calcium being of importance in 
the treatment of osteoporosis in man remains controversial?
A positive calcium balance resulting from calcium 
supplementation of the diet has been widely reported 
(Owen, Irving and Lyall, 1940; Anderson, 1950; WTiedon, 1959; 
Harrison and Fraser, I96I; Nordin, 1962a), However, Smith 
and Frame (1965) were imable to demonstrate any relation 
between vertebral density and calcium intake in 2,000 women.
Dent and Lyal Watson (1966) are sceptical of the significance 
of calcium supplements being an effective therapy. Certainly 
no evidence of an increase in bone density after administration 
of calcium therapy has ever been reported.
Surprisingly little attention has been paid to the 
possible importance of phosphorus in relation to the development 
of osteoporosis. Investigations that show that changes in 
phosphorus intake produce significant clinical effects have 
aroused little controversy, Bergstrand (l92l) demonstrated
16
the development of parathyroid hyperplasia in association 
with the phosphate retention of renal failure, Stoerk and 
Carnes (l945) demonstrated a rise in the weight of the 
parathyroid glands of animals given a high intake of 
phosphorus, Goldman and Bassett (l95S) showed that a high 
phosphate intake was associated with a rise in the plasma 
phosphorus and a rise in the filtered load, hut a fall in 
reahsorption by the renal tubule which they attributed to 
parathyroid stimulation* Similar results were obtained by 
Crawford, Osborne, Talbot, Terry and Morrill (l950)g
The effects of hyperparathyroidism on bone are well- 
known, Hossain, Smith and Nordin (l970) showed that the 
cortical area/total area ratio was significantly lower in the 
post-menopausal patients with hyperparathyroidism than in 
either pre or post-menopausal women with hypoparathyroidism 
or in pre-menopausal women with hyperparathyroidism* Jowsey 
(1966) showed both increased bone formation and destruction 
in primary hyperparathyroidism, but the increase in destruction 
rate exceeded the rate of bone formation* The amount of 
phosphorus in the diet, could therefore be a contributory 
factor to changing bone mass by its influence on the parathyroids
17
Wacluuan and Bernstein (1968) suggested that since phosphate 
was the main buffer system, the intake of high acid ash diets 
might contribute to phosphate loss and therefore to loss of 
bone,
A number of authors have reported diminished bone gro^ vth 
in animals fed on a low protein diet (Gardner, 1945; Armstrong 
and Fstremera, 1948; McCance, I96O; Dickerson and McCance, 
I96I; El"Maraghi, Platt and Stewart, 1965; Platt and Stewart, 
1962; Shenolikar and Narasinga Rao, I968), It is possible 
to have stunting of growth but to have relatively normal bone 
per unit volume. It is not always clear from the ivork reported 
above whether there has been merely failure to grow or whether 
there has also been a diminution in the amount of bone per 
unit volume* Gardner (l945) and Armstrong and Estremera (l94S) 
reported substantial falls in body weight but only small falls 
in the weight of the skeleton* However, El-Maraghi et al
(1965) found that low protein diets did cause osteoporosis, 
irrespective of the calcium content of the diet* A low protein 
diet increased faecal calcium excretion (McCance, Widdowson 
and Lehmann, 1942; Shenolikar and Narasinga Rao, 1968)*
The latter authors concluded from their studies that this was 
due to increased excretion of endogenous faecal calcium.
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Garn, Rohiiian, Eehar, Viteri and Guzman (1964) reported 
that children who had been admitted to hospital with acute 
protein-calorie deficiency showed marked deficiency of cortical 
hone* The degree of ossification was similar to that of the 
population from which these children were drawm* They felt 
that this evidence was in keeping with bone loss and was not 
simply the result of failure to grow* The measurement they used 
was the cortical width, and this was not therefore corrected for 
size* On the evidence given, these differences could have 
arisen from a primary failure of growth* Moreover, there was 
no evidence given which would exclude vitamin and mineral 
deficiencies as contributory factors* In fact, the evidence 
for pure protein deficiency producing osteoporosis in man is 
very poor* All populations in whom the intake of protein is 
low invariably have deficiencies of other important dietary 
constituents* Albright, Forbes, Bartter, Reifenstein, Bryant, 
Cox and Dempsey (l950)? and Albright, Bartter, Dempsey, Forbes, 
Henneman and Reifenstein (l953) claimed that albumin infusions 
improved calcium balance in osteoporosis and Dent and Lyal Watson
(1966) reported a positive balance in one patient so treated*
The significance of low protein diets in the production of 
osteoporosis in man therefore remains doubtful.
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Rickets in children was a well-known clinical entity 
when this was described by Whistler in 1645*
Trousseau (1862) used fish oil as a remedy for rickets 
in children £ind reported the findings of Bretomean in 1827 when 
a dramatic cure was effected in one of his young patients*
In 1868, Gee (quoted by Franklin, 1954) was convinced 
of the therapeutic value of cod-liver oil? Palm (l890) was 
the first researcher to suggest that lack of sunlight might be a 
contributory factor in the development of rickets*
Mellanby (l918,192l) was able to produce rickets in a 
young dog and then effect a cure with cod-liver oil* This 
was also investigated in rats by McCollum, Simmonds, Parsons, 
Shipley and Park (l92l) and McCollum, Simmonds, Shipley and 
Park (1921)4 Kandutsch, Murphy and Dreisbach (l956) were 
able to show that 7“"dehydrocholesterol found in the sebaceous 
glands of the mouse and the guinea-pig produced vitamin 
The significance of vitamin D in the development and treatment 
of rickets and osteomalacia is evident* Further investigations 
have shomi that vitamin D increased calcium absorption (Underwood, 
Fisch and Hodge, 1951; Nicolayseii and Eeg-Larsen, 1956; 
Haavaldsen and Nicolaysen, 1956; Gershoff and Hegsted, 1956; 
Schachter and Rosen, 1959)# The general conclusion was that
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vitamin D increased calcium absorption in the upper small 
intestine* Vitamin D is also reported to increase the 
absorption of phosphorus from the gut (Carlsson, 1954; Nordin 
and Smith, 1967)0 This effect may be secondary to increased 
calcium absorption as Nicolaysen (1956) was unable to demonstrate 
increased phosphorus absorption in the absence of dietary calcium* 
However, Nordin and Smith (1967) showed an increased absorption 
of phosphorus in patients with treated osteomalacia before the 
calcium absorption responded to vitamin D*
Vitamin D is also known to have a direct effect on the 
reabsorption of phosphorus by the renal tubule. In large doses, 
in the treatment of hypoparathyroidism, vitamin D decreases the 
reabsorption of phosphorus (Albright and Reifenstein, 1948)*
In smaller doses, in the treatment of rickets and osteomalacia, 
vitamin D decreases phosphate excretion due to the suppression of 
secondary hyperparathyroidism (Harrison and Harrison, 1941; 
Crawford, Gribetz and Hurst, 1954; Nordin and Smith, 1967)e
Vitamin D is Imown to have a direct effect on the metabolism 
of bone quite apart from the indirect effects it might have by 
affecting the absorption and excretion of calcium and phosphorus.
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Progressively increasing doses of vitamin D will 
eventually result in a rise in plasma calcium without significantly 
increasing calcium absorption (Lindquist, 195^; Carlsson and 
Lindquist, 1 9 5 5 ) This almost certainly explains the 
excessive resorption of bone when vitamin D is administered in 
large doses (Pollis, 1955; Crawford, Gribetz, Diner, Hurst and 
Castleman, 1957), the action being a direct one on the bone?
The role of vitamin D in the development of osteoporosis 
remains obscure* Although not attributing a specific role to 
vitamin D deficiency in the treatment of osteoporosis, most 
researchers would recommend an adequate vitamin D intake, 
usually with the comment that this should be given to ensure 
adequate absorption of calcium (pourman, 1965)» However, Rose 
(1964) demonstrated that though vitamin D increased calcium 
absorption, there was a significant rise in urinary calcium which 
resulted in only a small or negligible improvement in balance. 
Smith, Rizek, Frame and Mans our (l964) estimated the serum anti­
rachitic activity (Si\RA) in II6 women from Michigan and 65 women 
from Puerto Rico* All the women were over 45 years of age.
The serum antirachitic activity was assayed on rachitic rats*
The state of the spinal density was assessed by two independent 
observers on a 4 point scale - normal, grade 1, grade 2 and 
grade Grades 2 and 5 were taken to indicate severe
osteoporosis. In the subjects from Puerto Rico, the SARA 
was significantly higher than in the subjects from Michigan* 
There was a seasonal variation, the SARA level in the Michigan 
subjects being higher at the end of the sumjuei* than in the 
spring* The SiUhV level was lower in the older Michigan 
subjects and in the women with severe degrees of osteoporosis 
compared with those subjects who had normal spinal densities 
or grade 1 osteoporosis? . The serum calcium and phosphorus 
values were also found to be higher in the subjects from 
Puerto Rico. Smith et al (l9ô4) suggested that the lower SARA 
values in the Michigan subjects could result from the lower 
exposure to sunlight, and that this might affect the older women 
in particular in whom the sebaceous secretion of the skin was 
diminished*
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Seasonal variations in serum phosphorus have been 
reported in children (Hess and Lundagen, 1922), and in serum 
calcium values in infants (Bakwin and Baluvin, 192?)o 
Similar variations in serum phosphorus in healthy men have 
been reported by Havard and Reay (l925)e In subjects with a 
good dietary intake of calcium, vitamin D was not found to 
affect calcium balance (Bogdonoff, Shock and Nichols, 1953)« 
In fact, in other studies vitamin D has been reported to 
improve calcium balance in elderly men and women (Shorr and 
Carter, 1947; Ackermann and Toro, 1953; Lutwak and Whedon, 
1963)2 The evidence is therefore far from conclusive that 
vitajnin D is a contributory factor in the development of 
osteoporosis in some subjects, but is sufficient to suggest 
that further investigation is important#
These problems have been considered in Chapters VII,
VIII, IX and X?
In Chapter VII, the relation between dietary intake 
and bone mass has been examined in normal men and women* In 
addition an isotopic test of calcium was used to assess the 
differences in absorption which might be associated with age and 
sex* The urinary calcium/creatinine ratio was used to assess: 
the changes in urinary calcium excretion?
Chapter VIII is concerned with the assessment of dietary 
intake of calcium and phosphorus in patients who had undergone 
gastric surgery, and the relation of diet to bone mass*
The method of measuring bone mass on the third metacarpal 
proved sufficiently accurate and reproducible to permit a study 
of the effects of calcium supplements on bone mass* These 
results are reported in Chapter IX*
The final chapter (Chapter X) is concerned with a further 
examination of the effects of calcium supplementation on balance, 
faecal excretion of calcium, fat and bile acids, and the urinary 
excretion of hydroxyproline* This was then considered in 
relation to the study of the effects of calcium supplements in 
man*
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The conclusions based on the experimental evidence 
are stated under this heading (p* 270)*
Finally, there are four Appendices which though 
not a direct part of the investigations, are concerned with 
describing more fully the methods used where these are not 
well established routine techniques*
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CHAPTER I
BONE MINERAI. COPIENT IN HEALTH AND IN DISEASE
lo Bone mineral content in normal male and female subiects
Attempts to study the effects of age, diet and the many 
other factors affecting calcium balance, and therefore the mineral 
content of bone in health and in disease have had to await the 
development of accurate methods of estimating small percentage 
changes* Numerous attempts have been made to define a simple and 
reproducible technique* These fall into two broad groups 
Firstly, there are the morphological measurements such as the 
cortical width of the metacarpal, femur and radius (Barnett and 
Nordin, I96O; Meema, I963) and the measurement of spinal bicon­
cavity (Barnett and Nordin, I960)* Secondly, many attempts have 
been made to estimate the density of various bones; the spine 
(Nordin, Barnett, MacGregor and Nisbet, 19^2); the ulna (Keane, 
Speigler and Davis, 1959; Doyle, I961); the radius (Meema, Harris 
and Porrett, 1964); the os calcis (Mayo, I96I), and the metacarpal 
(Bywaters, 1946; Koch and Kaplin, I96I)* The morphological 
methods have the advantage of simplicity but only a moderate degree 
of accuracy* Moreover, morphological measurements do not allow 
for changes in bone porosity which occur with age and in osteoporosis 
(jowsey, 1963a; Jowsey and Gershon-Cohen, 1964) nor for the changes 
in mineral content without loss of bone tissue, for example, in
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osteoporosis (jowsey a.nd Gershon-Cohen, 1964; Dollerup, 1964), 
or even more obviously in osteomalacia? Morphological methods 
are insufficiently accurate to make an assessment of therapy 
where a yp change implies a substantial loss of bone and which 
is less than the error of measuring the cortical width of a bone 
such as the metacarpal (Anderson, Shimmins and Smith, 1966),
Methods
A combination of morphological and density measurements 
give much more information about the skeleton than either type of 
measurement taken alone? In the following study, such a combina­
tion has been used, and the methods and the degree of accuracy 
and reproducibility are more fully described in Appendices I and II, 
The morphological methods are those described by Barnett and 
Nordin, 1960? Standard films wore obtained of the right hand and 
the left femur (antro-posterior) and a lateral tomogram of the spine^ 
The standard films were used to calculate the osteoporotic indices, 
the measurements being made with a micrometer caliper* The ratios 
of the total cortical width to shaft diameter was determined at 
the midpoint of the second metacarpal of the right hand for the 
Metacarpal Index (M,I*), and at the widest part of the cortex of 
the femoral shaft for the Femoral Index (F*!?)? The lumbar 
vertebral body biconcavity index (S@I*) was measured on the tomogram
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of tlie third lumhai' vertebrae<, This is the ratio of the 
vertical height at the centre of the body divided by the 
vertical height of the anterior border? The Relative 
Vertebral Density (EoVoD?) was measured from a tomogram of 
the third lumbar vertebrae, the patient and standard spine 
being X-rayed side by side on the same film* This method 
was developed by Nordin et al (1962) and is described in 
Appendix II?
In order to obtain a more accurate and reproducible 
measure of the mineral content of bone, which was especially 
important if the effects of treatment were to be followed, 
a method for measuring the density and mineral content of 
the 3rd metacarpal was developed and is reported elsewhere 
(Anderson et al, I966)* A description of the method is 
given below and the technique detailed in A.ppendix I, 
Initially, the aluminium equivalent of the midpoint of the 
3rd metacarpal is determined by measuring the absorption of 
X-rays at this point? To do this, the hand is placed 
alongside an aluminium step-wedge, and an X-ray film taken 
under standard conditions? The conditions are imposed in 
order to eliminate variations due to the X-ray source (the 
*heel* effect), and those due to scattered radiation*
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Noii'-screen film is used to obtain improved definition, and 
to eliminate variations consequent upon the non-uniformity 
of response of the screen (Doyle, I961)* The screens were 
removed from screened film for this purpose as no non-screen 
film suitable for automatic processing was available* The 
aluminium step-wedge and hand were X-rayed on the same film
to reduce variations due to exposure and development of the
film* The aluminium equivalent is determined making 
allowance for soft tissue replaced by bone and for marrow 
which has an X-ray absorption significantly different from 
soft tissue* The 3rd metacarpal was chosen in preference to 
other bones because it is relatively easy to measure on the 
X-ray and is reasonably uniform in shape* Further, the 
soft tissue mass is uniform and relatively small in amount 
so that baseline variation and scatter are minimal*
From the aluminium equivalent, four further measure­
ments of bone mineral content were made;
1) The standardised aluminium equivalent (S,A,E*)*
This is derived by dividing the aluminium 
equivalent of the bone in the metacarpal by the
width of the bone at the point at which the
measurement was made* This allows for the 
difference in sizes between individuals, and is 
a measure of the mineral per unit width in the 
whole metacarpal? It is, therefore, a measure 
of whole bone density (Fig* l).
AJ-
2) Lambda ( A )o This is the absorption 
coefficient of the metacarpal cortex 
and is found, by dividing the aluminium 
equivalent by the cortical width at the 
midpoint of the metacarpal, /This ;is 
therefore a measure of the density of 
the cortical bone (Fig l)?
3) Total corcical mineral (T?CoMo)^ This 
is the total mineral per unit length
of cortical bone* This is derived by 
multiplying the cortical density ( A  ) 
by the cortical area TÏ (r^  
where is the radius measured to the 
periosteal surface and r^ the radius 
measured to the endosteal surface 
(Fig l)p
4) Standardised total cortical mineral 
(SpTpCoM*)* This is derived by 
dividing the total mineral content 
(TpGpM?) by the square of the total 
width. This again makes allowance 
for the difference in sizes between 
indivi duals (Fig 1),
Subjects studied
Volunteers were obtained by approaching the relatives 
and friends visiting patients in the general medical wards of 
the Western Infirmary, Glasgow? The scope of the survey 
was explained to them, and with their full permission X-rays 
were taken and a standard questionnaire completed* The 
questionnaire was designed (Appendix III) to elicit the 
incidence of fractures, backache, any history suggestive of 
malabsorption or diarrhoea, gastric surgery, corticosteroid 
therapy, the occurrence of renal colic or stone, and symptoms 
suggestive of urinary tract infection*
A past or present history of endocrine disorders was 
queried# Subjects with secondary bone disease 
(Nordin, I961) were excluded from the normal survey#
In addition, the age of the subjects was noted#
The social class was recorded, the social class of a 
woman being that of her husband if married or her own 
if single or widowed* The social class was determined 
from Appendix B1 of the Registrar Générales Classification 
of Occupations (1960)*
In the female subjects, the time of onset of the 
menopause, defined as the age at the time of the last 
period, was noted and whether it had occurred naturally 
or as the result of hysterectomy or oophorectomy* The 
number of pregnancies and the incidence of breast feeding 
was recorded*
Four separate normal groups were studied* Group I 
consisted of 152 normal women studied between I96I and 1963» 
Group II consisted of 75 male subjects studied between 
1963 and 1966* In these groups the X-ray measurements made 
were of the Metacarpal Index, Femoral Index, Spinal Index 
and the Relative Vertebral Density* Dietary histories were
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were taken and an isotope test of calcium absorption was 
carried out* Ikvo urine samples were taken and the calcium/ 
creatinine ratio estimated for each# The mean of the two 
readings was calculated and recorded#
Two further groups of subjects were studied between 
1964 and 1966# These consisted of 317 female and 312 male 
volunteers# These subjects were recruited in the way 
described above, and a standard questionnaire completed as 
described in Appendix III# The social class of the subjects 
was noted, and with their permission an X-ray of the right 
hand was taken along with an aluminium standard as described 
in Appendix I# From the aluminium equivalent of the bone, 
the SoA*E#, X  t ToC#M* and S?T?C?M# were calculated*
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RESULTS
Social class
The recorded social classes of the subjects in 
Groups I, II, III and IV are shown in Table I* The 
frequency distribution of the numbers in each of the five 
social classes is shown for each group and the percentage 
of subjects in each class indicated. The final columns 
show the breakdown into social classes of the Central 
Clydeside Conurbation* In Group I (normal female) there 
is a preponderance of social class 3 which is reflected in 
the patients referred for investigation of osteoporosis 
(p# 193 ) and probably reflects accurately the population 
served by the hospital at that time* In Groups II, III and 
rV the distributions still show a preponderance of subjects 
in social class 3 though this more nearly approaches the 
distribution within the Central Clydeside Conurbation 
(Appendix B1 of the Registrar Générales Classification of 
Occupations,i960 )* This difference is thought to reflect 
some of the change in occupation of the subjects studied, and 
also the re-housing of subjects associated with the demolition 
of many of the older houses in the area.
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Age distribution and incidence of backache
The frequency distribution by age of the subjects 
in 5 year age groups and the incidence of backache in each 
group is shown in Figs* 2, 3s 4 and 5» There is a higher 
incidence of backache in the female subjects in Group I 
than Group III at all ages but the differences do not reach 
statistical significance* The male subjects in Groups II 
and IV and have a lower incidence of backache than the female 
subjects in Groups I and III, again at all ages*
Menstrual history in Groups I and III
In Group I the menstrual history was not recorded in 
nine of the subjects# Eight of the subjects had had either 
oophorectomy or a hysterectomy sometime between 27 and 56 years 
of age, the average age being 40 years* The mean age of the 
81 women in whom the menopause had occurred naturally was 
47 years?
In Group III, the menstrual history was not recorded 
in ten of the subjects# Nineteen of the subjects had undergone 
oophorectomy or hysterectomy between 23 and 66 years of age, 
the average age at operation being 45g7 years# The mean age 
of the menopause in the I60 women who had undergone a natural 
menopause was 47«8 years#
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Other medical history
The incidence of other medical conditions present in
the subjects who volunteered are shown in Table II# The
incidence of urinary symptoms are higher in the female
Groups I and III* A higher proportion of subjects in
Groups II and IV had had gastric surgery than would have been
expectedj but the proportions were small — 0*6^ and 1*2^ —
and would not be expected to significantly affect the normal
distribution©
X—ray measurements
(a) Group I (l32 normal female subjects) and
Group XI ( 75 normal male subjects)
Group I (Normal females)
There was a highly significant fall in the Metacarpal
Index (MoX*)| the Femoral Index (?*!*), the Spinal Index (S#I*),
and the Relative Vertebral Density (RoVoD*) with age (Table III)®
The gradient was steepest in the fall in the RoV*D© followed
closely by the fall in the M*!#* The smallest and least
significant change was found in the Spinal Index (P < 0*005)*
The rate of fall in the Femoral Index (P < OtOOl) was intermediate
between that of the M#I# (P < 0*00l) and S*I# (P < 0*00l)*
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Group II (Normal males)
There was a significant fall in the Femoral Index (Table III)
with age (FigJ. 15), (p < OoOl)* Though both the Metacarpal
Index and the showed a tendency to fall with age,
this did not reach statistical significance (Figs# ll4and 117 )*
There was no fall in Spinal Index with age (Fig# 116)© The
M*I# and the were significantly lower in the female
subjects of group I above the age of 60 years when compared
with the male subjects of group II in the same age range
(Figs* 114and 117 )* No significant difference between the
sexes was found in either the F*I* or the 8*1# (Figs® 115 and lié )*
In group Ij (Figs# 6, 7 and 8), the changes in the
and F*I* are related to the menopause© The X-ray index
and density is plotted in relation to age in those women who
have not yet reached the menopause© In those individuals who
have passed the menopause# the bone mineral measurement is
plotted against the years since the menopause occurred© The
data has been analysed in 5 year groups and the mean and two
Standard Error (S#E©) range is shown* There is no significant
change in either the or the M«I© before the onset of the
menopause© By the second 5 years of the onset of the menopause,
the E©V©jD© fails significantly (Fig© 6)* In Fig* 7> it can be
seen that a similar change has been found in the M©I© but the
change is apparent 5 years later# A similar fall was found
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in the F*!# 15 years after the onset of the menopause (Fig# 8) 
There was no point at which an abrupt change in the Spinal 
Index occurred*
(b) Group III (317 normal female subjects) and
Group IV (312 normal male subjects)
The volunteers for these two groups were recruited in 
the same way as those taking part in GroupsII.This survey 
was carried out between 1964 and 1966® The questionnaire used 
was the same as that for the survey of Groups I and II and is 
described in Appendix iH.
The X-ray measurement was a single X-ray of the right 
hand along with an aluminium standard from which the Aluminium 
Equivalent (A^E#), Standardised Aluminium Equivalent (S#A*E®), 
Cortical density ( A  )? Total Cortical Mineral (T«CpM#) and 
Standardised Total Cortical Mineral (S©T®C*M*) were derived 
(see p# 30 )*
The data was first analysed in terms of the mean and two
S©B* range in 5 year age groups» In Group III (normal females),
the S#A*Eo rose from 20*9 between the ages of 5 and 9 years to a
mean value of 36©5 between 25 and 29 years of age (Fig* 9)» The
mean S«AeE* fell slowly thereafter to a value of 34*7 between
45 and 49 years, and then more rapidly to a value of 24*1 
between 70 and 74 years© The S*AeE# has been related to 
the menopause (Fig? lO)# There is an abrupt fall in the 
SoA*B® 5 years after the onset of the menopause (which 
occurred at the mean age of 47©8 years in this group) and 
much more slowly thereafter© In the male subjects (Group IV), 
the SftA.E* rose from a mean value of 21*1 between 5 and 9 years 
to 35^5 between 30 and 34 years (Fig© ll)® There was then a 
gradual fall to 29*7 between 70 and 74 years© At no five 
year interval was there any abrupt change in S^A^E© comparable 
to that seen in the female subjects (Group III), which is 
evident between 50 and 54 years (Fig* 9)© The differences 
between the male and female subjects in corresponding age groups 
have been tested for significance using Student*s ®t^  test*
The results are shown in Table IV© No significant difference 
arises until after the age of 64 years and thereafter the gap 
between the male and female subjects continues to widen.
On examination of the data, it is evident that there is 
an initial sharp rise and then a fall and finally the data tends 
to flatten with increasing age© Because of this, a third order 
polynomial has been fitted to the data to show the continuous
kO
change with age* Since a third order polynomial might 
place an unnatural constraint upon the data this was tested 
by applying the polynomial starting at various decades 
between 5 and 45 years# No significant change in 
distribution was apparent# In Fig# 12, the mean and 95^ 
Confidence limits for the data are shoivn for female subjects 
(Group Iv) by an interrupted line, and for the male subjects 
(Group III) by a continuous line# The mean values taken from 
the line of best fit show a rapid rise in the S#A„E# from just 
above 20 at the age of 5 to the age of 20 for both the male 
and female subjects# The value for the female subjects starts 
just below the value for the males, rises above the value of 
the male subjects by the age of 10 and remains above until the 
age of 48 years# Thereafter there is a more rapid fall in the 
values for female subjects taking them below the value for male 
subjects reaching a value of 23 at 75 years# The highest mean 
value for the female subjects is 36#34 which is reached at 
34 years of age# The male subjects reach a peak mean value 
of 35#4 at 36 years of age# Thereafter there is a much slower 
fall in the male subjects to a value of 29 at 75 years*
The value A , which is a measure of the density 
of the cortical bone, has been measured in both Groups III 
and IVo Initially, the data was analysed in 5 year age 
groups and the mean and two range is shown in Figs#
13f 14 and 15o In the female subjects, the density rises 
from a mean value of 4*4 between 5 and 9 years to reach a 
peak of between 30 and 34 years, and falls slowly 
thereafter (Fig# 13)o The relation to the menopause has 
been tested but no significant fall in density was found to 
be associated with it (Fig# 14)* In the male subjects, the 
mean density is 4*8 between 5 and 9 years (Fig# 15) rising 
rapidly to a value of 5<»6 between 25 and 30 years and then 
rising slowly to a value of 5o8 between 70 and 74 years#
The differences between male and female subjects has been 
tested for significance using the Student®t^ test, but no 
difference was found between the sexes except between 70 and 
74 years when the difference reached significance at the 5 
percent level, the female subjects having a lower density at 
this age( *îib]e iv).
A third order polynomial was again fitted to the 
data and the results are illustrated in Fig 16, The mean 
and 95^ Confidence limits are shown for the data, the results 
for the male and female subjects being superimposed so that 
they can be compared# The female subjects have a X  of 
4o49 at 5 years rising rapidly to 5«>8 at 25 years and then 
more slowly to a maximum value of 5*84 between 37 and 42 years, 
and falling slowly to a value of 5*65 at 75 years* The male 
subjects (Group IV) showed a rapid rise from 4*76 at 5 years 
to a value of 5«40 at 25 years and then a continuing slow but 
steady rise to 5*93 at 75 years* Both the male and female 
subjects showed a further small rise in density after the age 
of 75 years, but the significance of this is questionable, as 
the numbers were small* The value of X, for the female 
subjects rises above that for the male subjects at 13 years 
( A = 5*13) and falls below the value for the male subjects 
at the age of 6l years ( A  = 5*68)*
The total cortical mineral (T*C,M*) and the standardised 
total cortical mineral (S*TflC*M,) also vary with age* The 
results between 30 and 75 years of age are illustrated in 
Figs 17 and 18* The values are those obtained in the normal 
females (Group III) and in the male subjects (Group IV)«
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The T*CoM* rises from £xii initial value of 0*5 in female and 
0o75 in male subjects at the age of 5 years to 2*4 at 40 years 
in the female subjects and to a value of 2*9 again at 40 years 
in the male subjects* Since the ToCoM* is a measui’e of the 
total cortical mineral per unit length, and as the male 
subjects are on average larger than the female subjects, 
they would be expected to have a larger amount of mineral 
than the females# After reaching a peak, the T*C*M$ shows 
a small decrease in the male subjects up to the age of 75 years
of 4^L The female subjects show a steady fall in ToC^M*
after the age of 40, the fall being 25/^  between 40 and 70 years* 
The data is analysed in terms of a third order polynomial 
and the results for both the male and female subjects between
30 and 75 years are shown in Fig 17» The mean values at
one yearly increments are also shoxra*
The standardised total cortical mineral has been 
analysed in exactly the same way and the results are illustrated 
in Fig 18* These show the change in the standardised total 
cortical mineral with age in the normal female and male 
subjects *
The third order polynomial fit for both the male and female 
subjects is shown in Fig 18* Both methods of analyses, i*e# 
taking the mean value at yearly intervals, and analysis by 
third order polynomial, show good agreement. The S,T*C,M, 
reaches a peak value of 3<j8 between 30 and 35 years in the 
female subjects, and 3^6 between 35 and 40 years in the males*
The males then fall to a value of 3«3 between 70 and 75 years, 
the fall tending to flatten off at 70 years# The females 
show a much greater fall to a value of 2*8 at 75 years and 
have a higher SeT*C*M* than the males until the age of 50 years* 
The difference reaches statistical significance at the 5 percent 
level between the age of 60 and 65 years, the significance of 
the difference increasing thereafter*
Changes in external diameter, medullary width and cortical 
area with age
This has been considered in the two largest groups, 1,6* 
Groups III and IV, These consist of the 317 normal female 
and 312 normal male subjects* There is a steep rise in the 
external diameter from 5©9 at 5 years of age to 7o80 ram at 
30 years in the female subjects# In the male subjects this rise 
is from 6#1 at 5 years to 8*95 mm at 30 years. The changes 
between 30 and 80 years are illustrated in Fig 19o
45
In the female subjects there is a small continuing 
rise between 30 and 50 years from 7*80 to 8*15 mm and a 
small fall back to 8*05 imii at the age of 75 years* These 
changes are not significant* In the male subjects, there 
is a slow but steady rise from 8#95 at 30 years to 
9#2 mm at 75 years, an increase of 1*6^ which again does 
not achieve significance*
In both the female and the male subjects, the 
medullary width increases sharply between 5 and 30 years
from 2*5 iiini to 3o3 mm in the females and 2*6 mm to 3o4 mm
in the males* In the female subjects, the width
increases from 3^3 î>mi to 4*9 nm (53*9^J between 30 and
75 years* In the male subjects this rise is from 3^4 mm 
to 4*8 mm (32*7^)# These changes are highly significant 
(P < 0*OOl)o The changes in medullary width between 30 
and 80 years for both male and female subjects are illustrated 
in Fig 20* These changes in external and internal 
diameter have a significant effect on the cortical area*
4.6.
It is the combination of these changes in cortical area and 
density (.X) ^bich account for the characteristic distribution 
of ToC«Mo and SoTpGoM* shown in Figs 17 and 18# These changes 
also affect the Aluminium Equivalent (A#Eo) and the Standardised 
Aluminium Equivalent (S*A*Eo) to cause the changes between 
30 and 80 years illustrated in Figs 21 and 22#
Mineral content and social class
There is a preponderance of social class 3 in all four 
groupso This is most evident in Group I in which the percentage 
of patients in social class 3 is greater than that of the 
population as a whole^ The number of patients in social class 3 
in Groups II, III and IV are slightly below these in the general 
population*
Since differences in social class may result in 
differences in nutrition which might in turn affect the bone 
mineral content, this has been tested* In Table V, the 
S#A»Ee (whole bone density) in the male and female subjects 
of social classes 1 and 2 have been compared in each sex in 
10 year age groups with social classes 4 and 5^
No differences have been found, except
in one group of male subjects between 60 and 69 years of 
age in whom the subjects from social classes 4 and 5 were 
seen to have a significantly lower S#AoE# than those 
individuals in social classes 1 and 2 (P < 0*01)#
Discussion
The definition of disease is only possible if the 
limits of normality have first been defined* However, there 
are many definitions of normal, and where changes occur over 
many years in the general population and in the patients with 
disease, it is inevitable that the ^normal* will merge 
gradually into the abnormal* In this study, the normal 
subjects are defined as male and female subjects who were 
approached while visiting patients in the wards of the Western 
Infirmary, Glasgow* The scope of each survey was fully 
explained to them and they agreed to take part* In this way 
it was hoped to secure a cross-section of the population in 
Glasgow* This does, however, set limits on the population 
selected*
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Firstly, it would be expected that the population 
selected would reflect only the population served hy the 
hospital and, therefore, need not reflect the population 
as a whole* In the first survey, which was more detailed 
than the others, including as it did a medical history, 
dietary history, absorption test, urinary calcium measure­
ments, and X-ray measurements of hand, femur and spine, the 
numbers had to be more restricted than for the other surveys 
which involved only the completion of a questionnaire and 
an X-ray of the hand# In fact some evidence of 
selection is evident from the fact that there was a 
preponderance of subjects belonging to social class 3 in 
Group I (skilled occupations)* In the second survey, Groups II, 
III and W, carried out two years later, the percentage of 
subjects in each of the social classes closely represented 
those defined by the Registrar Générales Classification 
of Occupations for the countrj^ '# The distribution of
occupations within the social classes in Group I 
is very similar to that found in a group of hospital 
patients being investigated for osteoporosis, and the change
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in the normal Groups II, III and IV may reflect some movement 
of the population# There are certain other resemblances 
between the normal and abnormal populations studied and 
this is discussed later (p# 193)« The other sources of 
differences in the selection of normal and ®abnormal'^  
population might arise from the fact that the older and 
less fit relatives and friends might not be able to visit 
the hospital, and by a refusal of the less fit to volunteer 
for examination* However, comparisons between the normal 
and '^abnormal ^ population discussed later (p# 193) again 
suggest that the random selection of volunteers is fairly 
representative of the population as a whole, and the 
comparison between patients-and noraial subjects is valid* 
Comparison of the medical histories shows that a 
very similar proportion of the subjects in Group I complained 
of urinary tract symptoms (32^) compared with those subjects 
in Group III (30*3^)o There was a significantly higher 
incidence of backache in subjects in Group I (32^) compared 
with those in Group III (l6^)* In neither group was there 
any relation between the incidence of backache and any of 
the X-ray measurements of bone mineral content#
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This merely indicates that there are a great many causes 
of backache in women, and that osteoporosis may be only 
one of them* The principal site of the backache was the 
lumbar spine in both groups#
In the male subjects (Groups II, IV) the incidence 
of backache was 12*8 and 10*1^, and the incidence of urinary 
symptoms was 23 and 22*5^ which was very much lower than in 
the female subjects* Again no relationship was found 
between the incidence of backache or urinary symptoms and 
the X*-ray measurements*
In Group I, there is a fall in all the X-ray measure*-» 
ment8 with age, the fall being greatest in the Relative 
Vertebral Density (E^V^D*) followed by a smaller fall in 
the Metacarpal Index (Me»!#)* There is a much smaller fall 
in the Femoral Index (F*Io) and the smallest fall of all 
occurs in the Spinal Index (S*I*) which indicates the degree 
of spinal biconcavity* In Group II, though there is a fall 
in the M*I*, F*I,, and RoVeD,, only the fall in the F*!# 
reaches statistical significance#
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In Group III (Females) and Group IV (Males), the aimount 
of mineral in the 3rd metacarpal of the right hand has 
been measured in four ways# First, the Standardised 
Aluminium Equivalent (S*A#E#) measures the density of the 
whole bone* Second, is X  , which is a measure of the 
cortical density (see Appendix l)# Third, the 
which is a measure of the total calcium per unit length of 
metacarpal# Fourth, the S*ToC*M* which is a measure of 
the T*C@Mo divided by the width of the bone to allow for 
differences in size between individuals*
There is a rapid rise in the whole bone density with 
age in both male and female subjects over the first 20 years 
and then reaching a peak at 34 years in the female and 
36 years in the male# Thereafter there is a slow, steady 
fall in the whole bone density of the metacarpal in the male 
subjects up to the age of 75 years# The female subjects 
show a decline very similar to that of the males until the 
age of 50 years when a rapid decline in the whole bone density 
occurs* The mean SoAcE# for the female subjects remains 
slightly above that for the males up to the age of 49 years*
A fall in the cortical width with age has, of 
course, been reported by other workers# Meema and Meeina 
(1963) reported 0, fall in the width of . the humeral cortex 
in both male and female subjects, the fall starting earlier 
and occurring more rapidly in the female subjects* Similar 
results were obtained by Fujita, Orimo and Yoshikawa (1966) 
in measurements of the metacarpal* Morgan, Spiers, Pulvertaft 
and Fourman (1967) reported changes in the metacarpal 
cortical width with age in men and women* They preferred 
this measurement as they were unable to show a relationship 
between the marrow cavity and the total diameter.
They also employed a densitometry technique but found 
it did not give any better results than the simj^ le measurement 
of cortical width» However, the technique used by them has 
two sources of error which may have led to a loss of precision# 
Firstly, no allowances were made for the *heel* effect and 
secondly, scatter from the water bath and the bone due to the 
positioning of the step-wedge would not be uniform over the 
aluminium step-wedge. This would lead to an unpredictable 
variation in the X-ray density of the wedge*
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We have found greater reproducibility in our 
densitometric technique than in the simple measurement of 
cortical width (Anderson et al, I966 - Appendix I )#
Furthermore, as women generally are smaller than 
men and therefore have smaller bones, a direct comparison 
can only be made between them if allowance is made for size*
This is most usefully done by dividing by the width of the 
bone or some derivative of this*
Morgan et al (1967) made an estimate of the relation 
of the calcium content of the metacarpal with age from the 
X-ray measurements, i,e# a measure of density of the cortex*
It is interesting to note that these results resemble those 
presented here* They found no statistical difference between 
the male and female subjects over the age range studied, 
though the cortical density of the metacarpal in the female 
•subjects was slightly higher than in the males* The mean density 
of the cortex showed a continuing rise with age except within 
the 7th decade* The female subjects showed a rise until the 
5th decade and then fell gradually# Dollerup (1964) measured 
the mineral content in samples of bone taken from the iliac
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crest at post-mortem examination* He found a rapid rise in 
mineral content up to 20 to 30 years of age# There was a 
peak at 40 years, but if this is ignored, there was a slow 
hut steady rise with age in subjects up to and over 90 years 
of age*
The change in density with age is surprising* The 
female subjects do show a slow fall after the age of 50 years 
but this is slight* In the male subjects, the rise continues 
throughout life# A rise in bone mineral density up to the 
age of 20 years would be expected# Young subjects have a 
higher proportion of young bone with a higher water content 
and lower mineral content than mature bone* The density of 
bone as a tissue will also be affected by the porosity and the 
degree of mineralisation# dowsey (l963a) reported an 
increased intracortical porosity in the femur with age which 
would tend to cause a fall in density# Epker, Kelin and 
Frost (1965) found very little chcuige in the porosity of the 
human rib with age# Change in porosity in the metacarpal 
with age has not yet been reported# Jowsey (1963b) reported 
an increasing incidence of plugged and filled lacunae with age*
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The plugged lacunae were hypermineralised when compared 
with surrounding bene, the density being 1*63 gm/cc 
compared with 1#44 gm/cc in normal bone as shown by 
Howlandj) Jowsey and Marshall (l958) using a quantitative 
microradiographic technique# This suggests one possible 
mechanism which may cause an increase in density with age 
though this is insufficient to do so on its own#
Changes in the total cortical mineral (T#CoM») 
with age show a different pattern from the SoAoEo*
In the male subject there is no significant change after 
the age of 30 years# In the female subject, there is a small 
change between the age of 30 and 45 years, but a significant 
continuing fall is seen thereafter# The changes with age 
of the S„T#CpMo in the male and female subjects are similar 
to those seen in the but the male to female rate
of change is different# The differences in the patterns of 
distribution with age are important because this is of 
considerable significance in the quantitative definition 
of osteoporosis and the part it plays in increasing the 
incidence of fractures in the elderly#
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These parameters measure different things and account 
for the apparent discrepancies in the literature, 
where hone loss is described as starting at ages 
ranging from 20 to 50 years (Epker et al, 1965;
Takahashi and Frost? 1966; Nordin et al, 1966)# It 
is therefore very important to be absolutely clear as 
to what is measured by each of the four measurements*
The S#A®E# is a measure of the whole bone density 
per unit volume, 1*0  ^ it is a measure of the density 
of the metacarpal per unit volume enclosed by the 
periosteal surface and the marrow cavity is, therefore, 
included in this volume measurement* A  is a measure 
of the mineral of the cortex per unit volume* The 
T*C*Me is the total mineral in the cortex per unit 
length of the bone& Finally, the S^ToCoH# measures the 
total cortical mineral per unit length divided by the width 
of the bone* The 8#A@E» and S#T*C«M# allow for the 
differences in size between individuals so that they may 
be directly compared* This is necessary as it is obvious
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that a lean 15 stone man will have much larger hones and 
therefore more mineral per unit length than an individual 
weighing 8 stones, even if neither is osteoporotic »
Since all parameters fall with age, it is apparent that 
the simple qualitative definition of osteoporosis so far 
applied hy many workers in this field is totally inadequate* 
This problem is examined further in the next two chapters#
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CHAPTER II
BONE MÏNER.IL CïïMGES IN NORMAL AND PATHOLOGICAL STATES
The normal population has been defined in Chapter I as 
being the relatives and friends of patients in the general medical 
wards who volunteered to have X-ray measurements of bone carried 
out^ The reasons for accepting these subjects as a representative 
sample of the population served by the Western Infirmary? Glasgow? 
have been discussed*
In the following study bone density measurements in patients 
referred to a special clinic because they were judged to be 
osteoporoticj and patients with various metabolic bone diseases, 
are related to the normal values previously obtained# Though 
studies of bone density have been made in various conditions, the 
absence of an adequate quantitative definition of loss of bone 
mass in relation to the normal population has made assessment of 
various pathological states difficult# The present Chapter and 
the following Chapter are therefore concerned with the investigation 
and definition of normal and pathological bone density*
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Bone mineral content in disease
The bone mineral content of the 3rd metacarpal of 
the right hand has been measured by the technique described 
in Appendix I (Anderson et al, 19b6) in patients with conditions 
affecting calcium metabolism* The whole bone density (S#A*Eo) 
and comical density ( A  ) have been determined and are compared 
with the values obtained in the 317 female (Group III) and 312 male 
(Group IV) volunteers* In each one of the patients, the 
questionnaire described in Appendix III was completed#
Subjects studied
The patients investigated were referred to a, special 
Bone clinic or formed part of a special survey# The diagnostic 
groups were patients referred because they were thought to have 
osteoporosis, or were known to have fractures of the femoral neck; 
patients who had undergone gastric surgery for peptic ulcer, and 
patients suffering from steatorrhoea, osteomalacia and primary 
hyperparathyroidism# The number of patients in each diagnostic 
group is shoivn in Tables VI,. VII, VIII and DC*
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Diagnostic criteria
The definition of normality has been discussed 
earlier© That is the normal subjects were volunteers in 
Groups III and IV*
The ^osteoporotic* subjects were referred to a 
special Bone clinic because they were thought to have 
osteoporosis by the referring physician or surgeon on 
inspection of X—rays of their spines and/or peripheral 
bones#, Each patient had a serum calcium, phosphorus and 
alkaline phosphatase measured and the urinary calcium was 
assessed on at least two separate occasions a.s a 
calciums creatinine ratio (Nordin and Smith, 1965)# Any 
history of endocrine disease, gastric surgery or renal stone 
or diarrhoea led to their exclusion from this group* The 
patients who had had fractures of the femoral neck or 
intertrochanteric fractures had also undergone measurements 
of their serum calcium and phosphorus, and urinary calcium, 
and had a questionnaire completed# Abnormal findings again 
led to their exclusion from this group*
62
The patients who had undergone gastric surgery 
for peptic ulceration were part of a group who were 
investigated in greater detail and are discussed later 
(chapter VIIl)a They were patients who had undergone 
either a polya-gastrectomy or gastroenterostomy with vagotomy 
8 to 12 years before#
The patients with steatorrhoea had more than 5 gm 
of fat per day in their stools* Eighteen of the 29 patients 
had had jejunal biopsies done and were found to have 
villous atrophy# iUiy patients with evidence of osteomalacia 
as defined by a low serum calcium, low serum phosphorus, 
raised alkaline phosphatase, low urinary calcium or raised 
Phosphate Excretion Index were excluded from this group#
Patients with osteomalacia formed a more heterogenous 
group and consisted of patients who, with and without 
steatorrhoea, had undergone gastric surgery for peptic 
ulceration, osteomalacia secondary to idiopathic steatorrhoea 
and patients who had no evidence of associated pathology, but 
in whom the dietary intake of vitamin D was low* The 
definition of osteomalacia rested on the presence of frank 
osteoid borders on bone biopsy# In addition there was 
evidence of biochemical osteomalacia (Nordin and Smith? 1965)<
6:5
The patients with primary hyperparathyroidism all 
had raised serum calcium, Phosphate Excretion Indices, and 
the presence of a parathyroid tuüî.our confirmed at operation#
Results
Since marked changes in bone mineral content and 
density occur with age, it is necessary to allow for this in 
any assessment of pathological bone loss# In order to do 
this? a third order polynomial was fitted to the normal data 
to give a series of lines of best fit to derive the cumulative 
percentile lines# The 5; 10? 20, 30 and 50 percentile lines are seer 
in Pigs 23 and 24 for the normal female subjects, and in 
Figs 25 and 26 for the normal male subjects# Tables have 
also been compiled so that the precise percentile S*A#E# or 
values for any patient can be determined# A sample of this 
Table is illustrated in Appendix IV#
Using these values, patients with reported disorders 
of calcium metabolism are considered in Tables VI to IX©
All the Tables are arranged so that the pathological condition 
identified in the first column, the number of patients in the 
group in the second column, and the percentile values at the top 
of the Tables# The cumulative number of patients below each 
percentile value is shown in the remaining columns#
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1* Comparison of the in normal and pathological states
Of the 169 female patients referred to the Bone clinic, 
58^ were below and 42^ above the 50 percentile level (Table Vl)# 
They did not differ significantly from the normal popnlationo 
The male subjects suspected of having osteoporosis showed a 
very different distribution (Table VII) ? 83fo of the 26 patients 
being below the 50 percentile level#
Of the 69 female patients with fractures of the neck 
of femur, though 33o4j^  were below the 20 percentile, 43o8^ 
were above the 50 percentile (Table Vl)# Of the male subjects? 
50^ were below the 20 percentile level and 34#5^ above the 
50 percentile (Table VIl)#
Eighteen female and 11 male patients who were found 
to be suffering from steatorrhoea were assessed in the same way# 
83*5^ of the females and 73^ of the males were found to lie 
below the 50 percentile level (Tables VI and VIl)#
Of 86 male patients who had had gastric surgery for 
peptic ulcer? 74^ were found to have an SoAoE# below the 
50 percentile level# Only 3 female patients had had gastric 
surgery, but they were all below the 20 percentile level 
(Tables VI and VIl)o
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Of 8 female and 5 male patients with osteomalacia^
62*5^ of the females were below the 40 percentile level? 
and all three male subjects were below the 20 percentile 
level (Tables VI and VIl).
Of 6 female and 4 male subjects with primary 
hyperparathyroidism? a third were above the 50 percentile 
level (Tables VI and VIl)^
Of 6 female patients with hypoparathyroidism, 4 
were below the 50 percentile level (Table VI )
Comparison of A  in normal and pathological groups
The density measurements in these groups in terms 
of their distribution in the different percentile levels 
are shown in Tables VIII and IX^
None of the groups with suspected osteoporosis? 
fractured neck of femur and gastrectomy? or the female 
patients with hypoparathyroidism differ significantly from 
the normal population* Surprisingly? two-thirds of the male 
patients with steatorrhoea have better than average densities* 
This is quite different from the distribution in the 18 female 
patients with steatorrhoea of whom are below the mean for 
their agc^ With regard to the patients with osteomalacia?
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all three male subjects and 87*6^ of the female subjects 
are below the 30 percentile level* Two-thirds of the 
patients (both male and female) with hyperparathyroidism 
are below the 50 percentile level*
The relation between the mineral in the metacarpal and the spine 
The relation between the measurements on the spine 
and the are considered in Figs 27 and 28* In Fig 2?
the percentile levels of the SpAoE* have been plotted against 
the Spinal Index in 136 female patients referred to a Bone 
clinic because they were suspected of having osteoporosis^
As can be seen, though the spine score of those subjects who 
are below the 5 percentile level have a slightly lower mineral 
content than those above this, there are a number of patients 
with very low spine scores who lie above the 40 and 50 percentile 
levels* In Fig 28 the spine score is plotted against the 
actual SçAoE,* If an arbitary line is drawn at a spine score 
of 80, below which there is definite biconcavity, and an SpAoE* 
of 28, which is the 5 percentile between 30 and. 40 years, it 
is found that 46^ of the patients below and S*A„Eo of 28 have 
low spine scores, and 25^ of those above this value have low 
spine scores*
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In Fig 29> the ash weight per cc of the spine has 
been plotted against ash weight per cc of the metacarpal 
in 16 unselected patients at post-mortem exaiaination* The 
values are related (r =0*64; P < 0*005)«
Conclusions
No firm conclusions can yet be drawn about some of the 
diagnostic groups as the numbers are too small* However ? 
of the 11 male and female patients with osteomalacia? nearly 
all have density values ( X, ) below the 50 percentile*
This would be expected, as patients with osteomalacia have 
osteoid borders which contain virtually no mineral* Of the 
29 patients suffering from steatorrhoea, three quarters of them 
have a 8*A.Fo below the 50 percentile level and 85^ of the 
female subjects have a 1 ow density value* However, tw^ o thirds 
of the 11 male subjects have a density value above the 50 
percentile* This may be related to the duration of the disease, 
6 out of 8 of the female subjects having suffered from idiopathic 
steatorrhoea while 7 of the 11 male patients had had gastrec­
tomies less than 10 years before and the steatorrhoea would be 
of more recent origin* In fact, this suggestion is borne 
out by the fact that all 4 of the male patients with idiopathic 
steatorrhoea were below the 50 percentile level.
68
The low cortical density values obtained in steatorrhoea 
might be duo to early osteomalacia and associated secondary 
hyperparathyroidism* Alternatively, the greater severity 
of the osteoporosis may have resulted in an increase in the 
porosity of the bone which would also lead to a low density*
The patients with primary hyperparathyroidism also tend to 
have a lower than average and cortical density than
the normal population* This is compatible with increased bone 
turnover resulting in a higher percentage of new bone and 
increased bone porosity* The patients who had undergone 
gastric surgery show a lower than average whole bone density,
73^ of the 89 patients being below the 50 percentile, but 
their cortical density was not significantly different from 
the normal subjects^ 54«4fi being below and 45*6^ above the 50 
percentile level* This contrasts with the results obtained 
in the patients with steatorrhoea and osteomalacia, and suggests 
that these patients are developing osteoporosis rather than 
osteomalacia* The patients who have undergone gastric surgery 
are considered in more detail on p* 222* The 6 female subjects 
with hypoparathyroidism did not differ significantly from the 
normals in either S*A*E* or X  «
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The female subjects who had suffered from 
fractures of the neck of femur do not differ significantly 
from the normal population in either whole bone density or 
cortical density^ The male subjects show a normal 
cortical density but the whole bone density is reduced in 
65^ of the subjects being below the 50 percentile level*
Some caution must be observed as the numbers are relatively 
small but if this difference between the male and female 
subjects is genuine then it must be explained* There are 
several possible explanations: first, that these differences
may be explicable by change in the nature of the bone leading 
to greater susceptibility to fractures in the female subjects: 
second; that the difference arises from the nature and 
frequency of the injuries sustained which would require the 
injuries to be more severe and more frequent in female subjects: 
third; that fractures occur when a certain proportion of bone 
loss has occurred, and therefore female subjects who lose a 
substantial amount of bone will become liable to fracture, 
whereas only a small proportion of male subjects who fall 
below this critical value become fracture proneo This is
examined further in Chapter III*
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The most difficult group to define are the patients 
with ®osteoporosis * 0 The female subjects who were referred 
for investigation because they were thought to have osteoporosis 
did not in fact differ from the normal population. This is 
in contrast to the 26 male subjects referred for investigation? 
of vdiom 83/p were below the 30 percentile level* These 
differences are certainly due to the way in which the patients 
were referred to the clinic^ The majority of the patients 
were referred to the clinic because they had attended with a 
history of back pain or because they had recently had a fracture 
and on X-ray examination wore thought to have *thin* bones*
This assessment is made on an ideal bone thickness judged on 
the appearance of bones in the young by the referring physician 
or surgeon or experienced radiologist* It is evident from the 
inspection of the normal data (Fig 12) that there is a marked 
fall in the whole bone density of the metacarpal in the noimial 
female subjects, but a lesser fall in the normal male subjects* 
It would be expected therefore that a greater number of male, 
patients who were judged to have thin bones would be below the 
50 percentile simply because normal male subjects show only a
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small fall in mineral content with age* The normal female 
subjects; however? show a marked fall with age? and thin 
bones? judged on the criterion of bone mineral content in 
the young patient? will fall within the normal range when 
age is taken into consideration* However? this merely begs 
the question as it leaves us no nearer a definition of 
osteoporosis* The generally accepted definition of this 
disease (Poinmer? 1885; Albright? Burnett? Cope and Parsons? 
1941a) is that the amount of bone present per unit anatomical 
volume is decreased? though the bone that is present is 
normal both histologically and biochemicallyo That is? 
there is thinning of trabeculae? thinning of rhe cortex and 
the appearance of increased porosity? but the calcium:nitrogen 
ratio is normal* That the bone mineral content of osteoporotic 
bone might be slightly reduced has been suggested by Jowsey 
and Gershon-Cohen (1964)? but further evidence is lacking*
Even if there is a small mineral deficiency of 5S^ ? this does 
not alter the essential problem of definition which is that 
osteoporosis is simply the result of a decrease in the amount 
of bone present*
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A decrease from a particular level is implicit in this 
statementhut no attempt has been made to define this 
level from which the bone mineral content must be reduced 
for the patient to be considered osteoporotic*
Since the bone mineral content varies throughout 
life; one possible definition could be to term all subjects 
who have a mineral content of less than the 5 percentile 
for their age group as being osteoporotic* However? two
important weaknesses emerge* First? it would be possible 
for a subject who was initially at the 95 percentile to fall 
to the 10 percentile level? and though this individual will 
have lost a substantial amount of bone? he will still? by 
definition? not have osteoporosis^ Nor is it possible to 
Itnow if a measurement is made at a single point in time? 
if the patient who is at present at the 10 percentile was 
not always at the 10 percentile or whether he has come down 
from the 90 to the 10 percentile over a period of some years* 
Second? this definition takes no account of the fact that 
for the patient to have a definition of osteoporosis? this, 
must imply that some risk is attached to the level of bone 
mineral content* For instance, it might imply that the
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patient is at risk from the point of view of more easily- 
developing a fracture from relatively minor tramia^ ,
From inspection of Fig,2? , it is evident that 
a number of patients with completely normal mineral content 
for their age have a significant degree of biconcavity of 
the vertebral bodies which means that there has been 
crushing of the spine and could reasonably be considered 
to have osteoporosis* This suggests three possibilities* 
First? that the S*A*Fo is not a good measure of the mineral 
content of the spine* In fact the post-mortem studies show 
a good relation between the density (ash per cc) of the spine 
and the density of the metacarpal (r = 0*6* P < 0*01)»
Second; that there is a change in the character of the bone 
which is more liable to fracture even though the mineral 
content is relatively normal* This is implied in the electron 
microscopic studies of Little? Kelly and Courts (1962), but 
there is little other evidence to support this* In fact* 
Weaver and Chalmers (1966) have tested the resistance of the 
spine to a crushing force and found a good direct relation 
between the force necessary to deform the spine and the
Ik
minerai content (r = 0(j827)© Tliii'd? if the tendency to 
fracture is directly related to the mineral content of the 
spine as implied by the studies of Weaver and Chalmers (1966)? 
then it would be expected that there would be an increased 
incidence of crush fractures of the spine and peripheral bones 
as the mineral content of the bone falls. It is evident 
that the quantitative definition of osteoporosis is a difficult 
one which must be considered in relation to the incidence of 
fracture^ This is examined in detail in the next Chapter*
In Figo 28, it can be seen that the 136 female patients 
referred to the Bone clinic because they were suspected of 
having osteoporosis show an increase in the incidence of 
biconcavity of the vertebral bodies with decreased mineral 
content of the metacarpal© In this Fig* the Spinal Index 
of B0| shown by the horizontal line? indicates a significant 
biconcavity* Biconcavity•implies crushing and fracture of 
the trabeculae of the vertebral body© Since the force with 
which crushing of the spine occurs decreases with decreasing 
mineral content of the spine and the mineral content of the 
spine is related to the metacarpal mineral content? then ideally 
it should be possible to define the possibility of a patient
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developing a crush fracture from a knowledge of his 
SpAoEôo However? biconcavity being a fracture must 
to some extent depend upon the strength of the force 
applied at any particular time? and a very large number 
of subjects would have to be X-rayed to achieve this 
predictability* Nevertheless? a useful clinical 
definition of osteoporosis is possible* From inspection 
of Fig* 2 6? it can be seen that if an value of 28
is taken as shown by the vertical line, there is a very 
great increase in the incidence and severity of biconcavity 
below this value? k6fo of the patients having significant 
biconcavity* The value 28 is the 5 percentile value 
for normal women between the ages of 30 and 40 years 
when the mineral content of the bone is at its peak*
In the male subjects? the 5 percentile level between the 
ages of 30 and 40 years when the mineral content of the 
bone is a value of 27* This définition does serve a 
useful clinical purpose* First? it is possible to 
determine the rising incidence of osteoporosis with ageing. 
This in fact gives a much higher incidence of osteporosis 
than has previously been described (Collins? 1959; Beck
/o
and Nordin, I96O)© If these values are used to define 
the lower limit of normal ? then 68*6^ of uhe female patients 
referred to the Bone clinic and 40^ a of the male subjects 
are below this value© Of the female subjects with 
fractures of the femoral neck? 84*2^ had an S^AcE* of less 
than 2 8 Alffram (l964) showed a sharp rise in the 
incidence of fracture of the femur above the age of 60 years 
at which age 40^ of the normal population have an S^AoE* below 
28* Fractures of the lower end of the radius also increase 
rapidly between the ages of 50 and 60 years of age (Allfram 
and Bauer? I962)* In the normal population? the number of 
women who have an 8*AoE* below 28 rises from 15J^ to 40^ of 
the subjects at these ages*
The normal male subjects show a much smaller fall 
in bone mass with age? and only 11^ of the 26 patients referred 
have an S*A©E* value of less than 27© Of these 26 patients# 
nine had crush fractures and 6 of these patients had an 
S,A*Eo below 2?*
Of the patients with fracture of the neck of the femur g
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only kkfo had an Sc,A*E* of less than 27o However? from 
inspection of Table VII^ it can be seen that there is a 
bimodal distribution in the percentile level of their bone 
mineral content* This would be expected if the male 
patients were dra^ vn from two groups, one a younger age 
group with normal bones and the other a group of patients 
with minor trauma resulting in fracture because of 
osteoporosis*
It would appear therefore that the risk of fracture 
or development of spinal biconcavity and crush fracture of 
the spine is related to the mineral content of the bone*
A useful working definition of osteoporosis is that women 
with an 8«A«Eo value of less than 28, and men with a value 
of less than 2? are substantially at risk in the development 
of fractures? and should be considered to have osteoporosis* 
The assessment of the effect of pathological conditions on 
bone mineral content is best considered in such a way as to 
allow for the fall in mineral content which occurs with age
/o
in the normal population* This is best done by 
determining the percentile level which allows for the 
changes with age. The relation between bone density 
and fracture is examined further in the following 
Chapter*
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CHâPTER III
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THE INCIDENCE OF MIACTOBE AND ITS DELATION TO BONE 
MINEllAL LOSS IN RLVLE AND FmtVïE SUBJECTS
Several attempts have been made to relate mineral 
loss in bone to the incidence of fracture* Newton-Jolin 
and Morgan (1968) compared the rate of loss of bone with 
age in women derived from a study of thirty publications, 
with the incidence of fracture of the neck of femur and the 
lower end of radius? and were able to demonstrate a good 
relation between the two*
Hov/ever? it is evident that there are a number of 
fractures at a variety of sites which do not fit the pattern 
described* Such fractures include the phalanges? metacarpals 
and the upper end of radius* Another important feature to 
which little attention has been given is the rate of bone 
loss which is much greater in females than in males and 
obviously should be related to the incidence of fracture in 
the sexes* Further? the rate of change in bone mineral is a 
fiuiction of the measurement used (Chap, I)© This is 
associated in part with the changes in external diameter of
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the bone to which attention has been drawn by Trotter#
BroHian and Peterson (1960); Sedlin, Villanueva and Frost
(1963); Smith and Walker (1964); Epker and Frost (1966);
Takahashi and Frost (I966); Garn, Rolaraann, Wagner and
Ascoli (1967)0 It is evident therefore that a more
detailed study of the incidence of a variety of fractures
in relation to bone mineral content is called for.
Methods and materials 
subjects studied
The rates of change in bone mineral content were 
studied in the volunteers (Groups III and IV) described in 
Chapters I and II® They consisted of 31? female and 312 
male subjects*
The incidence of fracture at different sites, in 
relation to age and sex was obtained from a survey carried 
out by Knowlden# Buhr and Dunbar (1964)* In that study? 
the incidence of fracture in relation to age and sex is 
described in 6,500 subjects admitted to hospitals in the 
Oxford and Dundee areas between 1954 and 1958* The incidence- 
of fracture was calculated using the census publication of
1961 for the two cities, Kiiovrlclen et al (1964) 
chose Oxford and Dundee for their study because the 
services dealing with fractures were within the well 
defined city areas and were centralised® This allowed 
an accurate assessment to be made of the incidence of 
fracture by site, the relation between the typo of 
accident, and the variation with sex and age*
Bone mineral changes
The changes in bone mineral content with age 
have been discussed in Chapter The rates of change
have been calculated from the data on , SoA*E,,
T©G*Moj and S*TbG*M* (Chapters I and II)* The 
densitometric method used is described in Appendix I. . 
Eesults
The fall in mineral content for each of the 
parameters against age was obtained by using the percentile 
Confidence limits which were calculated for each of the 
curves* On each of the percentile graphs, a line was 
drawn parallel to the age axis; the height above the axis
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being the maximum value of the 25 percentile curve*
The 25 percentile curve was chosen as the most 
convenient one to use since it fell within the spread 
of values over the whole age range* The value of 
prevalence of decreased mineral content at each age is 
the intercept of the horizontal line on the percentile 
curves (Fig 30)„ Prevalence? therefore? is that 
percentage of the population with values of AoE*, SpAoE©; 
ToCçMo ? and S*ToCoM* which are less than the peak value 
of the 25 percentile0 It is, of course? the rate of 
chance of prevalence and not the absolute values which are 
significant in the present context*
A,s might be expected from an inspection of Figs 17 
to 22, the rates of change show a more rapid rise for 
female subjects than for the males* There is also a
marked variation in the rates of change between male and 
female subjects depending upon the measurement used^
In Table X, the difference between male and female 
bone loss rates are illustrated by taking ratios of the
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slopes of prevalence of AsE* ? S*A*Eo ? , and S«ToCeM^ f
at the age of 50* The prevalence curves are shown in 
Fig 31© Table XI shows the rate of loss of mineral, 
using the different parameters of measurement in the male 
and female subjects between the ages of 35 to 75» The 
figures are shown as a percentage increase in prevalence 
of diminished bone mineral using the maximum value of the 
25 percentile as the starting value* The rate of increase 
in total mineral loss (T«CoM*) is very low in the male 
subjects compared with the A^B* ? S^AoE*? or SoT«CoMoo 
In female subjects? the increase in TeC^M* loss is again 
the lowest of these parameters? but is more than eight times 
higher than it is in the male subjects*
Changes in the external diameter of the 3rd 
metacarpal in relation to age are show in Fig 19 
in the male and female subjects* In the male subjects#
there is a small increase of between the ages of 30 and 
75 years* In the female subjects# there is a slight 
increase from age 30 to 55 years of 1©75/^  which thereafter 
falls slightly to achieve a value Vfù above the starting
value* The changes in medullary width are shown in 
Pig© 20^ The medullary width increases by 33^ for the 
males between 30 and 75 years and by 54^ in the female 
subjects over the same age range* The percentage 
incidence of fracture against age show in Fig* 32 which 
distinguishes between the change in incidence rate for 
industrial accidents leading to fracture, and the changes, 
in incidence of fractures sustained in the home® When 
these are compared with the rate of change of fractures 
at different skeletal sites, certain fractures are found 
to be sufficiently well reproduced from curve to curve to 
allow them to be separated into three groups (Figs* 33 to 39) 
and Table Xïl\ These are:
(a ) A group of fractures (Fig* 33 ) whose 
incidence tends to diminish with age and 
which are very similar to the pattern of 
incidence of industrial accidents shoim 
in Figo 32o
(b ) a  group of fractures at other sites 
(Fig* 34 ) which show an increasing
fracture incidence with age; both males, 
and females being similarly affected*
These resemble the age pattern of 
incidence of fractures occurring in the 
home (Fig* 32 )*
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(c) A third large group in which 
the fracture incidence is 
different from either of the 
above categories (Figs® 35 to 38 
Table XII The fractures
of this group are characterised 
by an increasing breakage rate 
with age for females while the 
males show little change with age 
up to the age of 75 years*
Most fractures show a marked increase in incidence
after the age of 75 years* With a limited number of data points
available for fracture rates at each site there is necessarily
a certain amount of deviation from the curve which represents
a particular group® Ho^ vever# in the majority there is no
difficulty in assigning the fracture incidence at a particular
site to one of the above groups* Fractures of ribs are
exceptional in that they show changes which do not fit into any
of the above patternsfî^Jg 59),
Accidents leading to fractures which occur during
industrial activity fall in prevalence after the age of 60 years
or more? but account for as many as 45^ of the fractures in
males in the age group 46 ^ 55 years* This fall in prevalence
is also evident in women (Fig* 32 )* Fractures due to falls
in the home are more prevalent in women# but show a marked
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increase over the age of 65 years in both male and female 
subjects® Over the age of 85 years# 6?^ of fractures in 
women and 6SJ^  of the fractures in males are associated 
with falls in the home*
In group (a) there are several obvious sites of 
fracture which could be expected to occur in an industrial 
coimnunitya These are the phalanges (hands and feet) 
tarsalsjr metatarsals# carpals and metacarpals (Fig* 33 
Table Xdl )^  These sites are at risk in persons involved 
in manual work and# as might be expected# the incidence 
rate is greater in the male* The fracture incidence rates 
do not adhere strictly to the curve representing the 
incidence of industrial accidents in Fig© 32 partly because 
of the way in which they are plotted* That is? at all of 
the sites fracture incidence rates are plotted as fractions 
of the value of incidence rate at age 40* In this way 
although information on absolute incidence rates is lost# 
it is possible to compare the nature of changes in incidence 
rates with age at all of the sites* However# Group (a) 
sites are typified by a steady fall in incidence rate after 
the age of 60 years in the male subjects* There is a very
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in> h al
small,rise in the fracture incidence with age at theseft
sites for female subjects*
Examination of the fracture incidence of the pelvis 
and spine (Fig. 3A* ) shows that these fractures have an
increasing incidence with age in both male and female 
subjects? very similar to the incidence of fracture in the 
home and these fractures therefore fall into Group (b )* 
Excluded from Group (b ) are any fractures showing a marked 
rise after the age of 75 years in which there is a marked 
difference in fracture incidence between male and female 
subjects over the age range 55 to 75 yearSg These latter 
are included in Group (c)* The main characteristic of this 
group is the increased fracture incidence with age in female 
compared with male subjects* There is a tendency for the 
incidence rate to flatten between 55 and 75 years before 
taking a marked upward trend after 75 years* In male 
subjects there is little change in fracture incidence up to 
the age of 75 years after which there is again a marked 
increase in incidence rate at many of the sites* The
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fractures included in this group are illustrated in 
Figs* 35 to 38 and listed in Table XII* Fractures of 
ribs (Figo 39 ) are different in the age incidence
changes from any of the fractures described above© 
Discussion
It is evident that the pattern of change in bone 
mineral content is very different depending upon the type 
of measurement used® These differences are important 
when considering a quantitative definition of osteoporosis 
and the prediction of the risk of fracture with age*
The various parameters measure different things 
and account for much of the apparent discrepancies in the 
literature where bone loss is variously described at ages 
ranging from 20 years (Spker et al? 1965; Takahashi and 
Frost# 1966) up to 50 years (Nordin? MacGregor and Smith, 
1966; Smith, Anderson? Shimmins? Speirs and Barnett, 1969)© 
It is therefore important to be very clear as to what is 
measured by each of these parameters as discussed on p* 30* 
To summarise, A 9E0 is a measurement of the amount of bone
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mineral in a fine colmm in the middle of the metacarpal 
(Fig# 1 )o The S#AoEo measures whole bone density? 
the TftCoMoj, the total mineral per unit length of bone 
and SoTfCüM*? the fuiioimt of mineral per unit length of 
hone divided by the square of the external diameter to 
allow for the difference in size between individuals*
An examination of the factors involved in the 
calculation of each of the measurements gives the 
explanation of these differences# The total width of 
the metacarpal increases by 1*5^ in the range 30 ™ 75 years? 
but stays almost constant in females? reaching a small 
peak between 50 and 60 years? and falling slightly there­
after* Sorenson? Mazess? Smith? Clark and Cameron (l96s) 
found an increase of 8}» in the width of the mid-shaft 
of the radius over the same age range in males while the 
width of the bone remained almost constant* However?
Meema and Meema (1969) observed no change in radial width 
in either male or female subjects? while Garn et al (1967) 
reported an increase in width of the second metacarpal of
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between 9Jjo and for male and female subjects#
Epker and Frost (1964) reported a continuing expansion 
in the diameter of the human rib between 2 and ?0 years(v 
Medullary widths of the third metacarpal were 
found to increase by 33{^  in males and 'oh^ o in females 
between 30 and 75 years of age in the present study*
There is therefore a redistribution of bone with age with 
loss from the endosteal surface and deposition on the 
periosteal surface in male subjects# In the female 
subjects deposition on the periosteal surface continued 
up to 55 years of age and fell slightly thereafter^
The measurement of the and the 8*A*Ep involves the
absorption of X-rays by bone mineral in one direction only 
(Figo l)* Hence, the narrowing of the cortex results in 
a marked diminution of the and 8*AoE* with age since
redistribution of mineral within the bone is not allowed 
for in these estimations^ The calculation of the ToC*Mo 
on the other hand involves the use of cortical area so 
that redistribution of bone is taken into account* The 
changes in T^CeM* are then attributed to actual changes
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in the amount of mineral present per unit length of bone* 
is calculated by dividing ToCo&L by the square 
of the diameter* Since bone diameters in males were 
found to increase with age? then the marked decrease in 
with age compared with T*CeM# results*
The changes in total cortical mineral described 
in this study show a similar distribution to the mineral 
changes described by Sorenson et al (1968) who used a 
direct scanning absorption technique with a radioisotope as 
a source of radiation# Using this technique the measurement 
derived is essentially the same as the T\CaM* described in 
the present studyg, They found a fall of about Wfo for males 
and 39/^  for females over the age range 35 to 75 years*
In the same age range? the ToC^M^ of the metacarpal in the 
present study? fell by 4^  ^in male subjects and by 26^ 0 in 
the females*
If the incidence of fractures is to be related to 
mineral content, then for a mineral parameter, say X, the 
changes in fracture incidence will be related to the changes 
in the distribution of the values of X in the population#
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That is? changes related to the fraction of the 
population possessing a value of X which is le^s than 
some arbitary fixed value* The value which has been 
used in this study is the maximum value of the 25 
percentile* This fraction? expressed as a percentage? 
is defined as the prevalence of X*
V^hen the fracture incidence in each of the 
groups is compared with the curves of prevalence of 
diminished mineral content (Fig 3l)? it is obvious that 
the fractures at the sites of Groups A and B are not 
related to the mineral prevalence curves* In the
case of Group A, where fracture incidence decreases 
after the age of 50 years in males and females? any 
relation between mineral content tind fracture incidence 
is probably swamped by the magnitude of the fracture 
rate associated with industrial accidents^ Although 
the steady increase in fracture incidence for males 
and females exhibited by sites of Group B (spine aiid 
pelvis) might be due to an increased tendency to fall 
with increasing age? it is not clear why these two
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sites should be different in their fracture prevalence 
from the sites of Group G@
It is at once obvious ? when typical fracture 
incidence curves of Group C are compared with those of 
prevalence of diminished mineral content? that they are 
basically similar? with the incidence of fracture and 
the prevalence of decreased mineral content for females 
increasing with age much more rapidly than for males#
It has in fact been shoim by Newton-dohii and Morgan (1968) 
that cui’ves representing the prevalence of mineral loss 
with age for females can be fitted quite well to fracture 
incidence rate curves for the lower end of radius and the 
neck of femur* It is these two sites at which the largest 
difference between male and female fracture incidence is 
seen* However? since the prevalence of mineral loss 
increases with age in both male and female subjects, it is 
evident that any of these parameters may be separately 
correlated with fracture incidence which also changes with 
age as has been shown for S«A*E# with increasing 
biconcavity of the spine in Chapter II# Therefore? when
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comparing the prevalence of the various mineral loss 
measurements with fracture incidence, it is important 
to take into account the relative behaviour of the 
incidence rates in both male and female subjects^
Where the prevalence of fracture and mineral loss 
correspond for both males and females, then this is 
good evidence of relation between these parameters#
The rate of change of loss of bone mineral 
measured as the tangent to the prevalence curve at the 
age of 50 years show the prevalence rates for males to 
females for ApE# ~ 1*2*53? SoA*Ee - l;2o08.? ToC*M* = lt8#33 
and for S#T*Ct,Mi> - l:3o33* Further? while there is a 
small increase in the prevalence of diminished minerali­
sation for males with age this is largest for A^E# and 
smallest for ToC^M* (Table )* The increasing 
prevalence of mineral loss are shown in Fig* 31 *
These curves are very similar to the fracture incidence 
curves of Group C@ Several of the fracture incidence 
curves can be well fitted by the T#CpM# prevalence curves* 
These are femur (shaft), clavicle, humerus (upper end),
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patella, radius (lower end) and tibia* Several of the
other fracture sites show a recognisably similar 
prevalence pattern? but the fit of the curves is
qualitative rather than quantitative* Part, if not the
whole, of the explanation here must lie in the limited 
number of data points because of relatively small nmubers*
It might be argued that the prevalence of 
diminishing mineralisation is derived from measurements 
of the metacarpal while incidence data involves a variety 
of sites, hence the two are not strictly comparable# 
Surprisingly little work has been done in comparing the 
variation in mineral content of bone with age at a variety 
of sites* There is a relation between the mineral content 
of the metacarpal and the spine (Fig 29? p$ 39)q ïhirthermore? 
the incidence of fracture at a variety of sites for both 
trabecular bone (e*g* lower end of radius) and in many of 
the sites involving cortical bone agree well with bone 
mineral loss as measured by the T*C*M* in the metacarpal? 
which strongly suggests that the rate of mineral loss is 
similar at these sites*
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One further fact calls for comment# It is 
evident from the inspection of the data in Fig# 31 
that while the rate of fall in diminishes with
age in both male and female subjects after the age of 
75 years 9 there is a marked rise in the incidence of 
fracture between 75 and 80 years in both sexes# It 
is evident that some factor other than the change in 
mineral content must be evoked to account for this#
One obvious suggestion is that there might be an 
increased tendency to fall awluvardly with age#
However? this explanation will not hold for both the 
steady increase in incidence of fractures in both 
males and females of spine and pelvis? and the sudden 
sharp increase in incidence of fractures in male and 
female subjects after the age of 75 at some of the sites 
in Group C*? Ageing has other effects beside the loss 
of bone tissue# Jowsey (1963b) showed that there 
is an increasing proportion of lacunae plugged with 
calcium phosphate following cell death with increasing 
age# This might well affect the chemical nature of
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the collagen and the nature of the mineral phase*
Chatterji and Jeffrey (1968) have shown an increase in 
the length of the apatite crystals with age which they 
suggest would lead to increased ^brittleness® of the bone#
A possible explanation therefore is that such changes 
could affect mechanical strength to become the dominant 
factors determining the incidence of fracture about 75 years 
of age#
It is evident? however? that if changes in the total 
cortical mineral (ï#C#M#) were used to quantitatively define 
osteoporosis then all small individuals would be osteoporotic 
when compared to large and this is not valid* Therefore? 
though the rates of change in total cortical mineral are 
clearly best related to the incidence of fracture? the 
fracture incidence cannot be the factor which determines the 
quantitative definition of osteoporosis# For this purpose 
it is evidently necessary to apply a correction for size 
and this can be done by making use of the width of the bone 
to derive the SsAoE* which measures whole bone density.
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Clearly trabecular bone loss can also be best described 
by a whole bone density measurement which allows for 
comparison between individuals* An alternative method 
would be to use the 8pToC*M#* The rates of change of 
bone loss here are similar though not identical with that 
shown by the 8#A«E# or whole bone density measurement*
There is no obvious reason for choosing one above the 
other# The measurement which is finally used will almost 
certainly depend most upon the way the measurements are made * 
With an x-ray technique? the simplest and most reproducible 
technique is the SoA#E* measurement and is the one chosen 
for this purpose in the thesis# The alternative method 
(i*e# the SpT#C*M#) would be the method of choice if the 
total calcium content per unit length was measured directly# 
This is most accurately done using the technique of Sorenson 
et al (1968)0
In conclusion, therefore? the risk of fracture is 
best defined by measuring the mineral content per unit length 
of bone# Osteoporosis? however? is best defined in terms 
of a measurement, such as the whole bone density, which allows 
for differences in the size of individuals#
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THE MEASUimiENT OF C A L C M  ABSORPTION
Many attempts have been made to measure calcium 
absorption using radioactive calcium as a tracer# Bronner?
Saville? Nicholas? Cobb and Wilson (1962) used a double isotope 
technique? one being given orally and the other intravenously; 
they measured the absorption of calcium from the differential 
secretion of the two isotopes in the faeces# A  similar study 
was done by de Grazia? Ivanovich, Fellows and Rich (1965), who 
measured the differential output in the urine# The relatively 
simple technique of administering an oral dose of a calcium 
isotope in 20 to 250 mg of calcium chloride as carrier, and then 
two hours later measuring the isotope level in the blood has been 
used by a number of authors (Bhandarkar? Blulim? MacGregor and 
Nordin? I96I; Avioli? McDonald, Singer and Henneman, 1965)0 
tJaworskij Broivn, Fedoruk and Seitz (1965) administered a single 
isotope by mouth and measured the loss in the faeces# Nordin, 
Young? Oxby and Bulusu (1968) extended the idea by including in 
their calculation equations which measured the rate of disappearance
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of isotope from the blood on the assumption that this 
occurred at a constant rate*
Tests used to measure calcium absorption may be 
designed for different reasons# Ideally, any method 
used should measure precisely the function it is designed 
to test# However, such an ideal may not be achievable 
or, if it can be achieved, is too complex to be used in 
clinical practice* This may be a problem especially when 
large numbers of subjects are being studied# In order to 
measure calcium absorption in a large population, the method 
used in the studies described later is that described by 
Bhandarkar et al (1961)# This technique is relatively 
simple and can be used for large numbers* However, it was 
necessary to test the efficiency of the method as a measure 
of calcium absorption# To do this, a double isotope 
technique has been used to determine calcium absorption, 
and the result compared with the two hour blood level*
An analogue has been used to determine calcium absorption#
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Theoretical c o ns i d e rat i o iis
The measurement of calcium absorption is a 
complex procedure for a number of reasons* Fig# 40 
illustrates the pathways that an orally administered 
isotope of calcium may follow once it has been absorbed# 
After the isotope is ingested? part will be absorbed and 
part will continue to pass down the gut* Once absorbed 
the isotope will be distributed throughout a rapidly 
exchanging pool consisting of the extracellular fluid, 
soft tissue and some su3:face bone* Once within this pool, 
isotope may return to the gut as endogenous secretion, 
and some of this may be re-absorbed* Some isotope will 
be lost permandhtly in the urine# Isotope from the rapidly 
exchanging pool will also enter the bone by long term 
exchange and active bone formation* It may return from 
bone by exchange and a very small funount by resorption 
(Shimmins and Smith? 1966)% In the present study, in order 
to allow for the changes in blood level due to the
J.U4
redistribution and loss of the isotope illustrated 
in Fig* 40 ? & double isotope technique has been
used# An intravenous isotope (^^Ca) has been used to 
measure the rate of disappearance from the blood pool? 
and a second isotope (*^Ca) has been used to measure 
the appearance of simultaneously administered oral 
isotope in the blood& An analogue computer has been 
used to solve the equations describing this situation# 
Procedure
All the patients involved in this study were 
admitted to a metabolic ward for calcium balance studies 
over a period of several weeks#
The eleven patients whose results are presented in 
this study represent a number of clinical conditions? 
including osteoporosis? hyperparathyroidi&m, osteomalacia 
and gastrectomy#
At the time of starting the test the patients had 
been fasting overnight and their fast continued until two 
hours after the administration of the isotope# Five pCi
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45of Ca wore given intravenously at the same time as
47the patient drank 20 pCi of Ca mixed with stable 
calcium chloride carrier# Blood Scuuples were removed 
at 10 minutes? 30 minutes? 1 hour, 2 hours and usually 
twice more within the first 6 hours# The specific 
activity of each isotope was estimated as described on p.153 
The analogue computer analysis described below applies to 
the serum activity within the 6 hour period#
Analysis of results
In analysing the results, it is assumed that 
equilibrium in the blood pool is reached rapidly and that 
the pools are of constant size# The actual size of the 
pools, of course, do not matter# In this circumstance 
the specific activity can be used as a measure of total 
isotope in the pool#
45The experimental points are plotted out and the Ca 
curve extrapolated back to zero time* This gives the value 
of the initial voltage used in simulating the behaviour of
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intravenously administered isotope# The model fujrther 
assuiaes that the movement of endogenous calcium into the 
gut is negligible within the 6 hour period of this study#
Fig# 41 shows the fractional turnover rates which
are evaluated# Ka is the fraction of calcium in the gut
transferred to the blood per hour* The analogue model 
and the pool systems it represents is shown in Fig, 42*
The first stage of the analysis is to fit a curve to the 
data for the intravenous isotope# This is done by applying 
an initial voltage to integrator number one and adjusting 
potentiometers 1? 2 and 3o Note that there is no transfer 
into pool number 3o The kinetic parameters for this two- 
compartment system have no physiological significance*
They do, however, provide an electrical circuit which 
dissipates charge in the same way as the blood pool dissipates 
intravenously administered isotope^
J.U {
The third integrator is now introduced to represent
activity in the gut# The initial voltage is transferred
to this integrator to represent the orally administered
isotope# It is assumed that when this isotope is
transferred into the serum pool, its behaviour is exactly
that of the intravenously administered Ca# The transfer
rate into the serum pool is simulated by potentiometer 5
while potentiometer 6 represents other transfer from this
gut pool, ioO* movement down the gut# Adjustment of these
last two potentiometers makes it possible to obtain a curve 
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which fits the Ca serum activity* A typical example is 
shown in Fig# 43 *
The values found for ka ranged from 0#4/hour to 
0#89/hour# That is, on average 68^  ^of the calcium in the 
first gut pool is transferred to blood in one houra The 
values of kg ranged from 0#0024/hour to 0*33/hour# ICg is 
the fraction of the calcium in this first gut pool which is
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removed from the pool by movement down the gut# The 
values of ka were plotted against the two hour blood 
levels multiplied by body weight# This plot is shown in 
Fig 44o Although the relationship is good, the 
correlation is not ideal (r ~ 0#48)o Clearly? the 2 hour 
blood level is related to parameter ka* Fig 45 shows 
a plot of ka against the dietary intake less the faecal 
excretion over a period of two weeks during which our 
experiment was performed# There is no relationship between 
ka and the net calcium absorption (diet-faecal excretion) 
over this period (r ~ 0*09)#
No atxempt is made to analyse the serum activity 
fall of radioactive calcium after intravenous injection#
This depends on transfer in and out of a number of body pools# 
This rate of fall is simply reproduced by means of an analogue 
electric circuit# This makes it possible to obtain a measure 
of absorption? ka, valid over the 6 hour period of our study# 
The only assumption being that after calcium is absorbed, it 
behaves in the same way as the calcium already in blood©
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It is evident therefore that this test does not 
measure calcium absorption in absolute terms* It is 
possible for instance that even if ka is low, the calcium 
absorption may still be quite satisfactory, as ka measures 
the absorption from the upper part of the small intestine* 
However? ka represents an accurate estimate of calcium 
absorption from a specific part of the gut? and this does 
correlate v/ith the 2 hour plasma level which is a practical 
procedure for measuring absorption in large numbers of 
patients* That this does not represent the best estimate 
of net calcium absorption under true physiological conditions 
is not unexpected? and is probably true of all other isotope 
tests of calcium absorption*
CHAPTER V
Ill
FACTORS governing THE URIltlRY LOSS OF C/iLCIUM
It is evident that changes in the total skeletal mass 
are governed by the relative rates of bone formation and 
resorption* Theoretically, therefore? it is possible to 
determine whether the bone mass is increasing or decreasing 
at any time by measuring calcium balance^ Calcium balance 
itself is a function of intake and loss from the body#
Urinary losses of calcium play an important part in calcium 
balance* This chapter is devoted to a study of the various 
factors influencing urinary calcium losses# These are 
discussed under the following headingsî
1) The effect of calcium intake on urinary calcium excretion.
2) The effect of phosphate intake on total and ultrafiltrable
plasma calcium? phosphate clearance and urinary 
calcium excretion*
3) Renal clearance and resorption of calcium in osteoporosis?
hyperparathyroidism and hypoparathyroidism*
iu.i
l) The effect of calcium intake on urinary oal^ itini excretion 
The plasma calcium remains remarkably constant despite 
wide variations in dietary intake (Smith? Davis and Fourman?
I96O; Nordiiij 1961) though the urinary calcium is ImoTO to he 
influenced by dietary intake* However? it is also Imown that 
wide variations in urinary calcium will be found between 
different individuals on the same dietary intake of calcium#
It is clear that the urinary calcium is a function of the 
filtered load which is in turn a function of the glomerular 
filtration rate and the level of the plasmsi water calcium*
The level of the plasma water calcium will in turn be influenced 
by the level of activity of the parathyroid glands? the 
calcitonin producing cells and vitamin D# The dietary levels 
of phosphate and sodium may also affect urinary calcimn excretion, 
Since the filtered load of calcium is about 7 gm/day and the 
urinary calcium 200 mg/day? small changes in the filtered load 
could account for large changes in the urinary calcium excretion# 
The following work was planned to test the possibility that 
changes in urinary calcium might be brought about by small 
changes in the plasma calcium#
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Methods
fBMffttogy/jgjfcwm w  m  o#
Subjects studied
Fifty-teight subjects were studied? 11 were members, 
of the staff and k j were in-patients# Of the 47 in-patients? 
11 were suffering from osteoporosis?, one from osteomalacia? 
and 35 had miscellaneous disorders not connected with calcium 
metabolism? but agreed to the studies being performed^ One 
patient and three members of the staff were studied twice? 
making a total of 62 studies in all*
Procedure
In preliminary observations on 11 noii'^osteoporotic 
patients without any disorder of calcium metabolism? calcium 
excretion was determined in three 24-hour collections of urine 
on the ward diet followed by nine on a low calcium diet 
containing about 250 mg of calcium and 500 mg of phosphorus#
In the next 40 studies (27 of the subjects having no 
disorder of calcium metabolism? 24 being patients and three 
members of the staff) blood samples were taken at 9*50 aom# 
and 12*30, 2*30, and 4*30 pom* on two successive days, making 
eight samples in all from every subject except two from whom 
only six samples were taken# Urine was collected on both days
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and calcium excretion determined* In these studies the 
diets were given as follows? in 19 the ward diet was given 
on the first day and the low calcium diet on the second; 
in 21? the low calcium diet was given on both days but was 
sux>î>lemented with calcium lactate on the first day (in 17) 
or the second day (in 4) to make a total calcium intake of 
about 1?200 mg#
In a final series of studies? 11 members of staff 
took a low calcium diet for two days and ate 1 gm of 
calcium as calcium lactate on the first day# Blood waa 
taken from them at 9 Uom# and 12 Noon on each day for 
determination of the ultrafilterable calcium#
Thus, in 47 of the 51 plasma studies? the regime changed 
from an average to a low calcium intake and in four from a 
low to an average level# In 52 of these 51 studies, the 
only change in the diet was its calcium content.
Biochemical methods
Serojii and urine calcium were estimated by an 
AutoAnalyser (Technicon Instruments) with the following 
modifications to the standard technique;
1 The alkaline buffer line has an internal diameter
of 0*056 in, ( 1 i)46 mu) (yellow) instead of 
OoOT5 iue (l*14 mm) (red), giving a delivery 
of If,2 ml/minute instead of 0*8 ml*
2 A 40 foot (12 metre) time delay coil in a water
bath at room temperature was introduced before 
the colorimeter*
3 The working standards were made up in 0*15 M
sodium chloride 0
k A range expander (lleathkit resistance box) was
placed in series with the negative side of the 
reference photo cell in the recorder*
5 The calcium-releasing agent (hyamine and acetate.
buffer) was adjusted to pH 4 instead of pll 5*
6 The ammonium purpurate solution was adjusted to
pH 7 by adding diethylamine*
7 Urine dilutions were made with 0*15 M sodium
chlorideo
Ultrafiltration was performed on fresh serum transferred 
to cellophane tubing without exposure to the atmosphere and 
centrifuged at 57^0 for one hour at 2,000 g in tubes similar
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to those devised by Toribara, Terepka and Dewey (193?)o 
The calcium was measured by the AutoAnalyzer technique 
described above*
Kesuits
The effect of the low calcium diet on the 24-hour 
ujrine calcium in 11 subjects is shovm in .Fig* 46* The 
mean codcium excretion fell from 243<s2 mg on the third day of 
the ward diet to 179*1 mg on the first day of the low calcium 
diet* There was little further fall in the next S days*
The results of 27 blood and urine studies in patients 
without disorders of calcium metabolism are shown in Table XIII, 
The mean plasma calcium on the ward diet was 9*46 mg/lOO ml 
and on the low calcium diet 9®29 mg* The difference, 
although small, is significant# The mean urinary calcium 
excretion in these 27 subjects was 198*8 rag on the normal 
calcium intake and 135«7 mg on the low calcium intake* The 
difference of 63*1 mg is significant (Table XIV p being 
less than 0*02* The mean calcium/creatinine ratios were 
0*17 and 0*12 respectively, and this difference is also 
significant (Table XV ), P being less than 0*02*
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The 111 traf il te rah le calcium concentrations in 11 
members of staff on the normal and low calcium intakes 
are shown in Fig* 7^* The mean calcium concentration
on the normal intake was 5o56 mg/lOO ml and on the low 
intake 5*23 mg* The difference is highly significant 
(t - 3^9 ; P < OpOOl)o Fig* shows part of the
AutoAnalyzer tracing obtained when these ultrafilterable 
calcium concentrations were determined* The samples 
obtained on the two diets were fed in alternately and the 
difference in peak heights is clearly visible*
In considering-the relation between plasma and urine 
calcium the data from all the subjects (including cases of 
osteoporosis and osteomalacia) have been included* There 
was no correlation between the absolute plasma calcium 
concentration and the absolute calcium excretion, but there 
was a significant correlation between the change in plasma 
calcium and the change in urine calcium (r - 0*46; P < 0*005) 
(Fige )*> There was a slightly better correlation between
the change in plasma calcium and the change in urinary 
calcium;creatinine ratio (Table XVI )^
Ill
Discussion
ewaUfclMH» 11» «rt*UTHW4» HH MLw,« JVTTW WP*
There is a small but significant difference between 
the mean plasma calcium concentrations in 27 subjects on 
normal and low calcium diets* Though very small, this 
difference is more than enough to account for the effect of 
the change in dietary intake on urinary calcium* In fact, 
the relation between the plasma and urinary calcium changes 
is such as to suggest that the tubular maximum reabsorptive 
capacity for calcium (if such a maximum exists) was not 
exceeded in this group of subjects as a whole* Thus if one 
assumes that the ultraf ilterable calcium is 53/» of the total 
plasma calcium (Walser, I96I), then the observed mean change 
of 0*18 mg/100 ml in calcium corresponds to a change of 0*1 mg 
per 100 ml in the ultrafilterable calcium concentration* At a 
glomerular filtration rate of 100 ml/minute this could account 
for a change in urinary calcium excretion of 144 mg/day if 
tubular reabsorption remained constant (Fig* ), compared with
the observed change of 63%1 mg (Table XIV )*
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In order to reduce the possibility of error to a 
minimum most of the Scunples were put through the AutoAnalyzer 
in batches of eight, and in many the plasma or ultrafiltrate 
samples from the two days of the study were fed in 
alternately* The difference in the heights of the peaks on 
the normal and low calcium diet days was clearly visible, as 
shown in Fig 48*
It is not possible to say whether it is the ionic or 
complexed fraction of the calcium which is primarily involved 
in the changes observed, nor whether these changes have any 
effect upon the parathyroid glands* Nordin (i960; 1961)
reviewed the evidence which suggests that low calcium diets 
do not stimulate the parathyroid glands whereas high phosphate 
diets do, but the two procedures produce an almost identical 
fall in plasma calcium (Smith and Nordin, 1964)* High 
phosphate feeding produces a rise in the phosphate excretion 
index (PeE*!*) which is suppressible by calcium infusion, and 
this strongly suggests parathyroid stimulation (Smith and 
Nordin, 1964)* Low calcium diets, however, do not have any 
effect on the P.E*!* (Fig 52.)o Furthermore, Stoerk and 
Carnes (l945) have shown that high phosphate diets cause an
IZU
increase in parathyroid weight in animals* Grawfordp 
Gribetzj Diner, Hurst and Castleiiian (l957) have shown* 
on the other hand, that low calcium diets do not cause 
parathyroid hyperplasia so long as the diets are not 
deficient in vitamin D* Why comparable changes in plasma 
calcium should apparently have different effects u^ jon the 
parathyroid glands is far from clear, but it could be 
that the calcium fraction involved is different in the two 
situations or that the assessment of parathyroid gland 
activity is inadequate.
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2) The effect of phosphate intake on total and ultrafiltrahie 
plasma calcium, phosphate clearance and urinary 
calcium excretion
The parathyroid hormone has at least two actions; 
a calcaemic effect on bone and a phosphaturic effect on the 
kidneys* Its secretion is certainly regulated by the 
concentration of ionic calcium in extracellular fluid, but 
appears also to be influenced by the inorganic phosphorus 
concentration* It has long been imown that parathyroid 
hyperplasia is associated with the phosphate retention of 
renal failure (Bergstrand, 1921), and it has been shown that 
high phosphorus feeding increases parathyroid weight in 
animals (Stoerk and Carnes, 1945)/.» However, Ham, Littner, 
Drake, Robertson and Tisdall (l940) showed that hyper- 
phosphataemia in the absence of hypocalcaemia did not cause 
parathyroid hypertrophy and it seems probable that the 
effect of elevated plasma phosphorus on the parathyroids is 
produced by reciprocal depression of the ionic calcium 
(Nordin, 1962%
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It has been shoivn by Goldman and Bassett (l958) 
that high phosphorus feeding is associated with a rise in 
the plasma concentration and filtered load of phosphorus* 
but with a fall in the proportion of the filtered load 
reabsorbed by the tubules which they attribute to increased 
parathyroid activity* Somewhat similar results had 
previously been obtained by Crawford, Osborne, Talbot,
Terry and Morrill (l950)o Nordin and Fraser (1960) and 
Nordin (1962) recalculated the data from both these studies 
and found that the oral administration of phosphorus was 
associated with a rise in the Phosphate Excretion Index 
(P*E*Io), which suggested increased parathyroid activity* 
The objects of the present study were four-fold: 
first, to establish whether the raised Imown to be
produced by high phosphorus feeding could be lowered by 
intravenous infusion of calcium, which would suggest that 
it was due to secondary hyperparathyroidism (Nordin and 
Fraser, 1954)* Second, to establish by frequent blood
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sampling whether the supposed effects of the high phosphorus
diet on the parathyroids could he attributed to reciprocal
depression of plasma or ultraf ilterable calcium^ IhiTcl fhë
effect on urinary calcium excretion* FburHq, to test the
effect of a low calcium diet on phosphate excretion*
Methods
Procedure
There were four series of observations;
In 8 patients with osteoporosis the plasma 
calcium and phosphorus and PtE*!* were 
determined on the ward diet and after 
7*“ 10 days on a dietary supplement of 1*5 g 
phosphorus (as neutral sodium phosphate)*
On the following day, the PoEpI^ , was 
determined immediately before an 8 hour 
infusion of calcium gluconate (30 mg of 
calcium/Kg) and again 18 hours later*
The phosphate supplement was administered 
throughout*
In 8 normal subjects, the P*E*Io was measured 
while on a ward diet and 7 days after 
starting on a low calcium diet, between 
280 and 450 rag calcium per day*
In 3 members of staff and 7 patients without 
metabolic bone disease, plasma calcium and 
phosphorus were determined at 9 a*nio,
12 Noon, 3 p.ra* and 5 p*m* on the day
immediately preceding, and on the first
day of the high phosphorus diet*
In 9 members of staff, total and ultrafilterable 
calcium were measured on samples taken at 
the same time on the day preceding and on 
the first day of high phosphate feeding*
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Analytical methods; All blood samples were taken with 
disposable needles’ and syringes with a minimum of stasis^ 
Blood for ultrafiltration was collected uner paraffin* 
Serum was separated without delay*
Phosphorus and creatinine were measured in plasma 
and urine by standard AutoAnalyzer techniques (Technicon 
Instruments Limited)* Calcium was estimated by a 
modified AutoAnalyzer technique* It is a spectro- 
photometric method using ammonium purpurate as the 
indicator* In series 3j calcium was also estimated by 
titration with EDTA in an EEL titrimeter at pH 10*0 using 
ammonium purpurate as the indicator* Ultrafiltration 
was performed on fresh serum transferred to cellophane 
tubing without exposure to the atmosphere and centrifuged 
at 37^0 for one hour at 2,000 g in tubes similar to those 
devised by Toribara et al (l95?)®
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Results
First series: the effects of the high phosphorus diet on
the plasma concentrations of phosphorus and calcium are 
shown in Table XVII* In thirty observations on eight 
patients on the ward diet, the mean plasma concentration 
of inorganic phosphorus was 5*51 and of calcium 9*62 mg/lOO ml, 
In 29 observations on the high phosphorus diet, the mean 
plasma phosphorus was 3*92 and calcium 9*54 mg/lOO ml. The 
rise in plasma phosphorus (0*41 mg/lOO ml) is significant, 
but the fall in plasma calcium (0*08 mg/lOO ml) is not*
There was a rise in the ratio of phosphorus to 
creatinine in the urine, the phosphate/creatinine clearance 
ratio (Cp/Ccr) and the Phosphate Excretion Index (P*E*I,)
(Pig 50, Table XVIIl)* The P*E,I. rose above + 0*09 in all 
but one case.
The effect of calcium infusions on phosphate excretion 
in these eight subjects is shown in Pig 51 and Table XIX*
The infusions were invariably followed by.a substantial fall 
in the urinary phosphate/creatinine ratio, in the Cp/Ccr and 
in the PoE*I., the last, in all cases but two, to a subnormal 
valueo
Second series: a low calcium diet had no effect on phosphate
excretion (Pig 52)*
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Third series: multiple blood sampling in ten subjects on
the day preceding and the first day of the high phosphate 
diet yielded the results shown in Fig 33 and Table XX*
The mean plasma phosphorus rose from 3*40 mg/lOO ml on the 
day before to k^lS on the first day of high phosphate feeding: 
the mean plasma calcium fell from 9*75 to 9*51 mg/lOO ml.
Both changes were significant*
Fourth series: the total and ultrafilterable calcium in
nine subjects on the day before and the first day of high 
phosphate feeding are shovm in Table XXI# The mean total 
calcium fell by 0*23 mg^ and the mean ultrafilterable calcium 
by 0*29 mg^* Both changes were significant* The estimations 
were performed in 3 groups, and on each occasion the control 
and high phosphorus plasma were fed into the machine 
alternately* A fall in the calcium peak was observed in 7 
out of 9 pairs of tracings*
The total and ultrafilterable calcium were also 
measured by EDTA titration in these nine subjects* As Table XXI 
shows the EDTA values were slightly higher and more variable 
than those obtained with the AutoAnalyzer, but the calcium fall 
in response to phosphate loading was of the same order of 
magnitude*
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The urinary calcium/creatinine ratio was estimated 
on the first series of eight osteoporotic patients on three 
days preceding and three days following the start of the 
high phosphate diet* The mean calcium creatinine ratio 
fell by 0,10, This fall was highly significant
(Table XXII )^
Discussion
The results confirm the observations of other workers 
that a high phosphorus diet not only raises the concentration 
of inorganic phosphorus in plasma but also produces a dis­
proportionate rise in the Cp/C^^ which leads to a rise in the 
PgEal* (Goldman and Bassett, 1958; Crawford et al, 1950)«
The circumstantial evidence that the ?oE*I* reflects para­
thyroid activity is very strong (Nordin and Fraser, I960;
Nordin, 1962) and these observations therefore suggest that 
phosphorus feeding stimulates the parathyroid glands* This 
is compatible with the fact that high phosphorus feeding 
produces parathyroid hyperplasia in animals (Stoerk and 
Carnes, 1945)* It is well recognised that calcium infusions 
suppress parathyroid activity (Howard, Hopkins and Connor, 1953;
1^0
Kyle, Schaaf and Erdraan, 1954.), and in particular that the 
high Gp/C^^ of osteomalacia can he reduced in this way 
(Nordin and Eraser, 1954)* The present study has shoivn 
that the high FtE*!* produced by phosphate feeding can also 
be suppressed by intravenous calcium, suggesting that it too 
is attributable to secondary hyperparathyroidism.
There are at least two ways in which phosphate 
supplements might stimulate the parathyroid glands* The 
raised plasma phosphorus might act directly on the glands, 
or they might be stimulated by a ^reciprocal* depression 
of ionic calcium* There is no evidence that parathyroid 
activity is governed directly by the concentration of 
inorganic phosphate in extracellular fluid, but a great deal 
of evidence that it is governed by the concentration of 
calcium (Munson, Hirsch and Tashjian, 1963)0 It is, 
therefore, inherently probable that the effect of high 
phosphate feeding upon parathyroid activity is produced by 
depression of the concentration of calcium*
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It proved at first impossible to demonstrate a 
significant change in total plasma calcium by single 
daily blood sampling, but the examination of four blood 
samples a day in ten subjects before and during high 
phosphorus feeding revealed a small, but highly 
significant depression of calcium concentration* Any 
possibility that this might be an artefact produced, for 
instance, by fluid retention on the high salt load, was 
excluded by ultrafiltration of serum in nine subjects*
This procedure not only confirmed the previous observations 
but showed that the ultrafiltrable fraction fell if 
anything slightly more than the total serum calcium.
The results confirm that high phosphate feeding 
produces a small but rapid fall in plasma calcium* Since 
the ultrafilterable calcium falls at least as much as the 
total calcium, it seems reasonable to conclude that it is 
primarily the ionic calcium which is depressed, and that 
this is the cause of the parathyroid stimulation which we 
believe to be demonstrated# The high phosphate feeding 
also produced an immediate fall in urine calcium* It is
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not possible to say at present whether this is simply 
due to a fall in the filtered load of calcium or whether 
it too is the result of enhanced parathyroid activity 
(iQeeman, Bernstein, Rocicney, Dowling and Maxwell, 1961 )# 
The effects of phosphate feeding on plasma calcium 
and P*E«Io which are described are similar to the effects 
of phosphate infusions observed by Anderson and Parsons 
(personal communication)* They have found that phosphate 
infusions produce an immediate fall in plasma calcium and 
that after a few hours the phosphate Tm begins to fall*
The latter observation appears to be analogous to the rise 
in that has been described and seems to be probably
due to parathyroid stimulation, although Bartter (I961) has 
claimed that it occurs in the absence of the parathyroids# 
It is, of course, a well-lmoivn clinical fact that a 
high phosphorus intake is harmful or even dangerous in 
patients with hypoparathyroidism in whom tetany is easily 
precipitated* Similarly, the tetany produced in infancy 
by cow's milk is believed to be due to the high phosphorus 
content of the latter (Gardner, MacLachlan, Pick, Terry and 
Butler, 1950)* These clinical observations support the
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effect of phosphorus feeding upon plasma calcium concentration 
which have been demonstrated*
It would appear that high phosphate feeding elevates 
the concentration of inorganic phosphorus in the extracellular 
fluid, and that this depresses the calcium concentration*
The result is a state of secondary hyperparathyroidism and a 
disproportionate fall in the tubular reabsorption of phosphate 
which is reflected in a raised The mechanism of
the ^reciprocal* depression of calcium by phosphate is 
uncertain* It could be due to complexing of calcium by 
phosphate (Walser, I961), but since it was also observed with 
EDTA titration it could also be explained in terms of a 
physico-chemical equilibrium between bone mineral and its ions 
in extracellular fluid (MacGregor and Nordin, I960)#
It is evident that the urinary calcium falls with a 
high phosphorus intake* This could be partially due to a 
fall in the absorption of calcium due to the formation of 
calcium phosphate complexes# However, a significant 
contribution to this fall must be due to the fall in 
ultrafilterable calcium which in turn leads to a fall in the
filtered load* Another cause of the fall in urinary 
output of calcium could result from the increased 
parathyroid activity which causes an increased tubular 
resorption of filtered calcium, as discussed in part 3 
of this chapter*
3) Renal clearance and resorption of calcium in osteoporosis, 
hyperparathyroidism and hypoparathyroidism_______ ____
The excretion of calcium in the urine is a function 
of the filtered load and of the amount of calcium reabsorbed 
by the renal tubule* Kleeman et al (l95S) reported that there 
was decreased clearance of calcium in normal subjects 
following the administration of parathyroid hormone during 
calcium infusion* Loken and Gordan (l959) and Gordan, Loken, 
Bluhm and Teal (1962) reported that calcium clearance was 
in fact increased in patients with primary hyperparathyroidism* 
Bernstein, ICleeman and Maxwell (1963) showed a decreased 
calcium clearance in patients with hypoparathyroidism given 
parathyroid homone during calcium infusion* They also 
pointed out the importance of associating the calcium clearance 
with the level of the plasma diffusible calcium* In view
of the contradictory findings, the calcium clearance and tubular 
resorption of calcium has been studied in patients with 
hyperparathyroidism and hypoparathyroidism, in patients 
with recurrent renal calculi and in patients with osteoporosis*
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Patients studied
The patients in whom calcium clearance was studied 
all had normal renal function (Table XXIIl) as judged by the 
creatinine clearance* This is important as urinary calcium 
falls as renal function is impaired (Fig 54)* This figure 
shows the relation between the calcium/creatinine ratios in 
15 normal subjects and patients with varying degrees of renal 
failure*
First, 8 patients with normal renal function were 
studied# The whole bone density (S#A#Eo) was measured in 
each of the subjects and the percentile value relative to 
the normal population determined (Table XXIV)* Six of the 
subjects were osteoporotic as defined in Chapter II* That 
is, they had an SoAoF* value of 28 or under* All were below 
the 50 percentile value for their age (range 13 to 48), but 
were well within the two S#D# range defined by the normal 
population* For convenience, this group is referred to 
hereafter as the 'osteoporotic* group to distinguish them 
from the other subjects studied#
135
Second, nine patients with recurrent renal stone 
were studied* None of them had evidence of hyperparathy­
roidism as judged by the PeE#I* (or Cp/C^^)* Third, 
eight patients with primary hyperparathyroidism were 
investigated. Fourth, two patients with hypoparathyroidism 
were studied*
Methods
The calcium:creatinine clearance ratios and the 
calcium reabsorbed per 100 ml of filtrate were estimated in 
all the patients. In the patients with osteoporosis, 
renal stone and in two of the patients with hyperparathyroidism 
this was followed by an infusion of 10^ calcium gluconate in 
physiological saline* It was considered inappropriate to 
infuse calcium into the patientswith primary hyperparathyroidisi 
who had high initial serum calciums* In all the patients, 
the calcium was infused in a dose of 3*75 mg/Kg/hour. In 
two of the patients in the 'osteoporotic group* and in tv/o 
with hyperparathyroidism, the infusion was over a period of 
4 hours. In the remaining six osteoporotic subjects and 
in the patients with hypoparathyroidism, the infusion was 
continued for 6 hours.
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Urine was collected over hourly periods* Blood 
for total and ultrafiltrable calcium was collected at the 
midpoint of the urine collection. In the six remaining 
patients with hyperparathyroidism in whom it was considered 
inadvisable to infuse calcium, urine was collected over 
2 hourly periods and blood collected at the midpoint of the 
urine collection. The calcium:creatinine clearance ratio 
and tubular reabsorption of calcium were estimated on 
these samples#
Calcium was estimated on the plasma, ultrafiltrate 
and urine by a modification of the AutoAnalyzer technique 
(McFadyen, Nordin, Smith, Wayne and Rae, I965).
Creatinine was estimated by the standard AutoAnalyzer 
technique (Technicon Instruments Limited), Ultrafiltration 
was performed on fresh serum, transferred to cellophane 
tubing without exposure to atmosphere at 37°C for one hour 
at 2,000 g in tubes similar to those devised by Torribara 
et al (1957)0
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Results
The calciujüîcreatinine clearance ratio is seen 
to he directly related to the plasma ultrafiltrable calcium 
in all four groups of patients (Figs, 55,56 . Table XXV ), 
It is evident that calcium clearance can only be compared 
in the different groups between the same levels of plasma 
ultrafilterable calcium# The calcium reabsorbed per 
100 ml of filtrate is also directly related to the plasma 
filterable calcium and it is again evident that the 
percentage reabsorption in the different groups can only 
be contrasted at the same plasma ultrafilterable calcium 
levels#
In Fig* 55 , it can be seen that the calcium;creatinir 
clearance ratios in patients with primary hyperparathyroidisn 
are lower than the clearance ratios in the 'osteoporotic 
group', the 95^ Confidence limits of the data being shown 
by the cross-hatched areas* The differences between the 
clearances of ultrafilterable calcium between 6 and 9 mg^ 
are highly significant (P < 0*00l), In the patients with 
renal stone disease, the calcium;creatinine clearance ratios
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are significantly higher than in the patients with primary 
hyperparathyroidism (p < O.OOl) (between XTF Ca 6 and 9®5 pg), 
and those in the 'osteoporotic group* (P < 0*00l)* This 
is more apparent at the higher levels of plasma ultra- 
filterable calcium. The calcium;creatinine clearance 
ratios in the patients with hypoparathyroidism are shown 
in Fig. 56  ^ The calcium;creatinine clearance ratios are
significantly higher than those found in the osteoporotic 
group and in the patients with primary hyperparathyroidism, 
but do not differ from the patients with recurrent renal 
calculi.
In Fig* 57 , the reabsorption of calcium in ing/lOO m] 
of filtrate is seen to be directly related to the plasma 
ultrafilterable calcium inpatients with'osteoporosis’and 
in patients with renal stone disease# The reabsorption 
of calcium in patients with renal stone disease is 
significantly lower than in the osteoporotic group and this 
difference is accentuated at the higher plasma ultra- 
filterable levels, while it does not reach significance at 
lower levels* In Fig# 58  ^the tubular resorption of
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calcium in patients with osteoporosis is compared with the 
patients with primary hyperparathyroidism# The tubular 
reabsorption is slightly but significantly higher in the 
patients with primary hyperparathyroidism. In Pigs 59 
ÉS the reabsorption of calcium per 100 ml of filtrate in 
patients with hypoparathyroidism is compared with the 
tubular resorption of calcium in the hyperparathyroid 
patients# The tubular resorption is decreased in the 
hypoparathyroid patients# Again it is only evident at the 
higher levels of plasma ultrafilterable calcium# The 
reabsorption of calcium per 100 ml of filtrate tends to 
flatten in the renal stone patients and in the hypoparathy­
roid subjects# This is not evident in either the 
osteoporotic or the hyperparathyroid group# Thus, at 
the plasma ultrafilterable calcium levels which have been 
achieved, while the patients with hypoparathyroidism 
and renal stone disease appear to be approaching their 
maximum tubular resorptive capacity per 100 ml of filtrate* 
it is evident that this has not been reached in the patients 
with primary hyperparathyroidism and in the 'osteoporotic® group,
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Discussion
The subjects in the ’osteoporotic^ group hare normal 
renal function and are all well within the two 8*0* range of 
normal in tei-ms of their whole bone density* It is 
reasonable therefore to compare the calcium clearance and 
resorption in these subjects with those individuals in the 
different diagnostic groups*.
The lowered calcium clearance and raised calcium 
reabsorption in patients with hyperparathyroidism, and the 
raised calcium clearance and lowered resorption in patients 
with hypoparathyroidism, would appear to support the evidence 
of IQeeman et al (l958) and Bernstein et al (1963)? and not 
that of Loken and Gordan (l959) and Gordan et al (1962)0 
This confusion has arisen because Gordan and his colleagues 
have taken the clearance and resorption values in isolation 
instead of comparing them within similar plasma ultrafiltcrable 
calcium levelsp The diminished tubular resorption of calcium 
in the eight patients with renal stone disease is compatible 
with a renal tubular defect which could be congenital or 
acquired*
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Conclusions
It is evident that the urinary output of calcium 
is governed by'a number of factors* It is influenced by 
the dietary calcium and phosphorus, which cause small but 
significant changes in the plasma ultrafilterable calcium* 
Parathyroid activity itself can be influenced by dietary 
phosphate intake* The parathyroid activity will determine 
the plasma calcium level and so alter the filtered load. 
Increased parathyroid activity also increases calcium 
resorption by the renal tubule* Diminished parathyroid 
activity causes increased calcium clearance* The studies 
in patients with renal stone disease suggest, in some 
subjects at least, that there may be a change in tubular 
function which could lead to increased urinary loss of 
calcium* . The part played by urinary losses of calcium 
in the development of osteoporosis is therefore a complex 
function of a large number of different factors*
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CîhïPTRR V I
(part I )
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TÏ-ÎE MTES OF BONE FORMATION AND DESTRUCTION
The development of osteoporosis must result from
the relation between the rates of bone formation and
destruction, the bone formation rate being lower than the
rate of bone destruction® Either or both could be raised
or lowered, but as long as the rate of destruction exceeds
that of formation, the bone mass will diminish* Albright
et al (l941a) and Albright, Smith and Richardson (l941b)
from a study of osteoporosis in post-menopausal women, and
women with Cushing’s syndrome, suggested that the primary
defect in this disease was a failure in the synthesis of bone
matrix* This view was held for many years, but with the
introduction of the bone-seeking isotopes - ^^Ca, ^^Ca and 
85
Sr, a number of authors were unable to find any significant 
difference in the rate of ’bone formation’ in normal and 
osteoporotic subjects (Fraser, Harrison and Jones, I960; 
Dymling, 1964* Nordin, Smith and Glass, 1964; Lafferty, 
Spencer and Pearson, 1964; Jowsey, 1966), Nordin (l958; 
i960) suggested that osteoporosis might result from
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prolonged negative calciimi balance, and Jowsey {1966) 
claimed that the rate of bone formation was normal in 
osteoporotic subjects but that the bone destruction rate 
was increased* In this study, she used a technique which 
is discussed below*
The present chapter is divided into two parts*
Part I is an examination of the isotope techniques used 
to determine the rate of bone mineralisation; Part II 
is an examination of the ways of measuring the rate of bone 
destruction*
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The measurement of bone formation
Measui’ement of bone formation rate is a problem 
which has not yet been completely solved* One technique 
which has been used is by tetracycline labelling which 
depends upon the measurement of the area between two linear 
deposits of tetracycline in bone, two doses of the antibiotic 
being given separated by a period ranging from 14 to 28 days 
or morca This measurement is possible because the anti­
biotic is taken up at the sites of active bone formation, 
and the lines are detectable by their natural fluorescence 
in ultra-violet light* The area between the fluorescent 
lines will give a measure of the oppositional growth rate®
It can be usefully applied to cortical bone but not to 
trabecular bone* Another technique is that described by 
Jowsey (1966)* This involves the examination of micro­
radiograph sections of bone under the microscope in order 
to detect and measure sites of active bone formation and 
destruction* Bone formation and destruction are surface 
phenomena and the length of the surfaces undergoing 
formation and destruction can be measured and 
related to the whole surface lengthAvithin
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the microscopic field being studied* This technique is 
applicable to relatively small surface areas and the 
precise measurement of the lengths of the surfaces 
undergoing bone formation and destruction is difficult.
These techniques have supplied useful information 
though both require bone biopsy and supply information 
only at a very localised site, and any one site may not 
indicate what is happening in other parts of the skeleton* 
These methods have therefore been useful in the study of 
bone formation in animals, but have so far not been used 
widely in the study of bone formation in vivo in man.
In man, the study of bone accretion has been 
largely confined to the study of the mineral phase using 
the bone-seeking isotopes Ca, Ca and Sr« These 
isotopes give a measure of the rate of transfer of calcium 
from blood to bone, and the term Mineral Transfer Bate 
(M*T,R*) is used hereafter in preference to the term 
Bone Formation Bate (B*F*B*), The latter implies that the 
process of bone formation (i*e* the initial laying down of a 
matrix followed by the calcification of this matrix) is the 
process that is measured, when in fact only mineral transfer
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is measured using radioisotopes® It is evident that these 
two processes cannot be distinguished by present techniques 
A further complication arises from the very rapid exchange 
from blood to bone because the exchange is occurring from 
a small pool (i*e* < 1 gm in the E*C*Fo) to the very 
large bone pool, and the correspondingly slow exchange 
back from the large bone pool to the small extracellular 
pool* Yet another problem arises if a significant 
amount of isotope is returned to the blood by bone 
resorption and exchange, as the bone mineral transfer rate 
will be underestimated by an amount depending upon the 
rate of return of isotope® However, an estimate of the 
rate of isotope return can be made from our investigations 
(Smith, Speirs and Shirranins, 196?)« V/e showed that the 
isotope returning from bone enters the and from
here part is lost from the body and part is again taken 
up by bone* Using the mathematical approximation 
described by Shiramins, Allison, Smith and Speirs (1967), 
it is possible to estimate the rate of return of the 
isotope from bone from a knowledge of the whole body
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retention and the measured rate of loss of isotope from
the body (Fig* 60 )# With this knowledge, allowances
can be made for the slow exchange rate and the true
measurement of mineral transfer rate into bone
determined (Shirainins and Smith, 1970)* However, this
technique requires a knowledge of isotope retention up
to 90 days or more, and is not a practical technique for
measuring mineral transfer in larger groups of patients*
From an examination of the data it was apparent that the
method used by Bauer, Carlsson and Lindquist (l957)
applied between 7 and 14 days after injection of the
isotope gives the most accurate assessment of mineral
85
transfer rate measured by Sr and between 5 and 10 days 
using an isotope of calcium* There is discrimination 
between calcium and strontium in their transfer across 
biological membranes, and this has been examined in detail 
below*
If a number of patients are to be studied, then
85Sr is a convenient isotope to use*
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It is a y-emitter, and whole body retentions may 
conveniently be determined by using a whole body 
counter; the half-life of the isotope is 69 days and 
it is therefore very suitable for the study of patients*
Because of this, a number of patients have been studied 
with Sr to determine the
Discrimination between calcium and strontium by 
biological tissues in man
Discrimination between calcium and strontium in the 
transport of these ions across biological membranes has 
been recognised for some time* This discrimination has 
been shown to occur in transport across the gut (Bailey,
Bryant and Loutit, I96O; Spencer, Li, Samachson and Laszio, 
I96O; Samachson, 1963; Nordin, Smith, MacGregor and Nisbet, 
1964b), in reabsorption in renal tubules (Harrison, Raymond 
and Tretheway, 1933; MacDonald, Noyes and Lorick, 1957;
Barnes, Bishop, Harrison and Sutton, I96I) and in placental 
transfer (Hodges, MacDonald, Nusbaum, Stearns, Ezrairlian,
Spain and McArthur, 1950)® The discrimination between 
calcium and strontium at the bone surface has been investigated 
in several ways* The transfer of strontium and calcium
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tracer’s into bone powder has been followed (Harrison,
Luoisden, Raymond and Sutton, 1959; Boyd, Neuman and Hodge,
1959; Neoman, Bjornerstedt and Mulryan, 1965), and the
uptake of these tracers ^  vivo in animals (Bauer, Carlsson
and Lindquist, 1955; Comar, Wasserman and Nold, 1956;
Likins, Posner, Kunde and Craven, 1959), and in man (Dow
and Stanbury, I960; Nordin, Blulun and MacGregor, 1962;
Bronner, Aubert, Richelle, Saville, Nicholas and Cobb, 1963)
has also been investigated*
It is clear that there is discrimination against
the transfer of strontium as compared with calcium across
biological membranes, though why it occurs is not understood,
Whether discrimination occurs at the site of incorporation
into bone has not been clearly established*
Two series of studies in man are reported below:
first, the investigation of the effect of different stable
calcium intakes on the retention and faecal and urinary 
45 85excretion of Ca and Sr during continuous administration 
of these isotopes* This technique is described by 
Nordin, Smith and Nisbet (l964a): second, ^^Ca and 
was administered intravenously by a single injection, and
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the bone mineralisation rate was estimated with both 
isotopes* The results were combined with those of 
Dow and Stanbury (1960) to compare their uptake into bone* 
Experimental methods
All the patients were studied in a metabolic ward 
and they were undergoing calcium balance studies as well 
as isotope investigation. The urine and faeces were 
collected in 7 day aliquots*
C ont inuous“f ceding s tudie s 
45 85Ca and Sr were administered simultaneously
twice daily with the.morning and evening meals. Doses
45 85
of 0*05 pCi of Ca and 0*25 pCi of Sr were given in
2*5 to 5 mg of calcium as CaCl^® Three weeks were allowed
for equilibration before estimations were begun (Nordin
et al, 1964a), The isotopes and stable calcium were
estimated in the 7 day urine and faecal collections;
simultaneous plasma and urine samples were collected for
45 85the estimation of stable calcium, Ca and Sr*
The net absorption of each isotope was taken to be
the oral dose less the faecal activity averaged over
2“3 weeks* Skeletal retention was taken to be the
oral dose less the faecal and urinary activities
averaged over the same period* The mineral transfer
rate (M®TeE*) with ^^Sr as tracer was determined by
85
dividing the skeletal retention of Sr by the average
85 45
plasma Sr specific activity* The value with Ca
as tracer was found by dividing the skeletal retention
45 45of Ca by the weekly urine Ca specific activity*
Intravenous studies
45 85
Doses of 3 pCi Ca and 30 pCi Sr were administered
simultaneously* Both isotopes were estimated weekly in
the urine and faeces* The plasma specific activities
were estimated at 10 and 30 rain, 6, 12 and 24 hr, and
2, 3j 5? 7j 10, 12, 14, 21 and 28 days after administration*
The M*T*K* value was determined by the calculation of
Bauer et al (l95?) applied at 7 and 14 days* The plasma
and urine stable calcium were estimated by a modification
of the AutoAnalyzer technique (McFadyen et al, 1963)*
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Faecal calcium was estimated in an aliquot of a solution
of the ashed sample by titrating against EDTA with ammonium
85
purpurate as an indicator* Sr was determined in plasma
and in urine by counting 5 ml samples in an automatic well
85
scintillation counter* Faecal Sr activity was determined
by counting an aliquot of homogenized faeces in a large well
scintillation counter* Sufficient ammonium oxalate was
added to the plasma and urine samples to precipitate all
their calcium as the oxalate* This precipitate was then
filtered off on to a disc of glass-fibre filter paper, and
counted in a thin-window gas-flow Geiger counter* For each
85sample, the counts in the Geiger counter due to Sr were
85
estimated by counting a standard source of Sr, firstly in
solution in the well'scintillation counter and secondly, as a
precipitate in the Geiger counter* The ratio of these,
standard counts multiplied by the count-rate of the sample
in the well scintillation counter gave the count-rate of the 
85
Sr in the Geiger counter* By subtracting this count-rate
from the total count-rate in the Geiger counter, the
45 45
count-rate due to Ca was found* Faecal Ca was similarly
estimated by precipitating the calcium from an aliquot of the
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solution of ashed faeces used to estimate the stable
calcium® Each isotope sample was counted for the time
taken to record 5jOOO counts* Therefore, as the count-
rate due to the isotope fell, the standard error of the
counts due to the isotope increased* The least value of
this standard error was 1*5^ and this increased to 7^ when
the count-rate due to the isotope fell to its lowest value*
85
Thirty-two patients were given Sr by continuous
45feeding and 19 patients were given Ca* Six patients
45 85were given both Ca and Sr by intravenous injection^
The clinical details are shown in Tables XXVI, XXVIII.
The results of these investigations are shown in Figs 6l to 
65 and Tables XXVII, XXVIII* The patients described as 
having osteoporosis had decreased bone mass, but did not 
differ significantly from normal subjects when age was taken 
into consideration* This point has been discussed in detail 
in Chapters I, II and III*
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Results
At all levels of calcium intake in the continuous 
feeding studies, the net absorption of radiostrontium is 
less than that of radiocalcium (Fig, 6l If the
discrimination against strontium is simple competitive 
inhibition, it would be expected that the discrimination 
would increase with increasing calcium intake* However, 
there is no change in discrimination with increasing 
calcium intake, the average discrimination value being 
0*69* Bailey et al (1960) and Samachson (1963) found a 
discrimination factor of 0*5* Spencer et al (1960) found 
a factor varying from 0*40 to 0*45 by a single oral dose 
of the isotopes® Nordin et al (1964b)found a factor of
0*55 using a single oral dose and measuring the level of
45 85Ca and Sr in the plasma two hours later*
Discrimination by kidney
The urinary excretion of ^^Sr and ^^Ca during
continuous feeding of isotope at different calcium intakes
is sho\m in Fig* 62, The urinary excretion of ^^Sr
4 5is the Siune or slightly higher than that of Ca at all 
levels of calcium intake, and the excretion of both
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isotopes decrease with increasing intake® Since the
45 85
renal excretion of Ca and Sr depends in part upon
the plasma levels of these isotopes, discrimination by
the kidney can only be showi by comparing simultaneous
plasma and urine samples* This has been done and the
results are shown in Fig* 63® When compared in
85
this way, the urinary excretion of Sr is 3*34 times
45higher than that of Ca# This agrees well with the 
factor of 3*5.found in six normal subjects by Barnes 
et al, (1961)* Discrimination might arise in the 
glomerulus during filtration of plasma water or during 
reabsorption of calcium and strontium by the renal tubule*
If the protein binding of strontium is the same as calcium, 
then the above factor will be determined by tubular 
reabsorption assuming that all the smaller complexes are 
filterable* If the binding of strontium is different 
from that of calcium, then the renal discrimination factor 
would be affected by filtration* If the protein binding 
of strontium is less than that of calcium, as has been 
suggested by Samachson and Lederer (l95S), this would itself
157
tond to cause discrimination in favour of strontium*
In order to test whether the protein binding of
calcium was different from the protein binding of
strontium, serum samples drawn from patients given
strontium were divided into two* The serum calcium 
85
and Sr activity were measured in the first sample*
In the second sample, the serum was ultrafiltered by
the method described earlier (p* 115) and the scrum 
85
calcium and Sr activity determined in the ultrafiltrate*
QPJ
The specific activities ( Sr/mg calcium) were found 
not to differ significantly (Fig 64) indicating no 
significant difference in the serum protein binding 
of strontium and calcium.
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Skeletal discrimination
In the present investigation, the skeletal retention of
85 45
Sr is lower than that of Ca at all levels of calcium intake
in the patients on continuous feeding of isotopes* The
differences between ^^Ca and ^^Sr are factors of 0*6?, 0*57?
0,67 and 0*59 at intakes of 10, 10-20, 20-30 and 30-40 mg/lCg/day
(Fig* 65 )® These figures demonstrate that the proportion of
85 45
Sr retained shows little change compared with Ca, with
increasing calcium intake* The retention of both isotopes fell
with increasing calcium intake* Because of discrimination
against strontium at the gut and kidney, skeletal discrimination
can only be shown by measuring the mineral transfer rate* The
45 85
skeletal uptakes of Ca and Sr with the continuous feeding
85technique show a higher mineralization rate with Sr, but the
difference between the two, is not significant (TableXXVIl)*
There is no correlation between the ^^Ca and ^^Sr M,T*R» values
possibly because of the difficulty in obtaining an average plasma
85
specific activity for Sr as the isotopes were administered
twice daily* Because of this difficulty, the method of Bauer
et al (1957) was used to calculate MoT*R* between 7 and 14 days,
45following the simultaneous intravenous administration of Ca and
85Sr* This method of calculating MnToE® assiunes that no
isotope returns from the bone by resorption of labelled material,
and that the plasma has the same specific activity as the rapidly
exchanging calcium pools* The M®T*R* values of our six patients
are shomi in Table The only comparable data are
those of Dow and Stanbury (196O), which are in such a form that
it is possible to calculate the mineral transfer rates in the
same way by using the Bauer bone-mineralisation rate between
7 and 14 days* This has been done and the combined data are
shomi in Fig, 66® There is a correlation between the
45measurement of transfer of calciimi into bone by using Ca and 
^^Sr as tracers if all the cases are considered (r = 0*89) 
though there are individual discrepancies* Since the MpT*E« 
values do not have a normal distribution, only the normal and 
osteoporotic subjects are considered in Fig. ^7 and the ^^Sr
45M*T*R* values are significantly lower than the Ca values in
this group* As it is the ionic calcium and strontium that is
transferred into bone, a difference in the rate of transfer of
45 85
mineral from blood to bone, obtained by using Ca and Sr as
45tracers, could be due to the binding of Ca being different 
from the binding of ^^8r* Harrison et al (l955) found no 
difference between the protein binding of calcium and strontium 
in two patients, but Samachson and Lederer (l958) added ^^Ca
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85 85and Sr to plasma in vitro and showed that the binding of Sr
45was less than Ca* If the calcium and strontium are equally
bound then it is permissible to calculate mineral transfer rate
into bone by using plasma specific activity of ^^8r and ^^Ca.
If the binding of strontium is less than the binding of calcium,
85
the estimated bone-mineralisation rates with Sr are too high,
and the difference we have found between the bone-raineralisation
45 85
rates measured with Ca and Sr would be even greater than is
shewn in Fig* 67® Though the protein binding was not
found to differ significantly in the present study (Fig. )
there are other forms of bound calcium which could affect the 
results (Walser, 1961). A difference in the transfer rate of 
strontium and calcium into bone has been described in rabbits 
by Kshirsagar, Lloyd and Vaughan (1966)* They continuously fed 
young rabbits on a diet containing stable strontium and found 
that the skeletons of these animals contained a lower Sr/Ca 
ratio than the plasma and concluded that there is a discrimination 
factor of about 1*6 in favour of calcium in the transfer from 
blood to bone* However, this discrimination factor is only 
valid if the whole skeleton is labelled with strontium and is
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in equilibrium with plasma, and this has not been clearly
demonstrated to be so in these studies* Other workers have
found no difference in the rate of skeletal uptake of these
isotopes in animals (Bauer et al, 1955î Comar et al, 1956;
MacDonald et al, 195?)o In vitro experiments with bone powder
in a bathing fluid have sho’ivn a discrimination in favour of the
transfer of calcium ions into the bone powder in several studies
(Harrison et al, 1959; Boyd et al, 1959; Neuman et al, I963)*
The uptake of isotope in bone powder is, of course, due to
exchange* The discrimination appears to depend upon many
factors, such as temperature, pH, ionic concentration of calcium
and phosphate, and the concentration of other ions, and there
seems to be no good reason why this will not occur iu vivo®
Boyd et al (l959) in their work on bone powder have postulated
that under certain conditions the limiting factor determining
exchange of calcium and strontium into bone is the release of
stable calcium from the bone* Neuman (1964) also suggested two
different lattice positions for calcium ions, one of which is
not available for exchange of strontium ions* The evidence thus
85does support a discrimination against the uptake of Sr by bone,
85 45
but there is a correlation between Sr and Ca so that relative
changes ’in M<,T*R# of calcium may be determined from the study of
85the skeletal uptake of Sr in man.
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Bone mineral transfer rates in relation to age
The difficulties and limitations of measuring isotopes 
have been discussed above* However, there does appear to be a 
relation between the true bone formation rate and the mineral 
transfer rate (Heaney, 1964)* The problem lies mainly in the 
amount of mineral transferred from the extracellular fluid by 
exchange in contrast to the amount taken up by true bone mineral 
accretion* Heaney (1964) points out that from clinical data 
high accretion rates as measured by isotope kinetics are found 
in those pathological states in which high bone formation rates 
are apparent from the measurement of the alkaline phosphatase 
which is Imomi to be related to bone formation rate, and in whom 
the histological features are in keeping such as Paget’s disease, 
hyperparathyroidism, ■ and bone disease associated with hyper­
thyroidism* Conversely low values are found in those clinical 
conditions in whom the bone turnover rates are Icnown to be low 
such as hypothyroidism and hypoparathyroidism.
It is further evident that if the conditions associated 
with secondary osteoporosis, such as osteoporosis following 
gastrectomy, and associated with steatorrhoea, Cushing’s disease, 
hyperthyroidiam and other conditions with a clear metabolic or 
endocrine upset are excluded, then osteoporosis is most clearly
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linked to ageing (Chapters I and II)* The following study 
therefore is concerned with the measurement of the Mineral 
Transfer Rate in relation to age*
Method
85
Patients were given 30 pc of Sr by intravenous injection® 
The whole body retention of the isotope was measured using the 
whole body counter of Glass et al (1964) modified by adding more 
shielding round the detector without altering the iso-response 
field© The patient first lay supine and then prone on an 
arc of le25 m radius© A plastic scintillator of 17*3 cm diameter 
and 10 cm depth was placed at the centre of the arc© The whole 
body retention was calculated as the mean of the counts in the 
supine and prone positions© Whole body retention was measured 
2 hours after the injection, and this was taken as the 100 per 
cent retention value© Counts were repeated every 3rd or 4th 
day thereafter for 14 to 21 days© Blood samples were taken 
at the same time as the whole body counts were measured©
o K
The specific activities (i©e« per cent dose Sr/mg Ca) of the 
sera from the blood samples were measured by counting 5 ral of 
sera in a Nuclear Chicago automatic well scintillation counter 
and estimating the calcium in each serum calcium.
Ib4
Since discrimination is not possible with a plastic 
scintillator, and as redistribution of isotope within the body 
might affect the counts obtained, the whole body retention was 
examined further* This was done by comparing the whole body 
retention obtained in the counter with that obtained from 
estimating and subtracting the isotope lost in the urine and 
faeces from the dose given* All collections were done in a 
metabolic unit, and the results are compared in Table XXIX*
There was good agreement between the results using these two 
techniques© The mineral transfer rates were estimated between 
7 and 14 days using the calculation of Bauer et al (l95?)e
Patients studied
The patients studied comprised 65 females referred to a 
special Bone clinic for further investigation because they were 
considered to be osteoporotic by the referring physician or 
surgeon* Each of the patients had a hand X-ray and the metacarpal 
index (Appendix H  ) was measured (Table )#
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Results
The age5 weight; mineral transfer rates and metacarpal 
indices of each of the patients is shown in Table XXX^
There was no significant fall in weight with age (Fig 6S)p 
There was a fall in the Metacarpal Index (M^I@) with age 
(Fig 69)0 This measurement did not differ significantly 
from the measured in the 152 normal subjects (Group I -
Chapter l)^  The weight of these latter subjects falls 
slightly but not significantly with age* The mineral transfer 
rate measured by the method of Bauer et al (l95?) between 
7 and 14 days are also shown in Table XXX* The mineral 
transfer rate fell significantly with age (P < 0*005); the 
rate of fall being 140 mg/day (i.e* 310 to 1?0 mg/day) between 
40 and 90 years of age (Fig ?0)* This means a fall of:
n 170)
. 310) X 100 “ 1@27^ per year
50
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CHAPTER VI 
(PART if)
16?
TÎIfî MEASUREMENT OP BONE DESTRUCTION RATES
The measurement of the bone destruction rate in man 
is a more difficult problem than the measurement of the bone 
formation rate* At present there is no way of measuring the 
bone destruction rate directly using bone-seeking isotopes* 
However; if the bone formation rate is measured at the same 
time as a calcium balance is performed, then the bone destruction 
rate can be determined from the difference between them*
The one direct method of measuring bone resorption is that 
described by Jowsey (1966) which has been discussed on p. 145«
The problem with this technique is that it is limited to a 
small area only and it may not be representative of the whole 
skeleton*
Another method which has been used to determine the 
relative rate of bone resorption in man is to measure the 
excretion of hydroxyproline in the urine* Hydroxyproline is
an amino acid present exclusively in collagen* Various 
estimates of the amount of bone collagen in the body range 
from 40^ (Lightfoot and Coolridge, 1948) to 57/^  (Klein and 
Curtiss, 1964), The urinary hydroxyproline is not a direct 
measure of the collagen turnover as some is coming from 
sources other than bone, such as skin, while some collagen 
is also reutilised in the body amino acid pool*
J.UÜ
However, it has been shomi by Gerber et al (1960) using  ^
labelled proline, and by Neuberger and Slack (l953) that 
bone collagen turns over two to five times faster than skin 
collagen* Therefore, over 70/^  of the urinary collagen will 
have come from bone*
Prockop and Sjoerdsmo (1961) considered that the 
urinary hydroxyproline measured collagen breakdown, and 
would therefore reflect the rate of bone resorption* High 
values have been reported in these conditions in which the 
bone turnover is known to be high, such as Paget*s disease, 
hyperparathyroidism with bone disease and in hyperthyroidism 
(Dull and Henneman, 1963)0 Conversely, low values have been 
reported in conditions in which the bone turnover is laiown to 
be low, such as hypoparathyroidism and hypothyroidism (Benoit 
et al, 1963)4 Klein and Curtiss (1964) suggested that the 
urinary hydroxyproline was derived during the presence of 
bone synthesis* They derived this opinion from the measure­
ment of urinary hydroxyproline and calcium excretion in rats 
following parathyroid hormone injection* They claimed that a 
fall occurred in the urinary hydroxyproline at the same time 
as there was a rise in the urinary calcium followed by a rise
in the urinary hydroxyproline to higher than normal values 
four days later* They interpreted this as indicating an 
initial fall in the rate of hone formation, as suggested by 
the studies of Gaillard (1961), and the subsequent rise in urinar; 
hydroxyproline as being due to a rebound rise in the bone 
formation rate* However, these findings are in direct contra­
diction to those of Henneman (1964) who injected parathyroid 
hormone in man in both normal and hypothyroid patients in whom 
no initial fall in urinary hydroxyproline excretion occurred. 
There v/as a rise in serum and urine calcium from the start*
The urinary hydroxyproline rose four days later as occurred in 
the experiments of Klein and Curtiss (1964)* In a patient who 
had a parathyroidectomy for primary hyperparathyroidism,
Henneman (1964) found a rise in the alkaline phosphatase at the 
same time as there was a fall in the urinary hydroxyproline*
In a patient with Paget^ 's disease he demonstrated a fall in the 
alkaline phosphatase with a rise in the urinary hydroxyproline 
when the patient was immobilised* Klein and Curtiss (1964) 
also demonstrated a fall in urinary hydroxyproline and alkaline 
phosphatase in patients suffering from rickets who were being 
treated with vitamin D* However, this is contradictory to
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the rise in hydroxyproline excretion reported by us (Smith and 
Nordin, 1964; Nordin and Smith, 1967), when patients with 
osteomalacia were treated with vitamin D« Further, the dichotomy 
between the serum alkaline phosphatase and urinary hydroxyproline 
excretion is well shown in patients with hyperthyroidism in whom 
values of hydroxyproline excretion may reach more than twice the 
normal value without a corresponding rise in serum alkaline 
phosphatase* It is also evident from the values given by Klein 
and Curtiss (1964) for bone formation and bone destruction that 
in those conditions where the bone formation is raised, there is 
also a rise in the rate of bone resorption*
The object of the present study was to determine the bone 
destruction rates on a varied calcium intake by an isotopic 
method: to compare the results obtained with the changes in
urinary hydroxyproline output in the same subjects: to examine
the urinary hydroxyproline output in relation to age: to test
the effects of increased calcium intake on the 24 hour' urinary 
output of calcium.
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Procedure and methods
Three studies are described below;
In the first study, 14 subjects were investigated* 
Eleven were osteoporotic as determined by their bone density, 
the remaining three were normal* Details are shown in 
Table X>Dil,
All the subjects were admitted to a metabolic ward
and were maintained on a constant diet. The calcium intake
was varied as shown in Table XXXI, A dose of between 0*03
45and 0„05 pCi of Ca was administered twice daily in 2*5 mg
of calcium as calcium chloride. The urine and faeces were
45collected in 7 day aliquots and stable calcium and Ca 
determined (p,153 ), In 9 of the osteoporotic subjects, 
the urinary hydroxyproline was determined on 7 day urinary 
collections*
In a second study, 24 hour urinary collections were 
made on 119 female subjects and the urinary hydroxyproline 
measured* . The urinary hydroxyproline output in relation to 
age was examined* In 106 of these patients, the urinary 
creatinine was measured on the same 24 hour urine collection, 
and the urinary hydroxyproline/creatinine ratio plotted 
against age*
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In a third study, a group of 87 subjects were 
investigated* 24-hour urinary samples were collected and 
the urinary hydroxyproline was estimated* In 75 of these 
subjects the urinary collection was made while they were on 
their home intake* In 64 of these subjects the urinary 
hydroxyproline was estimated after the addition of calcium 
supplements (calcium glycerophosphate gm 2, t*i«d*) to their 
home intake for a period of not less than one week* Fifty 
of the subjects were common to both groups* All of the 
urinary hydroxyproline collections were carried out on these 
subjects while they were on a gluten-free diet*
The stable calcium in urine and plasma was determined by 
a modification of the AutoAiialyzer technique as described on 
p* 115o The faeces were ashed and the calcium determined by 
titration with 1ÎDTA using ammonium purpurate as an indicator* 
Radiocalcium was assayed as described on p, 153o Urinary 
hydroxyproline was estimated by the method of Prockop and 
Udenfriend (l96o)*
Calculations
The bone mineralisation rate was estimated as described 
on p* 152. The bone resorption rate was estimated by subtracting 
the calcium balance from the bone mineralisation rate*
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Resu'J ts
The plasma specific activity was recorded at frequent 
intervals during the first 21 days of isotope administration 
in 11 patients as shown in Fig 72, The plasma specific
activity rose for approximately 10 days and then became stable, 
but the urinary specific activity appeared to rise for about 
2-3 weeks (Fig 73 )« This stable level was generally lower
than the specific activity of the diet, the difference between 
the two being a function of the calcium intake.
The mean weekly percentages of the dose excreted in the 
first 8 weeks is shown in Table XXXII and Fig 73* The mean 
faecal activity varied between 55 and 65/^ of the dose and did 
not change significantly with time, although the mean levels 
were slightly lower during the first two weeks than subsequently* 
The urinary activity rose slightly in the first 3 weeks to reach 
what was virtually its equilibrium value of about lOJ^  of the dose 
by the third week* The mean isotope retention fell to its 
final value of about 25^ by the fourth week*
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Effect of intake on excretion and absorption
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The relation between calcium intake and isotope 
excretion and retention are shown in Table XXXI and 
Figs 74 and 75^ There was no relation between calcium 
intake and the amount of isotope excreted in the urine* 
Faecal activity, however, rose with increasing calcium 
intake from approximately 50^ to 70^ of the dose at the 
higher intake (Fig 74)*
There was a definite fall in isotope retention with 
increasing intake due to reduced absorption (Fig 75)®
The absorption of the stable and labelled calcium are 
related to the calcium intake (Fig ?6)* The absorption 
of the labelled calcium falls with intake, the absorption 
of stable calcium rising with intake*
Bone mineralisation and destruction rates
The mineralisation rates and destruction rates are 
shown in Table XXXI and in Figs 77 and 78* The bone 
mineralisation rates ranged from 2*7 to 17*2 mg/lCg/day, but 
the majority were below 10 mg/l(g/day* The mineralisation 
rate was independent of the calcium balance as sho^ vn in 
Fig 77o There was an inverse correlation between the calcium 
balance and the bone destruction rate as shown in Fig 78*
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In 9 of the osteoporotic patients the urinary hydroxy­
proline was estimated during the period of the above study#
The urinary hydroxyproline output was inversely related to 
the calcium balance (Fig 79) and directly related to the 
bone resorption rate (Fig 80)*
In a group of 106 subjects, the urinary hydroxyproline 
was collected over a period of 24 hours while they were on a 
home dietary intake from which gelatin was excluded^ Eighty- 
two of these subjects had been referred for investigation of 
osteoporosis* Their metacarpal indices were measured and the 
results compared with those obtained in 152 norma,l women* It 
is evident from Fig 81 that they did not differ significantly 
from the nonnal subjects* The remaining 24 patients did not 
have their metacarpal indices measured but there was no history 
suggestive of bone disease, endocrine disease or steatorrhoea*
In Fig 82, the 24 hour urinary hydroxyproline was plotted against 
age. There was a tendency for the hydroxyproline to be higher 
in the older patient, but this did not reach significance* In 
Fig 83, the urinary hydroxyproline/creatinine ratio measured in 
the same urine samples in 106 patients showed a significant rise 
with age* Fig 84 illustrates the urinary hydroxyproline excretioi 
in the 75 subjects studied on their home intake and in 64 with 
the addition of calcium glycerophosphate gm 2, toi^d** The 
patients on calcium supplements in addition to their home intake 
had a significantly lower urinary hydroxyproline output (p < OoOl)*
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Discussion
The measurement of bone formation rate is clearly 
important in the determination of the cause of loss of bone 
with advancing age, especially in women# The most practical 
method of determining the rate of bone formation in man is 
the use of bone-seeking isotopes* The two most couimonly used 
isotopes are those of calcium and strontium* The early part 
of this study is concerned with the comparison of the rates 
of calcium and strontium transfer across the gut, of the 
comparative rates of loss through the kidney, and the relative 
rates of uptake by the bone#
There is clearly discrimination against the transport 
of strontium across the gut as has been shown during the twice 
daily oral administration of these isotopes over a period of 
several weeks to patients undergoing a calcium balance study*
The average discrimination was 0*69 which compared well ivith a 
factor of 0*5 found by Bailey et al (i960) and Samachson (1965); 
and a factor of 0*55 found by Nordin et al (19646), the factor 
in the last three instances being determined by a single oral 
dose of the two isotopes* A similar but slightly lower factor
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ranging from 0*40 to 0*45 was found by Spencer et al (l960)e
These authors again used a single dose of the isotope*
The discriminatory factor of 0*69 in the present series was
not found to alter with varying calcium intake, and simple
competitive inhibition is therefore unlikely to contribute to
this discrimination#
There is also renal discrimination between calcium and
45 85strontium as judged by the urinary losses of Ca and Sr*
This results in a loss of strontium in the urine 3o34 times
greater than that of calcium* This could be due to lower
plasma protein binding of strontium, but from Fig* 64
45 85it can be seen that the protein binding of Ca and Sr did 
not differ significantly* The other site of discrimination 
could be in the reabsorption of these ions by the renal tubule, 
and would appear to be the likely site at which discrimination 
occurs a
The skeletal retention of both ^^Ga and ^^Sr fell with 
increasing, calcium intake* However, as there is discrimination 
against strontium in its transport across the gut and across 
the renal tubule, discrimination against strontium in its uptake 
by the skeleton must be tested for by measuring the mineral
transfer rates* The urinary specific activity of calcium
correlates well with the serum specific activity but
because of discrimination against the reabsorption of
strontium, the urinary strontium specific activity is not
representative of seruiu specific activity* In the continuous
feeding experiment, the plasma specific activities vary with
time because of the twice daily administration of the isotope#
Thus, this is not a satisfactory method of comparing the
uptake of calcium and strontium by bone. This is best
85done by giving a single intravenous injection of both Sr 
45
and Ca and estimating the mineral transfer rate between 
7 and 14 days by the method of Bauer et al (l957)o When 
this method is used there is evidence of discrimination 
against the uptake of strontium compared with calcium in the 
uptake of these isotopes into bone. Moreover, there are 
individual discrepancies* However, the M,T*B« measured by 
strontium does correlate with the measurement using calciuu 
(r = 0*89) and it is therefore legitimate to use ^^Sr
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and though it does not measure the true rate of calcium
transfer it does measure a function of it*
85
Since Sr proved a useful isotope in practice, it 
was used to measure the MoT*Kc in 65 subjects who were 
referred to a special Bone clinic because they were 
considered to be osteoporotic* As can be seen from Fig 69? 
these patients do not differ significantly from normal 
subjects as measured by the Metacarpal Index* As discussed 
in Chapter I, the total cortical mineral in female subjects 
falls from 2*5 to 1*8 between 40 and 75 years of age;
(1 ls3)
I °^e 2*5) X 100 - Co94^ per year 
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This figure is very close to the rate of fall of the M*T«R., 
and means that there is no significant fall in the MoT#R* 
per unit mass of bone with age though there is a fall in the 
total bone mineral transfer rate per year. The rate of fall 
in bone mass of a largely trabecular portion of bone mass is 
1*15^ per year in preliminary measurements done by us using a
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photon absorption technique, but this does require to be 
confirmed*
One of the major problems in any isotope study is to 
determine the relation between bone formation and the mineral 
transfer rate* From a study of quantitative autoradiography 
(Marshall, White and Cohen, 1959a; Marshall, Eoivland and 
Jowsey, 1959b; Marshall, Jowsey and Rowland, 1959c; Marshall 
Rowland and Jowsey, 1959d; Lacroix, 1962) it is evident that 
a bone-seeking isotope may enter bone and remain there for a 
reasonable time* First,forming osteons rapidly take up 
considerable quantities of isotope* These areas appear as 
intense black hot spots on the autoradiograph* Second, 
osteons which are not completely mineralised take up smaller 
quantities of isotope as they slowly mineralise* They appear 
as less intense hot spots in autoradiographs* Third, the 
rest of the bone takes up the tracer uniformly* This is the 
diffuse label0 The uptake of isotope is illustrated in Fig, 71» 
Any newly formed bone will pass through each of these stages 
in turn* ïiirther, short-term exchange processes occur which 
give rise to intense hot spots round blood vessels which disappear
lyi
soon after injection# Thus, a proportion of the isotope 
uptake measured by the MoT^R* will be true bone formation 
and a proportion will be due to exchange# Howland (1961)
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calculated that in dogs given Ra " the fraction of the 
isotope in diffuse label was 0*43 per cent* In I6 patients
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who had ingested Ra " the ratio was 0*47? 23-41 years after
85
taking the radium* If this held for Sr then the true bone
formation rate would be lower than the value given by the
mineral transfer rate* There is discrimination between
calcium and strontium at the bone surface, the ratio at
85
7-14 days being Oo85île The Sr M*T*R* would therefore be 
about 30/^  higher than the true bone formation rate# However, 
of even greater importance is the constancy of the proportion 
of the isotope going into bone by exchange and true bone 
formation* This has been examined by us in the dog using 
quantitative autoradiography (Shimmins, Lee, Wood and Smith, 
1970). In this study a comparison was made between the 
results obtained by autoradiographic studies of the quantity 
of isotope distributed as diffuse label and hot spots, and 
the bone formation rate as measured by tetracycline labelling.
Our study was carried out ou an elderly dog and compared 
with detailed information available from a study carried 
out by Lee, Marshall and Sissons (1965)0 Three facts 
emerged from this study* First, the rate of bone mineral
45transfer measured by Ca gave a higher value than that 
obtained from tetracycline, but the values correlated 
highly (r = 0*95)o Second, the bone formation rate measured 
with tetracycline and the mineral transfer rate measured by
45Ca both fell markedly with age. Third, the amount of 
isotope in the diffuse label fell with age so that the mineral 
transfer rate bore a constant relation to the true bone 
formation rate*
In the dog, the tetracycline value for the true bone 
formation rate was lower but very close to the mineral transfer 
rate* Few tetracycline label studies have been done in man, 
but the tetracycline values that have been obtained suggest a 
true bone formation rate considerably below that measured by 
the use of isotopes. This in itself would not matter so long 
as exchange and formation alter in the same proportions, but 
further information is required on this point*
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Jowsey (l9t)6) using the technique of microractiography to 
measure bone lorming and resorbing surfaces, claimed that 
the rare of bone formation per unit mass did not fall in 
osteoporosis but that the rate of bone destruction increased#
She did not study the changes in relation to age, but it is 
evident that osteoporosis, that is loss of bone mass, is a 
function of ageing, as shown in Chapters I,II and III.
Dymling (1964) also showed a lower mineral transfer rate in 
osteoporotic subjects and claimed that if the loss of bone 
mass with age was allowed for, then there was no significant 
difference between the normal subjects and the osteoporotic 
subjects* Both these studies are therefore compatible with 
the results obtained in the present study, which shows no 
significant fall in the mineral transfer rate when bone mass 
has been allowed for*
The measurement of bone resorption rate is a more 
difficult problem* Values for bone destruction rate can be 
determined with isotopes by measuring the mineral transfer rate 
and the calcium balance, and the difference will give the bone 
destruction rate# The difficulties involved in the measurement 
of the true bone formation rate have been discussed above#
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The measurement of the magnitude of the bone destruction rate 
will be subject to the same problem, though the tendency here 
will be to under-estimate the true value# In the present 
study, the object was to try and establish the relation between 
the rate of bone destruction and the urinary hydroxyproline output* 
There has been considerable controversy about this point* It 
is clear that urinary hydroxyproline output is a measure of bone 
^turnover*, this term being used to include formation and 
destruction* The output is high when bone turnover is high as 
in Paget*s disease and in patients with acromegaly (Nordin and 
Smith, 1965). To establish whether hydroxyproline output 
measures bone destruction rates or bone formation rates, it would 
be useful to study any condition in which either the bone formation 
or bone destruction rates were significantly different from one 
another* In most conditions where the bone formation is raised 
there is also a rise in the destruction rate due to remodelling 
as in Paget^s disease and in childhood* Henneman (1964) described 
a fall in the alkaline phosphatase which reflects osteoblastic 
activity, and a rise in urinary hydroxyproline in patients with 
Paget's disease who were immobilised* He also drew attention to 
the very high excretion of urinary hydroxyproline output in patients
with thyrotoxicosis even when there was no significant rise 
in the alkaline phosphatase# Klein and Curtiss (1964) took 
the view that urinary hydroxyproline was largely derived during 
the process of bone formation* However, they based their 
conclusions on the results obtained from injection of para­
thyroid hormone into rats, and these results were quite 
contrary to the results obtained by Henneman (1964) when he 
injected parathyroid into normal and hypoparathyroid subjects*
The conclusions of Klein and Curtiss (1964) also depended upon 
the results obtained by treating patients suffering from rickets 
with vitamin D in whom they claimed there was a fall in both 
the alkaline phosphatase and urinary hydroxyproline* These 
results do not agree with our findings,(Smith and Nordin, 1964; 
Nordin and Smith, I965) in patients with osteomalacia who were 
treated with vitamin D and in whom there was a rise in the 
urinary hydroxyproline*
In the present study, there was a fall in the bone
45
destruction rate measured with Ca with a corresponding decrease 
in the urinary hydroxyproline (P ^ 0,0l) (Fig 80),
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The decrease in urinary hydroxyproline correlated inversely 
with increasing positive balance (P < 0*01) (Fig 79 ),
During this study there was no change in the mineral transfer 
rate* The fall in urinary hydroxyproline was further 
confirmed in a group of patients on their home intake, on and 
off calcium supplements (Pig 84 ),
These findings suggest that the major component of the 
urinary hydroxyproline in osteoporotic patients comes from 
the destruction of bone# This does not of course exclude 
the possibility that some contribution is made to the urinary 
hydroxyproline from bone formation# It is also feasible 
that this contribution may be different in patients with 
abnormal conditions, such as Pagetdisease#
In 106 subjects, 24 hour urine samples were collected 
while they were on their home intake# In these patients 
there was a tendency for the hydroxyproline to rise with age 
but this did not achieve significance# However, the urinary 
creatinine output was also measured and when the urinary 
hydroxyproline/creatinine ratio is plotted against age there 
was a significant increase in output with age (P < O.Ol), the 
rate of change being 0*51^ per year# If a correction were
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to be applied for the loss of bone mass with age 
(about Ifù per year) then the rate of fall would be 
higher* These results are compatible with the loss 
of bone being due to an increase in the rate of bone 
destruction per unit mass while the bone formation 
remained constant„ This is in agreement with the 
results obtained by Jowsey (1966),
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CHAPTER VII
189
DIETARY mVÜŒl, CALCIUM ADSORPTION 
URIN'UIY CMDIUM EXCRETION IN RELATION 
TO B O m  M:\SS AND AGE IN MEN AND V/OM']N
It has been shown (Light and Frey, 1941; Greaves,
Scott and Scott, 1959? Harrison and Fraser, I960) that a 
variety of laboratory animals fed on £i low calcium diet, but 
with adequate vitamin D and phosphorus, developed osteoporosis# 
Jowsey and Gershon-Cohen (1964) confirmed these findings in 
cats# They also demonstrated that cats made osteoporotic with 
a low calcium diet, and then given supplementary calcium therapy 
showed an increase in bone density. That a positive balance 
can be produced in osteoporotic patients by feeding supplementary 
calcium has been reported by a niunber of authors (Owen, Irving 
and Lyall, 1940; Anderson, 1950; V/hedon, 1959; Harrison and 
Fraser, I96I; Nordin, 1962a), The relation between dietary 
intake and osteoporosis in man is therefore of considerable 
interest# Smith and Frame (1965) investigated 2,000 ambulatory 
women# They found a progressive loss in the vertebral density 
and cortical bone of the metacarpal and femur with age* They 
were not, however, able to demonstrate any relation between 
osteoporosis and calcium intake, the calcium intake being 
calculated from a diet history.
This study is in three partso The first part is 
concerned with the investigation of the dietary intake of 
calciuinj phosphorus, protein and vitamin D in normal female 
subjects, and in female patients referred to a special hone 
clinic because they were thought to have osteoporosis. On 
these same subjects, calcium absorption was estimated using an 
isotope of calcium, and the urinary calcium excretion was 
measured^
The second part of the study is an investigation of the 
relation between the dietary intake of calcium, phosphorus, 
protein and vitamin D and the X-ray indices of bone mass in the 
same normal subjects and also in the patients referred because 
they were considered to be osteoporotic «
The third part of the study is a similar investigation 
in normal male subjects, and a comparison between the males and 
females.
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Subjects studied
Three groups of subjects were studied. The first was 
the control group of 152 normal female volunteers recruited from 
the relatives and friends visiting patients in the wards of the 
Western Infirmary, Glasgow (Group I - see Chapter l)^  Diet 
histories were available in 141 of these subjects* The second 
was a group of 97 patients referred for investigation and 
treatment of severe back pain or recent fracture, and who were 
thought to be suffering from osteoporosis by the referring 
physician or surgeon on examination of standard X-rayso These
97 patients represent the first 97 patients of the 136 osteoporotic 
subjects described in Chapter II<, The third was the control group 
of 75 normal male volunteers, as described in Chapter Diet
histories were available in 68 subjects*
Procedure
The subjects were interviewed and the standard questionnaire 
illustrated in Appendix III completed for the three groups of 
patients* Skeletal X-rays were taken and the Metacarpal Index, 
Femoral Index and Spinal Index, and Relative Vertebral Density 
measured as described in Appendix Il(*ordin$ Barnett, Smith &  Anderaon, 
1966), A radiocalcium test of calcium absorption was performed
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(Bhandarkar et al, I96I) (Chapter IV), Random urine 
specimens were taken on two separate occasions and the 
moan of the two calcium:creatinine ratios recorded (Nordin 
and Smith, 1965)« Patients with secondary osteoporosis 
(Nordin, I96I) were excluded from the survey«
Diet histories, with particular reference to 
calcium, phosphorus, protein and vitamin D, were obtained 
from all the subjects by a dietitian especially employed for 
the purpose* The validity of the diet histories in terms of 
the weekly-weighed diet is being reported elsewhere (Nordin 
and Harrison)* All the data were recorded and processed by a 
medical data processing system utilising magnetic tape record 
files and flexible search on routine statistical processing*
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Dietary intake, calcium absorption, urinary calcium excretion 
and bone X-ray changes in w o m e n ____
Results
a) Social class
The social classes of the normal female volunteers 
(Group I, Chap* I ) and patients were recorded according to their 
husbands* occupations (or their oivn if widowed or single)* The 
two groups are compared in Table XXXIII* The social classes of 
both the control group and the patient group are very similar*
Both show a preponderance of subjects in social class 3 (skilled 
workers)*
b) The menopause \ ^/ -----— — " in normals
The average age of the onset of the menopause^was 4? years 
and in the patient group, 46*6 years, the subjects who had had 
an artificial menopause being excluded* The difference was not 
statistically significant when tested by Student's *t*^ test* A 
higher proportion of the subjects in the patient group had had an 
artificial menopause (23?0 compared with the control group (lO^), 
The average age at the time of the artificially induced menopause 
was 41 years in both groups* Eighty-one of the normal group were 
post-menopausal and 84 of the patient group*
c) Incidence of fractures
This is shomi in Table XXXIV* The incidence of fractures 
is significantly higher in the patient group than in the controls^
In both groups, the highest incidence of fractures was in the 
upper limb*
194
(I) Incidence niid site of backache
The incidence and site of backache in the two groups 
is shown in Table XXXV* Backache affected 34^ of the control 
patients and of the referred patients* The patient group 
were older and, as can be seen from Table XXXVI, the incidence 
is highest from 41-30 years. No relation between backache 
and the X-ray score was found* The pattern in the two groups 
is very similar, the commonest site of back pain being the lumbar 
region, followed by a high incidence of pain in that site 
radiating down the logs, suggesting the presence of a disc 
lesion* Pain in the sacral region wns surprisingly common*
Pain in the thoracic region and cervical region were less 
frequently complained of*
e) Other clinical features
These are shown in Table XXXVII* The high incidence of 
urinary symptoms was striking* Four patients from each group 
complained of recurrent diarrhoea* Two subjects in each group 
had had renal stones, and three suojoctw in the patient group 
and one in the control group complained of loin pain at the same 
time in the past, suggestive of renal colic* The incidence of 
symptoms was slightly higher in the patient group than in the 
controls, but again the pattern was very similar*
1^9
f) Obstetric history and breast-feeding
In patients over 50 years of age, who would be expected 
to have reached the end of their reproductive life, the average 
parity in the normal group was 2*0 and in the osteoporotic group, 
2*2* Of the subjects under 50 years of age, the mean parity in 
both the controls and the patient group was 2*2* In Table XXXVIII 
the mean parity in each of the decades between the 3rd and ?th 
decades, and in subjects over the age of 70 years is shown*
Again, there was no significant difference between the groups*
The average number of months that each subject with one or more 
children breast-fed their offspring in the normal group was 16,7  
(S*E* - 1*35) and 20*4 (S*E* - 2*95) in the patient group*
There was no significant difference between the two groups 
(P > 0.05),
g) Comparison of X-ray indices between normal subjects 
and patients, and the relation of the X-ray 
indices to ago________ ________________________
The X-ray indices were correlated with age (Table XXXIX)
It is clear, except for the spine index in the osteoporotic
group, that X-ray indices of bone mass fall significantly with
age in both groups* The two groups were compared by relating
the Metacarpal Index, the Femoral Index, the Spine Index and
the Relative Vertebral Density to age in 5 year age groups*
The results of the comparison relating the Metacarpal Index
to age are shown in  Fig 85# As C£in be seen, there was no
significant difference at any 5 year age group between the two
groups though the patient group were slightly lower than the
control group at each age* Similarly, when the two groups
were compared in terras of the Femoral Index, Spine Index and
Relative Vertebral Density, no significant difference at any
age range emerged*
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h) The relation between age, weight and dietary intake
The mean and two standard error range of intake of 
calcium (mg/day), phosphorus (mg/day), protein (gm/day), 
and vitmiin D (international Units/day) in the normal and 
osteoporotic groups are shown in Pig 86, There was a
significantly lower intake of phosphorus (P < 0*001), 
protein (P < 0*001), and vittunin D (P < 0*00l) in the patient 
group, hut the intake of calcium was not significantly 
different in the two groups* As body weight might be 
expected to influence dietary intakes, the weights of the two 
groups were compared* The mean weight of the normal women 
was 62*0 ICg (S*E* = 0*93)y and of the osteoporotic women,
58oO Itg (S*E* - 1,10), The 'osteoporotic* patients were 
therefore slightly but significantly lighter in weight than 
the normal subjects (Pig 8? )*
The age distribution of the normal and osteoporotic 
subjects were compared* The patient group were found to be 
significantly older than the control group, the average age 
of the osteoporotic patient being 61,8 years, and of the 
control subjects, 51*6 years (Pig 88 .), The body weights
were regressed against age in both groups separately and
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together. There was a slight but not significant fall in 
body weight with age (normal subjects r = -0*035? 
osteoporotic subjects r - -0*058 - nonnal subjects plus 
osteoporotic subjects r = -O^IO?)* Since the patient group 
is both older and lighter than the control group, the dietary 
intakes were adjusted to take this into account and the 
results are shown in Fig 89 * As can be seen, there is no 
significant difference between the groups when studied in 
this way*
In both groups, the dietary intakes appeared to fall 
with age and this was further investigated* The results 
are shown in Table XIj  ^‘ The dietary intakes are correlated
with age in both groups separately and combined* The analysis 
was repeated after the dietary intakes were divided by body 
weight* The intakes of phosphorus, protein and vitamin D, 
but not the intake of calcium, fell significantly with age in 
the control subjects. However, when the dietary intake was 
divided by body weight no significant relation between intake 
and age was found* In tlie patient group, only the protein 
intake, not divided by body weight, showed any significant fall 
with age* V/lien the groups were combined, all dietary intalces
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showed a small fall with age* 'When the intakes were divided 
by body weight, there was a significant fall in the intake of 
phosphorus, protein and vitamin D but not in calcium with age^ 
i) Calcium absorption
The absorption of calcium as measured by the radiocalcium 
absorption test is plotted against age in 10 year age groups, 
and the results are sho’tvn in Fig 90* There is no significant 
difference between the groups, except between 6l and 70 years, 
when the patient group showed a significantly lower calcium 
absorption* However, this difference was no longer apparent 
after the plasma specific activity, was corrected for body 
weight* There was no significant fall with age when the groups 
were studied separately, but when both were taken together there 
was a small but significant fall in absorption with age 
(r = 0*18; P < OoOl)o Since body weight would be expected 
to influence the measurement of the plasma level at 2 hours 
after ingestion of the radioisotope because the calcium pool 
would be larger in the heavier subject, the two hour serum value 
was multiplied by body weight* No significant difference emerged 
between the groups, but there was a significant fall in 
absorption when both groups were taken together (r = 0*235; 
t = 3.512; P < O.OOl),
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i) Urinary calcium excretion
The urinary excretion of calcium, as measured by the 
mean of two separate estimations of the calcium:creatinine ratio 
in the two groups, did not differ significantly (Pig 91),
Again, when regressed against age, there was no fall in urinary 
calcium output with age when the groups were considered separately 
or together.
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The relation between X-ray indices and nutrition 
i n f eni a 1 e s ub je c t s
It is evident that the normal subjects (Group l) 
and the patients referred because they were considered to 
be osteoporotic (Group II), do not differ significantly in 
their X-ray scores at any decade» The mean X-ray score of 
the patients in each decade is very slightly lower than that 
of the control group though this is not surprising in view of 
the way in which they were selected* Further, the rate of 
fall of bone mass with age in both groups is virtually 
identical» The age of onset of naturally occurring 
menopause was 46*6 years in the patient group and 47 years in 
the control group* Parity was similar in both groups*
The length of time of breast-feeding was slightly but not 
significantly longer in the patient group than in the controls* 
The distribution of the social classes within the groups was 
very similar* The incidence of fracture and backache was 
higher in the patient group, but again this is not surprising 
as it ivas for these reasons in the main that the patients had 
been referred for investigation.
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The dietary intakes in the two groups when adjusted 
for age and weight again do not differ significantly*
Calcium absorption was very similar in the two groups except 
between 6l and 70 years when a small but significant difference 
was found* The importance of this, however, is doubtful as 
the mean absorption was virtually identical in all other 
decades* Furthermore, no significant difference in absorption 
at any decade was found when the plasma activity was corrected 
for body weight. The urinary excretion of calcium is again 
very similar in the two groups*
Since it is the fall in bone mass which is the important 
factor in determining whether or not fractures will occur, and 
both groups have similar bone mass on X-ray and in whom the bone 
mass falls at the same rate, studies of the effect of diet on 
the bone mass in the two groups have been combined and the bone 
mass and dietary intake compared*
Results
1o X-ray score and dietary intake
In Figs 92 to 95 the dietary intake of calcium, phosphorus, 
protein and vitamin D have been plotted against the X-ray indices* 
The dietary intakes of calcium and phosphorus are plotted in 200 mg 
intervals, vitamin D in 10 International Unit divisions and 
protein in 10 gm intervals* Since it is evident that body weight 
is an important variable, the intake of each of the constituents 
has been divided by body weight and the results are shoTO in 
Figs 96 to 99*
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The corrélations between dietary intake and X-ray scores
are shown in Tables XLI, XLII, and XLIII*
Tables XLI and XLII show the relation between the various X-ray 
indices in the normal and 'osteoporotic® female subjects separately, 
Before dividing the dietary intake by body weight there is a 
positive correlation between Metacarpal Index and calcium intalte 
in both groups* The Metacarpal Index in both groups and 
Relative Vertebral Density in the normal group are related to 
phosphorus intake* There is no relation between the X-ray indices 
and protein or vitamin D intake in the 'osteoporotic® subjects, 
but in the normal group all the indices except the Spinal Index 
are related to protein intake* The Spinal Index mid Relative
Vertebral Density are related to vitamin D intali:e in the normal
subjects* V/hen the dietary intakes are divided by body weight 
there is no relation between the X-ray indices and intake in the 
patient group* In the normal female group there is a relation 
between Metacarpal Index and phosphorus and protein intake, and 
Relative Vertebral Density and vitmnin D intake only* When the 
two groups are combined there is a significant relation 
between all the X-ray indices and protein intake; between 
all the indices except the Femoral Index and vitamin D 
intake, and between all the indices except the Spinal 
Index and phosphorus i n t a k e O n l y  the Metacarpal
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Index is weakly related to calcium intake* When the 
dietary constituents are divided hy body weight there is 
no relation between calcium intake o,nd the X-ray indices*
There is weak relation between Metacarpal Index and 
phosphorus intake* The protein intake is related to the 
Metacarpal Index and Relative Vertebral Density* Vitamin D 
■intake is related to all the X-ray indices except the Femoral 
Index*
The X-ray indices fall with age (Table XXXIX),
There is also a fall in dietary intake with age (Table XL)* 
There is a slight though not significant fall in body weight 
with age* When the dietary intake is divided by body weight 
then there is still a significant fall in dietary intake with 
age of phosphorus, protein, and vitamin D (Table XL)*
Therefore, age is the major factor determining the value
of the X-ray indices, and the data is re-analysed in Figs 100
to 111* These figures illustrate the dietary intake 
of calcium, phosphorus, protein and vitamin D in the combined 
group, the subjects being divided into decades from the 5th 
to the 7th, In each decade, the subjects were divided into
those having high and low X-ray scores the mean being the
dividing lino* The dietary intake of those subjects with
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high and low X-ray indices have been compared* This 
comparison was made before and after dividing the dietary 
intake by the body weight*
Between the ages of 41 and 50 years, there was no 
relation between the dietary intake and the Metacarpal Index 
(Fig lOO). There was a significantly lower intake of
phosphorus and protein in those patients with low femoral 
indices which was no longer apparent when the individual 
dietary intakes were divided by body weight (Fig lOl),
There was a significantly lower intake of phosphorus/l(g body 
weight in those patients with spinal biconcavity (Fig 102), 
There was however no difference between the dietary intakes 
of those patients with low and high Relative Vertebral 
Densities, (Fig 105).
In the 6th decade, those subjects who had a low 
Metacarpal Index had a significantly lower intake of calcium, 
phosphorus and protein than those with a high Metacarpal Index 
(Fig 104), Only the difference in protein intake remained
significant when the dietary intake was divided by body weight*
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There was no significant difference in intake uf any dietary 
constituent in those subjects with high or low femoral indices 
(Fig 105)# There was no evidence of a lower dietary
intake in those subjects who had spinal biconcavity (Fig IO6). 
However, those subjects who had a low Relative Vertebral 
Density had a significantly lower intake of phosphorus, 
protein and vitamin D whether the dietary intake was divided 
by body weight or not (Fig 107).
In the age range 6l to 70 years, it was only in those subjects 
who had spinal biconcavity (i*e* a low Spinal Index) that there 
was a slightly lower intake of vitamin D (Fig llO), 
but this difference was no longer apparent when the vitamin D 
intake was divided by body weight (Fig llO), There was
no significant difference between the dietary intakes and 
the subjects with high or low metacarpal, femoral or spinal 
indices or Relative Vertebral Densities, (Figs 108, 109, 111).
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A comparison between the dietary intake, calcium absorption, 
urinary calcium excretion and bone mass in male and 
female sub;jects _______ ___________ _____ _______________ _
It is evident that the major problem of osteoporosis
in the ageing population is the bone loss that affects women*
There is a much smaller loss of bone in men with age as has
been shown in Chapter I and as has been illustrated in studies
by Gitman and Kamlioltz (1965), Morgan et al (1967), Garn,
Rohman and Nolan (1964), and Meema, Bunker and Meema (19^5)«
Moreover, the importance of this difference is evidenced by
the higher incidence of fractures in women and the much higher
rate of increase in the prevalence of fracture with increasing
age (chapter III)* This increase appears to be directly
related to the rale of bone mineral loss up to the age of 75
to 80 years after which the rapid increase in fracture incidence
is obviously related to factors other than the rate of bone
mineral loss which tends to decrease after the age of 70 years*
It is evident therefore that a study of the differences
between the dietary intake, calcium absorption and urinary
excretion of calcium in male and female subjects could be of
considerable interest* This study is concerned with the
investigation of dietary intake, calcium absorption, urinary
calcium excretion and bone mass in male and female subjects*
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Subjects studied
The female subjects are the combined normal 
group and the subjects referred to a special Bone clinic 
because they were considered to be suffering from osteo­
porosis* Both groups of subjects have been examined 
in the present chapter and were not found to differ 
significantly* The reasons for regarding them as a 
normal population has been discussed*
The male subjects were those of Group II (Chapter l)
and consisted of 75 subjects, as described on p, 37#
The procedure followed for the investigation of these
two groups has been described on p* 191*
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Results
The male subjects are significantly younger (Fig 112) 
and heavier (Fig 113) than the female subjects*
Ii] Chapter I, the social classes of the groups have 
been exmnined and there is a higher percentage of subjects in 
Social Class 3 in the female subjects*
The changes with ago in each group of the Metacarpal 
Index (M*I*) the Femoral Index (F*I*), Spinal Index (S*!*) and 
Relative Vertebral Density (R*V*D* ) are shown in each grou%) 
(Table XIjIV)» Only the fall in the Femoral Index in the 
male subjects reaches significance (p < 0*01)* All the X-ray 
indices fall significantly with age in the female subjects 
(p < 0*001 in each instance).
Since there are significant differences in age between 
the male and female subjects (Fig 112) they have been divided 
into groups by decades and the X-ray indices then compared*
The results are shown in Figs 114 to 11?, There is a 
relatively small fall in the X-ray indices with age in the male 
subjects, but even so significant differences between the males 
and females were only apparent after the age of 60 years.
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Further, this Vvus only evident in the M'»Io and though
the pattern of change was similar in the 3*1* and F*I,«
The male subjects had a significantly higher intake 
of calcium, phosphorus, protein and vittuiiin D than the female 
subjects (p < 0*001 in each instance), but this difference was 
no longer apparent when the dietary intakes were divided by 
body weight (Figs 118 and 119)» Since the male subjects were 
younger on average than the female subjects, the dietary 
intake was examined by decades (Figs 120 to 123)@ There was 
a significantly lower intake of protein at all ages in the 
female subjects and in vitamin D in the 5th and 6th decades* 
However, these differences were no longer apparent when the 
dietary intakes were divided by body weight (Figs 124 to 12?)* 
Calcium absorption falls significantly with age in the 
female subjects when considered as the 2 hour plasma specific 
activity and as the plasma specific activity multiplied by body 
weight to correct for differences in size of individuals*
The calcium absorption shows no significant change with age in 
the male subjects either considered as the 2 hour plasma specific 
activity or as this value corrected for body weight.
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The calcium absorption in the male and female subjects has 
been examined in each 10 year decade and the results are shown 
in Pig 128 and 129, When considered as the specific activity 
at 2 hours (Pig 127), the female subjects between 51 and 60 
years and 6l and 70 years have a significantly lower absorption 
of calcium than the males* When the value is corrected for 
differences in weight of individuals, the female subjects have 
a significantly lower absorption throughout the age range 31 to 
70 years (Pig 129)®
The urinary calcium excretion measured as the 
calcium/creatinine ratio shows no significant fail with age* 
When compared with the female subjects in 10 year decades again 
there is no significant difference between the male and female 
subjects, except between Si - 50 years* However, the male 
subjects have a lower mean Ca/Cr ratio throughout the age range 
from 31 to 70 years (Pig 130),
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The relation between dietary intake of calcium, 
phosphorus, protein and vitamin D, and the X-ray indices of 
bone mass in the male subjects are examined in Table XIV*
In contrast to the female subjects, it is only the Femoral 
Index that shows a significant correlation with dietary intake 
of calcium, phosphorus and protein, but not of vitamin D*
When the intakes of the various constituents are divided by 
body weight there is a weak positive correlation between the 
intake of calcium and phosphorus with the Relative Vertebral 
Density*
There is a small fall in the dietary intakes of calcium, 
phosphorus and protein with age in the male subjects (Table XLVl) 
but it is only the fall in protein intake that achieves 
significance (p < 0*05)® There was a slight fall in body 
weight with age (r - -0*225) but this did not reach significance 
(t = -1.949; P > 0,05).
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Dis eus si Oïl
The striking feature in this study is the similarity 
between the two groups of female subjects selected in completely 
different ways* The control subjects were selected as described 
previously (p* 31 ) by approaching the relatives and friends
visiting patients in the general medical wards of the Western 
Infirmary, Glasgow* The patient group consisted of patients who 
had boon referred to a special Bone clinic because they were 
thought to be osteoporotic® All had presented with symptoms 
such as backache or had had a recent fracture, and the referring 
physician or surgeon had felt that the patient had osteoporosis 
after the X-rays had been examined* All the patients had serum 
calcium and phosphorus estimations, and a calcium:creatinine 
ratio and phosphate excretion were estimated by measuring the 
Phosphate Excretion Index (P*E*I*) (Nordin and Fraser, 196o)„
In this way, patients who had evidence of other bone disease were 
excluded*
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The distribution within the social classes of the two 
groups was very similar, both showing a higher proportion of 
patients in social class 3 (skilled workers) which reflected 
the population served by the hospital at the time of the 
investigation*
The average age at the onset of the menopause was not 
significantly different* A higher proportion of the subjects 
in the patient group had had an artificial menopause, but the 
operation is done more frequently in patients who are approaching 
or have passed their menopause* The patients constituted an 
older group so that this finding is not surprising* The patient 
group had a higher incidence of fracture and of backache.
Again this is not a surprising finding* There were two reasons 
for this, the first being that these two features were the 
commonest reasons for referring the patients, and the second 
that the patient group were older. When symptoms were considered 
there was a slightly higher incidence of other symptoms in the 
patient group, but the differences were small* The striking 
feature is the high incidence of urinary symptoms in both groups* 
Parity did not differ significantly in either group considered as 
the mean or by decades. There was no difference in the average 
length of time that either of the groups had breast-fed their 
infants*
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Though the patient group had significantly lower X-ray 
indices and densities than the control group, they were older, 
and it is now clearly established that X-ray indices fall with 
age (Meema and Meema, 19&5; Nordin et al, 1966; Fujita, Orimo 
and Yoshikawa, I966; Morgan et al, 196?; Smith et al, I969),
Once age was allowed for, there was a striking similarity between 
the groups in the measurements of bone mass* Both groups also 
showed a fall in bone mass with agOo
The dietary intakes of the two groups showed a significantly 
lower intake of phosphorus, protein and vitamin D, but not of 
calcium in the patient group* However, the patient group 
constituted an older and lighter population and once age and 
body weight were allowed for, these differences disappeared*
The two groups did not differ in their absorption of calcium as
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measured by an isotope test of absorption using Ca, and no 
difference was found in the urinary output of calcium as measured 
by the mean of calcium:creatinine ratios in the urine.
There was a slight fall in calcium intake with age*
There was a more significant fall in the intake of phosphorus, 
protein and vitamin D with age* There was a very significant fall 
in bone mass with age* Though these dietary changes with age are 
small, only a small negative balance of less than 30 mg/day of
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calcium would be enough to account for the loss of bone in 
these subjects* However, this does not necessarily mean 
that dietary intake is related to the development of 
osteoporosis, as both the fall in X-ray measurement and 
dietary intake could be a function of ageing*
In this investigation, which is concerned with the 
relation between diet and bone mass, the patients and the 
normal female subjects were considered together* The reasons 
for considering them as forming a single population have been 
discussed and it is evident that once age and body weight are 
allowed for, that they do not differ significantly* The 
dietary intake of protein, phosphorus and vitamin D are 
significantly related to the X-ray indices of bone mass.
Calcium intake is only weakly related to the X-ray indices.
There was a more significant relation between the X-ray indices 
and the intake of phosphorus, protein and vitamin D, However, 
these differences could result simply from the fall in the 
dietary intake with age and be co-incidental to the fall of the 
X-ray indices with age* That is, the fall in both could be 
simply due to ageing or some unîmo\ra factor associated with ageing,
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The only way to eliminate this effect so that the importance 
of diet can be considered is to examine the dietary intake in 
subjects with high and low X-ray indices and Relative Vertebral 
Densities* The results are illustrated in Figs 100 to 111,
Only minor differences, which decreased markedly when body 
weight was allowed for, were evident in the 5th and ?th decades*
In the 6th decade, the differences in intake were more significant, 
There were small differences in calcium and vitamin D intake, 
but more significant changes in the intake of phosphorus and 
especially of protein* There is no immediately obvious 
explanation of why this should be so, but it is interesting 
that it is at this age that the rate of loss of bone is greatest 
in women* The menopause occurs at 4? years of age on average, 
and the X-ray indices fall markedly in the period 5"10 years 
after the menopause*
It is not an artefact due to there being a higher 
proportion of larger individuals in one or other group as these 
differences persist though the significance is decreased by 
dividing the dietary intake by body weight* Further, the X-ray 
measurements of bone themselves allow for differences in the 
size of individuals (Chapters I, II and III),
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However, it would be only too easy to over-emphasise 
these differences 5 and the mean dietary intakes would be 
considered completely adequate by the recommended intake 
of nutrients for rhe United Kingdom laid down by the Department 
of Health and Social Security Stationery Office, Report
on 3diblic Health and Medical Subjects No* 120)* This study 
emphasises the importance of allowing for the changes in body 
weight and bone mass with age. It is evident that the dominant 
factor concerned with the loss of bone in women is age or some 
factor associated with age*
In Chapter III, the importance in the difference in 
the changes in bone and its association with fracture in males 
and females has been discussed* The incidence of fracture 
increases in men and women with age, but the rate of this 
increase is very much higher in women. This is directly 
related to the total cortical mineral content, which falls 
much faster in women than in men. The differences between 
the mineral content in male and female subjects, once age and 
size have been allowed for, become significant after the 6th 
decade* The male subjects have a significantly higher intake
219
of calcium, phosphorus, protein and vitamin D* However, 
once allowance has been made for differences in weight, 
and the intakes of the various dietary constituents 
considered by decades, there is no significant difference 
between male and female subjects* This adds further 
support to the evidence that the development of primary 
osteoporosis is not related to dietary intake of calcium, 
phosphorus, protein or vitamin D in this Western urban 
population*
There is, however, a small but significant fall in 
calcium absorption with age in women, which does not occur 
in the male subjects* There is a small, but again 
significant fall in dietary intake, though there is no 
appreciable difference between the male and female subjects 
There is no significant fall in urinary calcium excretion 
with age in the female subjects in spite of the diminished 
calcium intake and calcium absorption* The male subjects 
do not show a significant change in urinary calcium with 
age, but they do show a slightly lower calcium excretion 
than the female subjects at all ages, though this does not 
reach significance, except in the 4th and 5th decades*
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Conclusions
The fall in X-ray indices of bone mass with age in 
women is associated with a fall in the dietary intake of 
calcium, phosphorus, protein and vitamin D* The smallest 
decrease in intake with age was in the calcium intake *
However, the female subjects show a fall in calcium absorption 
with age, while the urinary calcium excretion remained unchanged 
up to the age of 70 years* These changes were not observed 
in men who show relatively small changes in bone mass with age* 
The intake of calcium, phosphorus, protein and vitamin D were 
very similar in male and female subjects once age and differences 
in body weight were allowed for* Moreover, the male subjects 
had a significantly better calcimn absorption than the female 
subjects at each decade between the ages of 30 and 70 years*
The male subjects also had a lower urinary CEilcium excretion 
at each decade between the ages of 30 and 70 years, though these 
differences did not achieve significance at any one decade.
These differences between the male and female subjects would be 
sufficient to account for the differences in the X-ray indices 
which develop with age* There are also significantly smaller 
intakes of phosphorus, protein and vitamin D in the female
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subjects between the ages of 51 and 60 years, who have lower 
spinal densities* It is interesting that these differences 
in the spine should occur in trabecular bone in the main 
at the decade following the menopause. However, none of the 
above associations need imply causation. Most of the results, 
except the last, could be explained as being secondary to 
changes at the cellular level in bone, or in the factors, such 
as parathyroid secretion or the activity of calcitonin and 
growth hormones, which control bone formation and destruction.
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CILVPTER V I I I
BONE DENSITY M D  CAECimi MSIWBOLISM IN  PATIENTS FOLLOWING 
VAGOTOMY \'/ITH G/lSTRO-OEJTJNOSTOLIY AND PiUlTLVL GASTIffiCTOMY
In 1939j Ask-Uixuark predicted that partial gastrectomy 
might give rise to osteomalacia^ Nicolaysen and Regaard (l955) 
found a negative calcium balance in some gastrectomised patients* 
Osteomalacia, resulting from gastrectomy, has now been reported 
by a number of authors (Baird and Oleeslcy, 1957; Clark, Crooks, 
Dawson and Mitchell, 1964; Hall and Neale, 19&3; Melick and 
Benson, 1959; Harvald, Krogsgaard and Lous, 1962)*
Steatorrhoea is Imomi to occur in a proportion of patients 
following gastric surgery, and distrubances of calcium metabolism 
are inferred to arise from this source* However, a decrease in 
appetite is common following gastrectomy, and weight loss is 
usual (Avery Jones, Gumraer and Lennard-Jones, 1968)* Ekbom and 
Hed (1965) report on a series of 35 partial gastrectomised 
patients selected from a series of 317 patients because they had 
a history of malabsorption, 1,6* anaemia, weight loss and recurrent 
diarrhoea* Of these, 15 consecutive patients ivere studied in 
detail* Seven had increased calcium retention following calcium 
infusion* Two patients had raised alkaline phosphatase.
Eight patients had definite steatorrhoea with faecal fats of 
more than 9 gm/day and a further three patients had faecal fats
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greater than 5 gm/day* X-rays showed thinning of the bones 
in only three patients and this was mainly of the vertebral 
column* None had spontaneous fractures or Milkman*s fractures.
All the patients were unable to tolerate milk and some could 
not tolerate cheese either* Calcium intake in gastrectomised 
patients 199 - 1066, mean 649 - 6 <, Controls 604-1135? 
mean 883 — 41. The difference between the two groups was 
highly significant (p < 0*001)* Deller and Begley (1963) 
found * décalcification^ in 50^ of their patients - 100 patients, and 
100 controls* Clark et al (1964) found metabolic calcium
disturbance in of 55 patients* Thompson, Lewis and Booth
(1966a) reported a diminished absorption of vitamin D using 
trittium labelled vitamin D in 5 out of 6 patients with osteomalacia 
following gastrectomy* The absorption was virtually nil in one 
patient with associated pancreatic defect* The net absorption 
of vitamin D was normal in 4 patients following gastrectomy 
without osteomalacia, two of whom Imd frank steatorrhoea,
Thompson, Neale, Watts and Booth (1966b) reported further 
investigations in 28 out of 200 patients who had a raised alkaline 
phosphatase following gastric surgery* Three had hepatic
dysfunction, six had Paget^s disease and ten had osteomalacia* 
Most of the remainder had abnormal calcium infusion tests*
They concluded that in the absence of hepatic dysfunction and 
Paget*8 disease, a raised serum alkaline phosphatase is usually 
indicative of either overt or sub-clinical osteomalacia*
Deller and Begley (1963) and Clark et al (1964) 
reported abnormally high values of alkaline phosphatase in 
about 15^ of patients who Imd undergone gastric surgery*
However, Morgan, Paterson, Woods, Pulvertaft and Fourman (1965a) 
found a raised alkaline phosphatase less frequently than these 
workers and demonstrated that other causes were responsible 
for the rise in alkaline phosphatase in a number of patients* 
They found (1965b) osteomalacia in only 3^ of women and less 
than 1^ of men following gastric surgery* These authors 
suggested that the cause of osteomalacia was most probably 
due to vitamin D deficiency* Clark and Crooks (1965) are 
critical of the work of Morgan et al (1965a) on the grounds 
that they attempted to show response to vitamin D therapy in 
patients by a fall in alkaline phosphatase, but some of their 
patients had normal serum alkaline phosphatase before the 
investigation was started, and pointed out that early cases of 
osteomalacia might be missed if a low serum calcium was
considered to be invariably present in osteomalacia*
Another source of alkaline phosphatase in the serum is the 
intestine* Pulvertaft, Luffman, Hobson, Harris and Langman 
(1967) investigated this further as it had been suggested by 
Bamford, Harris, Huffman, Robson and Cleghorn (1965) that the 
higher alkaline phosphatase in patients with gastrectomy might 
reflect the contribution from the intestinal isoenzyme component* 
However, they concluded that the intestinal component of the 
alkaline phosphatase in the serum of patients operated upon for 
peptic ulceration were affected to much the same degree by diet, 
and ABO blood grouping, and secretory status as in healthy 
individualSo
Surprisingly little interest has been paid to the dietary 
intake of calcium, phosphorus and vitamin D in patients who have 
undergone gastric surgery* Moreover, it is evident that the type 
of gastric surgery might well influence the outcome in terms of 
changes in skeletal meteibolism* It is proposed therefore to 
consider the effects of vagotomy with gastro-jejunostomy and poly- 
partial gastrectomy and diet on calcium metabolism*
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Patients studied.
The study was started in the Western Infirmary, Glasgow, 
in 1954fl Male patients attending for elective surgery for 
duodenal ulcer were allocated randomly for treatment to either 
operation* Only patients who had been operated on at least 
eight years previously were included in the investigation, and 
the details of the patients so chosen are shoim in Table XIjVII* 
Fifty-six of the patients had undergone a polya-type 
gastrectomy* Fifty-one had a vagotomy with gastro-jejunostomy 
performed* These represented 82^  ^and Skfo of the patients 
available for the study* The mean age, height and weight were 
very similar in each group* The mean time elapsed since 
operation was again strikingly similar (Table XLVIl)*
The control group of subjects consisted of the 75 normal 
male subjects identified as Group II in Chapter I and discussed 
in detail in Chapter VII*
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Methods
X-rays
Skeletal X-rays were carried out in order to determine 
the Metacarpal Index, Femoral Index and Spinal Index (Barnett, 
and Nordin, I960)* The serum alkaline phosphatase was 
determined by the method of King and "Wootton (1956), The 
serum and urinary calcium were determined by titration with EBTA 
using ammonium purpurate as an indicator (Nordin and Smith, 1965)* 
The determination of serum and urinary phosphorus and creatinine 
were carried out by standard AutoAnalyzer techniques (Technicon 
Series N4a and Nila)* Dietary histories and weekly-weighed diets 
were carried out by a dietitian especially employed for this 
purpose*
Results
The serum calcium was very slightly reduced in one out 
of 51 patients who had undergone vagotomy and gastro-jejunostomy* 
It was also slightly reduced in 5 of the patients who had had a 
polya-type gastrectomy (Fig 131 ), the lower limit of normal by 
the method employed being 8*9 mg^ (Nordin and Smith, 1965)0
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The scrum calcium Wcis not related, to ago or to the time since 
operation in either group taken separately or when both groups 
were taken together, nor was it related to the dietary intake 
of either calciuju or phosphorus*
The serum phosphorus is shown for both groups in Fig 131s 
It was normal in all of the 53 patients in whom it was measured 
who had undergone polya-gastrectomy* It was slightly reduced 
(2*4 mg^) in one patient who had had a vagotomy and gastro­
jejunostomy* There was no significant difference in the serum 
phosphorus between the two groups. There was no relation 
between the serum phosphorus and the dietary intake of 
phosphorus either separately or when taken together* There 
was also no relation between the plasma phosphorus and the 
time since operation*
The alkaline phosphatase was raised in 5 of the 53 
patients who had had the polya-type gastrectomy, cxnd it was 
raised in 5 of the 51 patients who had undergone vagotomy and 
gastro-jejunostomy (Fig 131)« The alkaline phosphatase was not 
significantly different in the two groups* It was not related to 
dietary intake of calcium or phosphorus, or time since operation!
either group taken either separately or both groups taken together*
It was not related to age when taken separately, but there was a weak 
positive correlation with age when the data from both groups were 
combined (P < 0o05)a
The urinary calcium:creatinine ratio was slightly raised 
in 2 of the patients who had had a vagotomy and gastro-jejunostomy, 
and 3 patients who had undergone a polya-gastrectomy* In none of 
the patients was the urine calcium;creatinine ratio below the lower 
normal level of 0*03 (Nordin and Smith, 1965) (Fig 132)* The 
urinary calcium output was not related to dietary intake in either 
group and was not related to the time since operation or to age*
The urinary phosphate excretion, measured as the Phosphate 
Excretion Index (PoEoI®) was raised in 11 patients who had had a 
vagotomy with gastro-jejunostomy and in 15 subjects who had undergone 
a polya-gastrectomy. There was no direct relation between phosphate 
excretion and diet, age, or time since operation in either group 
considered separately or combined* There was no significant 
difference in the PoE»I* of the two groups (Fig *3%).
The dietary intake of calcium and phosphorus is considered 
in relation to age measured as the intake of each in mg/day (Figs 133 
and 134) and in mg divided by body weight (Figs 135 and 136)* The 
calcium and phosphorus intake are shown in each 10 year decade from 
31 to 70* In each decade, the detary intake of the normal subjects 
is shown first and is followed by the intake in the group who had had 
a vagotomy with gastro-jejunosromy followed by the intake in the 
patients who had had a polya-gastrectomy* The last column in each decai
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shows the intake of the two patient groups taken together*
The mean and two SpE® range is shown in each case® There 
was no significant difference between the intake of either 
calcium or phosphorus when the two patient groups were 
compared* However, the mean intake of calcium and phosphorus 
was higher in the patients, taken either separately or 
together than the intakes in the corresponding age groups in 
the normal subjects* In a number of instances where numbers 
and similar variances permitted comparison, the patients who 
had undergone gastric surgery had a significantly higher 
intake of both calcium and phosphorus than the normal subjects, 
The significance of the results are detailed in Table XLVIII.
Each patient who was found to have an abnormal 
biochemical result was sent an appointment to re-attend the 
clinic for further investigation* Five patients in each 
group had a raised alkaline phosphatase (Table XLVIX),
Seven of the ten patients had only marginally raised values 
(13™14 King Armstrong Units/lOO ml) and on re-testing on twn 
or three separate occasions these were all found to be within 
the normal range (Table XLVIX )* One patient with a
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significantly raised alkaline phosphatase failed to re-attend*
His other biochemical tests and bone X-ray indices were normal*
A patient (r „M„) with vagotomy and gastro-jejunostomy had a 
persistently raised alkaline phosphatase, with no evidence of 
liver disease^which did not respond to oral vitamin D*
The remaining biochemical tests were normal apart from a raised 
urinary hydroxyproline excretion; the presence of Paget*s 
disease of bone was considered to be the most likely explanation 
for the raised alkaline phosphatase* A patient (W«S«) with a 
persistently raised alkaline phosphatase who had had a polya- 
gastrectomy had a persistently lo'w serum calcium and raised 
phosphate excretion. Bone biopsy showed no diagnostic broadening 
of the osteoid borders, but following vitamin D therapy, all his 
biochemical values returned to normal, and the evidence in his 
case therefore strongly favours a diagnosis of osteomalacia*
Yet another patient with a vagotomy and gastro-jejunostomy, and 
three patients with polya-gastrectomies who had low serum calciums 
failed to re-attend* Of the remaining three patients (V/*S*) 
as described above almost certainly had osteomalacia* The 
other two patients had normal serum calciums on re-attending* 
(Table XLVIX)^ The diagnoses in the three remaining patients who
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failed to return therefore remains uncertain, hut their 
other biochemical tests were normal, and though 
osteomalacia could not be excluded, another explanation
which remains possible is that their plasma proteins
may have been low*
Eleven patients who had had a vagotomy with gastro­
jejunostomy and fifteen patients who had had a polya™ 
gastrectomy had raised phosphate excretions* The tests 
were carried out when on their home intake and the possible 
explanation lay in a high phosphate intake (Table L )^
All except three patients had a high phosphate intake *
These patients were requested to re-attend the clinic, but 
four failed to do so* When the tests were repeated after 
an overnight fast all but three had a normal phosphate 
excretion* Of these three patients one (W*8*) was 
osteomalacic, one (L*B») had evidence of early renal failure 
(blood urea 42 - 45) which is Imown to raise the P«E«I* 
(Nordin and Smith, 1965), and the remaining patient (C,N*)
had a persistently low plasma phosphorus in addition to a
raised BsE*!** Both these values returned to normal after 
treatment with vitamin D* Of the four patients who failed
to re-attend, all had normal biochemical values though in 
one patient the serum calcium was at the lower limit of 
normal.
Two of the patients therefore had good evidence of 
osteomalacia as judged by their response to therapy* Eight 
patients who had one abnormal biochemical tost - either a 
raised alkaline phosphatase, low serum calcium or raised 
phosphate excretion failed to re-attend for further investiga­
tion* Four of these patients had marginally raised phosphate 
excretions though their other tests were completely normal 
and the most likely explanation in this instance is the high 
dietary phosphate intake* Three patients with low serum 
calciums failed to re-attend* Their other biochemical tests 
were normal* One patient with a significantly raised serum 
alkaline phosphatase failed to re-attend; again his other 
biochemical values were completely normal*
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X-ray indices
Since age is an important factor in the loss of bone 
this has been examined and the results are tabulated in Table LI. 
The Metacarpal Index fell significantly with age in the two 
patient groups, but not in the normal subjects (Table LI 
and Fig 137 )* There was a significant fall with age in
the Femoral Index of the normal subjects, but not in either of 
the patient groups or in the combined patient group* Neither 
the normal subjects nor the patient groups showed any significant 
increase in spinal biconcavity with age as evidenced by the 
Spinal Index (Table LI )*
Since age is the dominant factor determining bone mass 
in order to compare the patient group and the normal subjects 
in Group II, all subjects have been divided into 10 year age 
groups and the X-ray indices have been compared. The results 
are illustrated in Figs 138,139 and 140  ^ The significance 
of the difference has been examined by the Student*s 't* test 
and are shown in Table LI I  ^ There was no significant 
difference between the patient groups for any of the X-ray 
indices in any of the decades tested (Table hll )  ^ There
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were small but significant differences between the normal 
subjects 6ind the patients who had had a vagotomy and gastro­
jejunostomy, and the patients who had had a polyagastrectomy 
(Table LIT )* When the two patient groups were combined 
there was a significantly lower Metacarpal Index between 51 
and 70 years, and in the Femoral Index between 50 and 60 years.
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Discussion
The estimations of serum calcium and phosphorus, and 
urinary calcium and phosphate excretion were carried out with 
two objects in view* First, was to make a diagnosis of 
osteomalacia if this was present* Second, was to determine 
whether the serum values of calcium and phosphate excretion 
were related to dietary intake* If the second objective was 
to be achieved, it appeared more reasonable to do the serum 
and urine estimations without fasting the patient, but to 
collect all the specimens between 11 a^m* and 12*30 p.m* between 
which times the patients attended a special clinic* Since 
diet can alter the biochemical values, any of the patients who 
had values outside the normal range were re-tested after an 
overnight fast*
A low serum calcium was found in one patient who had 
undergone a vagotomy with gastro-jejunostomy and in five patients 
who had undergone a polya type gastrectomy* There was a slightly 
reduced serum phosphorus in one patient who had undergone a 
vagotomy with gastro-jejunostomy* There was no relation between 
the dietary intake of either calcium or phosphorus and the serum 
values and the time since operation, but this result should be 
interpreted with caution as variations in dietary intake might 
have disguised any trends present; The groups were considered
both separately and together when the above relations were 
looked for*
The serum alkaline phosphatase was raised in five 
patients in each group* It was not related to dietary intake 
or to the time since operation when the two patient groups were 
considered both separately and together* There was a weak 
positive correlation with age when the data from both groups 
were combined*
The urinary calcium excretion was not related to diet, 
age or time since operation in the groups considered separately 
and together* Six of the patients had a raised urinary calcium 
(calcium/creatinine ratio greater than 0*28) but this was not 
related to any other specific biochemical abnormality* No 
patient had a calcium/creatinine ratio below 0*03 which would 
be considered abnormally low (Nordin and Smith, 1965)* Phosphate ■ 
excretion as measured by the P*E*I*g (Nordin and Fraser, I960) 
was raised in eleven patients who had undergone a gastro-jejunostomy 
with vagotomy and in fifteen of the patients who had undergone a 
polya-type gastrectomy* Though the P*E®I* did not correlate 
with diet, it would seem likely that the high phosphate intake 
in these patients could well have been responsible for these 
raised values.
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In the final analysis, one patient from each group 
had good evidence of osteomalacia; they had at least two 
persistently abnormal biochemical tests which returned to 
normal after treatment with vitamin D was started* One 
patient had early renal impairment (Blood urea between 
42 and 45 mg^)* One patient had a persistently raised 
alkaline phosphatase which failed to return to normal following 
treatment with vitamin D, and though there was no X-ray evidence 
of Paget*s disease, this was presumed to be the most likely 
diagnosis since liver function tests were repeatedly normal*
All the other patients had normal biochemical values 
on repeat testing* However, eight patients failed to re- 
attend in spite of many attempts to get them to do so* Of 
these, four had raised phosphate excretions, but all their 
other biochemical values including the serum creatinine were 
within the normal range* Of the remaining subjects, one had 
marginally low serum calcium, though all his other biochemical 
tests, including the alkaline phosphatase, were normal* One 
patient with an elevated alkaline phosphatase failed to attend 
though again all his other biochemical data were normal*
2k0
These results indicate an incidence ot osteomalacia in at 
least 2$ of these patients^ It seems unlikely that the 
remaining eight subjects had osteomalacia, but the possibility 
cannot be excluded and this would indicate a maximum value of 
lOfo^ However, minor degrees of osteomalacia might not be 
detected by these tests, Anderson, Campbell, Dunn and 
Runeiman (1966) have shovm that any or all of these values 
might be normal in patients in whom the criteria for osteomalacia 
might be satisfied on bone biopsy or the retention of calcium 
following a calcium infusion. One of the patients studied (WeS«) 
who had biochemical evidence of osteomalacia and whose biochemical 
tests returned to normal following vitamin D therapy did not 
have osteoid borders in the bone biopsy specimen examined^ It 
is evident therefore that early or slight deficiency of vitamin D 
need not result in the production of criteria which would satisfy 
a diagnosis of osteomalacia and the warning of Clark and 
Crooks (1965) would appear to be a timely one*
It is further evident that in spite of an intake of 
calcium and phosphorus, greater on average than that in the 
normal population, that the X-ray indices were lower in the patient 
groups than in the normal subjects. The vitamin D intake was
2hl
not assessed in these subjects, but the main dietary con­
stituent which raised the intake of calcium and phosphorus 
was milkg which would contribute significantly to the 
vitajiiin D intake* The finding of this high dietary intake 
is in direct contrast to the findings of Ekbom and Red {1963)9 
It was clear from questioning these patients that this high 
dietary intake had started following dietary advice before 
they came to operation, and they had continued to take a 
larger than average amount of milk after the operation*
Since the bone mass is lower in the patient groups than 
in the nonnal subjects, and if dietary constituents are the 
cause of the thinning of bones, then absorption of calcium and 
possibly of phosphorus might well be the factors responsible, 
Thompson et al (1966a and 1966b) found diminished vitamin D 
absorption in the patients who had undergone gastric surgery 
and had osteomalacia using tritium labelled vitamin D and even 
if the dietary intake was adequate, failure to absorb vitamin D 
could be a contributory factor. It is also evident that the 
older patient is more severely affected* There was no significant 
difference between the time since operation in the subjects above 
and below 90 years of age*
Hov/ever, it is only after this age that the loss of bone
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mass becomes an important factor* The time since operation 
would be expected to affect the bone mass, and the likely 
explanation for this not to be apparent is that all the 
subjects had been selected so that they had had their operations 
at least 8 years previously and none had had their operations 
more than 12 years prior to the investigation* The 4 years 
between may well be too small a range to allow for significant 
differences in bone mass to appear. However, as the time 
range since operation was sosmall between the two groups, it 
was possible to compare the effects of gastric surgery performed 
at different ages. It was evident that the older patients were 
affected most* The time since operation did not differ ‘ 
significantly between those patients under 50 years of age 
compared with those over 50 years* It was only after the age 
of 50 years that the differences between the patient groups and 
the normal subjects became evident* Before attaining the age 
of 50 years, the normal subjects and the patients with gastric 
surgery had very similar bone masses as measured by the X-ray 
indices described*
In conclusion, it would appear that gastric surgery 
results in the Iocs of bone to a greater extent than does 
occur in the normal population* Prank osteomalacia does 
occur but is relatively rare* Osteoporosis would appear to 
constitute the major problem of bone loss* Dietary deficiency 
was not seen to be a contributory factor in the two groups 
studied, and the loss of bone was almost certainly secondary 
therefore, to failure to absorb if dietary factors are implicated, 
that the removal of part of the stomoch might lead to the removal 
of some element concerned with calcium homeostasis can be 
discounted since the patients with polya-gastrectomies did not 
differ significantly from patients who had had a vagotomy and 
gastro-jejunostomy* The important dietary constituent 
concerned with the loss of bone mass remains speculative*
Failure to absorb calcium could be a contributory factor*
However, the mean urinary calcium excretion measured as the 
calcium/creatinine clearance ratio tended to be higher than that 
seen in normal subjects on a free diet (Nordin and Smith, 1965) 
(normal range 0*05 to 0*28)*
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The urine calcium is known to fall on a low calcium diet 
(Nordin and Smith, I965)? and it would be logical to expect 
a low calcium excretion if the absorption of calciiun was poor* 
The slightly higher values in the patients with gastric surgery 
could well be associated with the relatively high calcium 
intake, but the implication here is that the calcium absorption 
is adequate on their diet to maintain the urinary calcium 
level*
The measurement of calcium absorption in patients
following gastric surgery by us (Shiramins, Smith, Aitken, Orr
and Gillespie, 19?0) using a calcium isotope did not show any
evidence of poor absorption even in the patients with early
osteomalacia, though the absorption was diminished in one
patient with severe steatorrhoea and osteomalacia* The
method, employed in this study was that of the Occupancy
Principle (Orr and Gillespie, I968) and the calcium absorption
Avas measured over a period of two weeks* Other studies of
4.7
calcium absorption using Ca in patients who had had gastric 
surgery showed them to have a higher calcium absorption on 
average than w^ as seen in the normal subjects (Robinson,
Gutteridge, Joplin, Belcher and Fraser, 1964)* The use of 
techniques employed are open to suspicion that they do not 
necessarily measure the true absorption of dietary 
calcium, nonetheless, the balance of
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evidence at present is that there is no demonstrable 
evidence in favour of diminished calcium absorption in 
patients following gastric surgery.
On the other hand, the results of Thompson et al 
(1966a and 1966b) show that vitamin D absorption may be 
diminished following gastric surgery* If the above arguments 
in favour of adequate calcium absorption following gastric 
surgery are acceptable then the further implication is that 
if there is diminished vitamin D absorption it is not of 
such a degree as to limit calcium absorption. It is generally 
accepted that vitamin D has a direct effect on bone and it 
is possible therefore that minor degrees of vitamin D 
deficiency may cause the net loss of bone by leading to a 
diminished rate of bone formation or by an increased rate of 
bone destruction. This explanation would fit the information 
which is available, but direct confirmation is obviously 
desirable*
Finally, it is evident that there is no difference 
between the t^ vo patient groups, in their dietary intake, 
biochemical values, or in the degree to which their X-ray 
indices of bone mass have been affected* It is evident that 
gastric surgery does affect calciimi metabolism, but there is no 
reason to select one type of operation in preference to the 
other*
CIM^ÏEE IX
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THB EFFECTS OF CAECIEM SUPPLEMENTATION 
OF THE DIET ON BONE MlSS IN WOMEN
Since osteoporosis is a condition in Avhich the amount 
of hone present is diminished then clearly this must have arisen 
because the rate of bone destruction is greater than the rate of 
bone formation* This could arise from a fall of the bone 
formation, a rise in the bone destruction rate or a combination 
of these factors which results in the rate of bone formation being 
lower than that of destruction. These changes could in turn be 
due to some property of the osteoblasts or osteoclasts*
Alternatively, the cause could lie in some factor controlling 
the metabolism of the cells such as the secretion of parathyroid 
hormone, calcitonin and oestrogens, or could result from exogenous 
factors such as an inadequate dietary intake of calcium or 
vitamin D,
Albright et al (l941a) suggested that the cause of osteoporosis 
Avas due to a fall in the rate of formation of bone matrix. More 
recent studies have supported the view that the bone formation rate 
is normal in subjects developing osteoporosis, but that the rate 
of bone destruction is increased. The latter view is supported
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by the investigations in Chapter VI which do show a fall 
in the rate of bone formation, measured isotopically, with 
age, but as there is also a fall in the amount of bone present, 
the rate of formation per unit mass of bone is unchanged.
The urinary hydroxyproline excretion increased with age, and 
as the output of urinary hydroxyproline correlated inversely 
with the balance, and directly with the bone destruction rate 
measured isotopically, this finding is in keeping with an 
increased bone destruction rate with age*
Low calcium diets, in the presence of adequate vitamin D, 
have been reported to produce osteoporosis in animals (Weiske, 
1874; Pommer, 1929; Jaffe, Bodansky and Chandler, 1932;
Bell, Cuthbertson and Orr, 1941; Schmidt, 1937)o Jowsey and 
Gershon-Cohen (1964) repeated this work on cats and were able 
to demonstrate that the osteoporosis could be reversed by 
adding calcium to the diet* Positive calcium balances have 
been reported in patients when their diets have been supplemented 
with calcium (Owen et al, 1940; Anderson, 1990; Whedon, 1959; 
Harrison and Fraser, I96I; Nordin, I962),
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Since the object 01 therapy in osteoporosis is to 
increase the bone mass, the best parameter to measure would 
be the changes in mineral content of the bone* Until recently, 
the measurements of bone mineral content have been too crude 
to determine the relatively small change that occurs in bone 
mineral content even over periods of many months or years* 
However, with the development of the technique described in 
Appendix I, it has been possible to follow the bone mineral 
content changes in the third metacarpal of the right hand in 
patients who were referred to a special bone clinic because they 
were thought to be osteoporotic (Chapter VIl)* These patients 
have had bone mineral content measurements done at 6 monthly 
intervals from periods ranging from 18 to 54 months, and the 
results are reported below*
Procedure
All the patients had X-rays taken of their right hands 
under the conditions described in Appendix I ivith a standard 
aluminium stepwedge which was exposed at the same time on the 
X-ray plate* The patients investigated represent 94 of the 97 
patients described in Chapter VII*
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From the investigations in Chapter I, it is clear 
that there can be a fall in whole hone density without a 
significant fall in the total amount of bone present 
because of the relative rates of increase of the internal 
and external diameters of bone with age. Therefore, both 
the whole bone density (S,A,Eo) and the total cortical 
mineral (T,C,M*) have been estimated in these patients*
The patients in the study were given either calcium glycero­
phosphate in a dose of 2 gm t*idd@ (supplementary daily 
calciujii 1* 14 gm/day) or calcium Sandoz tabs* 1, t*i*d* 
(supplementary calcium 1* 14 gm/day)*
In a group of patients receiving therapy, such as 
calcium supplements over a long period of time, some assessment 
of the persistence with which the therapy Avas taken is necessary, 
Patients attended the clinic at 3 monthly intervals and the 
calcium supplements were issued, through the Hospital Pharmacy 
Department to cover the period until their next visit. This, 
associated with the frequent visits to this clinic, helped to 
assess Avhether or not the tablets Amre being taken* The 
patient Avas allowed time to ask for further prescriptions as 
this usually implied that the tablets were finished and must
therefore have been taken regularly* If not, the 
patients ivere asked if they needed a further supply.
They were also asked if bhoy were taking their tablets 
regularly* It Avas felt that a reasonable estimate could 
be made of those patients Avho were taking their tablets 
regularly* Those patients Avho did not take their tablets 
regularly were excluded from the trial, . X-rays were 
taken at 6-monthly intervals*
In every patient, the serum calcium, phosphorus, 
alkaline phosphatase and creatinine was estimated* In 
addition, the urinary calcium;creatinine ratio Avas estimated 
and the Phosphate Excretion Index (p*E*Ip) Avas calculated*
The questionnaire described in Appendix III Avas completed*
Any patient found to have other conditions which might affect 
the bone density Avas excluded from the trial*
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Patients studied
The patients studied were the female subjects referred 
to a special bone clinic because they were considered to be 
osteoporotic after examination of their X-rays by the referring 
physician or surgeon* They represent 94 of the 97 patients 
described in Chapter VII* No further attempt was made to 
select the patients except on the conditions described above*
In all 94 patients were studied for periods of not less than 
18 months and up to periods of 54 months* The nomal subjects 
with whom they are compared are those described in Group I and 
Group III in Chapter I*
Results ^
Fig 141 shows the initial whole bone density (SpAoE*) 
of the patients studied in relation to the distribution of the 
S*AoE* in normal subjects* The patient group had a slightly 
lower mean S*A*Eo than the normal subjects as can be seen in 
Fig 150 in which the S*A«E, percentile values are shown, but 
this difference does not reach statistical significance* The 
initial percentile value of the is shoim in Fig 151 o
Again the values are slightly but not significantly lower than 
those found in the normal subjects*
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Fig 142 is a histogram showing the age distribution 
of the patients studied* Eighty-seven percent of the 
patients lay between 50 and 80 years of age# The mean 
age of the patient group is 6l years#
The change in S#A#E* in relation to the time since
starting therapy is considered in Fig 143« The S*A*E# in 
each patient at the time of starting the trial, and at 6 monthly 
intervals thereafter, is shown# There is a small fall in the
SeA*E* over the period of the study* The mean rate of fall in
the S*AoE* and the T#C#M* in the normal subjects of Group III 
with age is plotted in Figs 144 and 145* It is seen that the 
rate of fall varies with age# The mean rate of fall in the 
S*A#E# in the normal population increases with time from 34 to 
62 years of age after which the rate of bone loss decreases with 
advancing age*
The mean rate of fall in the T#C*M# (Fig 145) reaches 
a value of -0,05 at 62 years and shoAvs little change thereafter* 
The rate of fall in the S*A#E* and the T*C#M. is regressed 
against age in each of the patients studied, and the rate of
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fall is plotted against the mean age of the patient during the 
period of therapy (Figs 144 and 145)© There is no obvious 
difference between the groups so studied*
In order to investigate this further, all the patients 
who had a statistically significant rise or fall in the 
or the T*G*M* Avere re-examined (Figs 146 to 149)* Three 
patients shoAved a significant rise in the 8,A#E* and two a 
significant rise in the TgCoM** TAventy-six patients showed
a significant fall in the S*AeS# and 24 a significant fall in 
the T*CqM,4 The number of patients showing a significant rise 
in the S#A*Eg and the TpC*M<, were small, but no specific feature 
in terms of initial SpA#E# or T„C*M* (Figs 146 and 148), 
marital status, parity, age at the menopause, social class, 
urinary calcium excretion oi" calcium absorption, distinguished 
these patients from the rest* The patients who showed a signifi­
cant fall (Figs 146 and 148) again were not found to differ from 
the population as a Avhole when considered in relation to the 
factors reported above* In Figs 147 and 149j the patients Avho 
did not individually show any significant change in S*A*E# or 
T*C*M* are illustrated* Again they did not differ significantly 
in any Avay from the normal population. The group as a whole 
are examined further by estimating the percentile values in 
relation to the normal population and the results are 
illustrated in Figs 150 and 151* There was a small
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fall in the percentile values of both the S.A.Eo and the T« 
with time since starting therapy* When regressed against 
time since starting therapy, this fall Avas found not to be 
of significance (Table LIIl), HoAvevor, there Avas a 
significant fall in both the SoA.E* and the T.C.Mo when the 
rate of change, measured as the difference from the initial 
value, Avas regressed against time on therapy (Table LIIl)#
This means, that as a group, the patients treated with calcium 
supplements arc showing a rate of fall in both whole bone 
density (S«A*Eo) and total cortical mineral (TcO#M«), greater 
than the rate of fall seen in the normal population*
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Discussion
The measurement used to detect differences in hone 
mass in the 94 patients studied Avhile they were receiving 
calcium supplements, Avas made on the 3rd metacar%)al*
As shown in Chapter II, the mineral content of the 
metacarpal is related to the mineral content of the spine*
The changes in bone mass with age are rather lower than 
those found in the mid radial shaft by Sorenson et al (1968) 
but show the same general pattern*
Conrad Johnston, Smith, Yu and Deiss (1968) described 
a more rapid fall in the loAver end of radius, which has a 
significant tmiomit of trabecular bone, than in the mid shaft* 
It is evident that the measurements in one bone Avill not 
accurately predict the rates of change in all bones*
HoAvever, the pattern of change is similar. The metacarpal 
measurement is a convenient and accurate one (Chapter I, 
Appendix II), and there is no reason to believe that it does 
not predict similar changes in other parts of the skeleton, 
even if the rates differ.
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The patients studied have been compared with the normal 
population of women, as described in Chapter I* They had a 
slightly lower whole bone density (S.AoE«) and total cortical 
mineral per unit length of bone (TgC.M,) than the normal 
population, but this was not statistically significant* The 
rate of fall of bone mass in the normal population varies with 
age as can be seen from Figs 144 and 145 > but the standard 
deviation does not differ significantly within the different age 
groups* The 94 patients studied did not differ from the 152 
normal subjects of Group I in terms of social class, age at onset 
of the menopause, parity, breast-feeding, dietary intake of calcium, 
phosphorus, protein or vitamin D, urinary calcium excretion or 
calcium absorption* The 152 normal subjects of Group I are 
described in Chapters I and VII* The normal subjects of both 
Groups I and III were recruited in the same way from the relatives 
and friends of patients in general medical wards* None of the 
patients had any metabolic bone disease that might have affected 
their bone X-ray measurements*
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The changes in the whole bone density (S.A.Ep) of 
the patients during the period of therapy are examined at
6 monthly intervals for the whole patient population (Fig 143),
There A\ras a small fall in the mean of each measurement over the 
period of the study* However, since the rates of change in 
the S.AcEp mid the ToC,lvI# vary with time (Figs 144 emd 145), 
the rates of change Avdth time as measured by the gradient of
the fall are illustrated for each patient at her mean age
over the period of study in the same figures* From inspection 
it is evident that though there is a wide scatter, the mean 
rate of change does not differ noticeably from that found in 
the population as a Avhole#
A small number of patients did show a significant 
im%]rovement in bone mass* The numbers are too small to piermit 
statistical analysis, but when compared with that proportion of 
the population which shoA\^ ed no significant change or with the 
normal population of Groups I or III, no obvious differences 
Avere observed* A large number of patients showed a significant 
fall in the S#A,E« and the TgCpM. with age. Again these patients
cannot be distinguished from those ivho had shoAvn no change 
or from the normal population at the age of onset of the menopause, 
marital status, social class, parity, length of time of breast­
feeding, dietary intake of calcium, phosphorus, protein or 
vitamin D, urinary calcium excretion or calcium absorption*
However, the normal population shows a significant 
fall in both the S.AoE* and the T.C.M* with age* Even if 
calcium can reduce the rate of fall below that of the normal 
population, it will be of benefit* Any change producing a more 
or less rapid fall in the patient group when compared with the 
normal subjects will be evident in a changing percentile value* 
These are illustrated in Figs I50 and 151, and regressed against 
time in Table LIII* The percentile value shows no significant 
change, and evidently the patients are showing a fall in the S*A*Eo 
and the T*CoM» which is close to that of the normal population^ 
However, when the change in percentile value is measured for each 
patient as the change from the starting value, then there is a 
significant fall in both ScAoE* and ToC*M* percentile with time 
on therapy* This fall means that the patients are showing a fall 
in both whole bone density and total cortical mineral per unit 
length of bone which is greater than that in the normal population*
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This must mean either that the patient population is different 
from the normal population, or that the calcium supplement is 
causing an accelerated rate of bone loss* The comparison 
between the normal and patient groups have not brought to light 
any significant difference between them* The evidence therefore 
is in keeping with the therapy being the cause of the accelerated 
bone loss in the patient group*
This is at variance with the positive calcium balances 
with calcium supplementation which have been reported so often, 
and with the evidence shown in Chapter VI* This evidence does 
exist, however, and it would be superficial to ignore it Avithout 
further investigation* Logically, all the oalance data 
reported must regularly and persistently overestimate balance 
studies when calcium supplements are added, or else the positive 
balance must be relatively short-lived in spite of claims to 
the contraryo This question is exajuined further in the next 
chapter*
CaVFfER X
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T Iffi EFFECTS OF C fX C im i SïTEPIxEMENTS ON 
C .lLC im i B/iMLNCE, F.\ECi\L CALCIUM IlND FAECAL FAT
Intro due t ion
It is evident from the studies in Chapter IX that 
giving calcium supplements for periods up to 54 months has 
not resulted in a significant increase in whole bone density 
(S*A,Eg) or total cortical mineral (t.C.M#) measured on the 
3rd metacarpal of the right hand* There has in fact been 
a fall in the SoAgE* and the TgCgM* which is significantly 
greater than that found in the normal female population of 
the same age* This is at variance with the reported positive 
balance by a number of authors (Owen et al, 1940; Anderson, 
1950; V/hedon, 1959; Harrison and Fraser, I96I; Nordin, 1962), 
and with the fall in urinary hydroxyproline and diminished bone 
destruction rate measured isotopically as shovm in Chapter VI* 
The studies in Chapter VII also show little evidence of a 
relation between dietary intake and the X-ray indices once age 
and Aveight have been allowed for* It is evident therefore that 
either the methods are inade(juate or else the positive balance 
achieved is only a temporary one* In view of these contradic­
tory findings, the effects of calcium supplementation have been 
investigated further, and the results are reported below*
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Materials and methods
Five female and one male subject were investigated*
These patients were admitted to a metabolic unit# The age, 
sex and diagnosis of each patient is shown in Table LÏV,
Also shown is the SgA„E« (Avhole bone density)* All the 
patients had a value below 28 which is used as a quantitative 
definition of osteoporosis (Chapter II)* The percentile 
value for the SpA.E* in each patient, which indicates their 
whole bone density relative to the normal population at their 
age is also shown* These patients remained on a basic diet 
with a fixed intake of calcium and fat, and this iva.s supplemented 
firstly as organic salts, then in the form of dried skimmed milk# 
The details of the calcium and fat intake for each patient 
during each period of study is shoAm in Table LIV# The
calcium intake on the basic diet ranged from 0*233 gm/day to 
0*733 gm/day* The fat intake on the basic diet ranged from 
32*9 to 65^9 gm/day* Each patient A\^as allowed one week to 
equilibrate on the basic diet before starting the investigation, 
and Avas first investigated on this basic diet for 4 to 6 weeks (Per­
iod a )® The calciimi intake Avas increased during the next 4 weeks 
(period B) by giving calcium glycerophosphate to patients 1 to 5
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and calcium gluconogalactogluconate to patient 6* This 
increased the calciwi intake by 1*14 gm/day* During the 
next 4 weeks (period C), the calcium intake was raised by 
1«24 gm/day above the basic level by giving the equivalent of 
1^ pints of dried skiiitoed milk daily to patients 1 to 5 q The 
fat content remained unchanged during Period B* There Avas a 
very small rise in fat intake when the dried skimmed milk Avas 
added to the diet, the increase being 0*3 gm/day during Period C, 
Faeces and urine Avas collected in 7 day aliquots# The 
faeces was collected directly into homogeniser cans, homogenised 
and aliquots taken for the estimation of fat, bile acids and 
calcium# The bile acids were extracted from freeze-dried faeces 
with 95^ aqueous ethanol under nitrogen for 6 hours. The bile 
acids were quantitated by thin layer chromatography (Mitchell and 
Diver, 1967), Dietary and faecal calcium Avas measured after 
ashing by titrating with FDTA ammonium purpurate being used as 
an indicator.
Resiilts
In Table LVj the calcium balance is shown in patients 
1 to 5o During the Periods A, B and C , the urinary hydroxyproline 
excretion is also showng The balances are taken as the mean of 
4-6 weeks during the control period, and as the mean of the last 
three periods in each of the Periods B and C, so that one week 
was allowed for equilibration^ As can be seen, all the patients 
were in negative calcirum balance on the initial intalces (Period A)o 
The balance improved during Periods B and C, a positive balance 
being achieved in all the patients during Period G„ The urinary 
hydroxyproline excretion decreased during Periods B and C, the 
lowest values occurring during Period Co
The change in excretion of faecal calcium, faecal fat and 
the faecal dry weight from the first week of the basal period is 
sho^m in Fig 152* The mean and standard error for each weekly 
period is indicated* In Table LVÏ, the mean faecal dry weight,
acid fat, total fat and calcium for the periods A, B and C is shown,
There is a significant increase in the faecal calcium (P < 0,001),
the faecal acid fat (P < 0*02), total fat (P < 0*05) and faecal
dry weight (p < 0*01) during period B (ioC* during calcium glycero­
phosphate supplementation of the diet). The substitution of dried 
skimmed milk for calcium glycerophosphate did not affect the faecal 
fat, dry weight or calcium compared with period B* The faecal 
dry weight and calcium remained significantly above the level of 
excretion during the period on the basic diet. None of the 
patients complained of any gastro-intostinal symptoms or had any 
diarrhoea during calcium supplementation of the diet (Table LVi),
266
In Pig 153ÿ the excretion of faecal bile acids is 
shoTO« There is a significant increase in the output of 
deoxycholic and lithocholic acid and also an increase in 
the total bile acid output» The increase became apparent
after the end of the first week and continued throughout 
the period of calcium supplementation (i^e* during both 
periods B and C) (Table XLVIl).
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Discussion
The total faecal calcium, faecal fat and laecal dry 
weight increased in all the patients studied during supple­
mentation of their diets* This was accompanied by an increase 
in the excretion of bile acids. It is possible that the calcium 
in the forms tested combined with the bile acids to produce 
insoluble salts, which in turn led to decreased émulsification 
and digestion of fat, though the formation of insoluble calcium 
soaps of fatty acids is perhaps more important*
It is interesting to note that the dried skimmed milk 
appeared to have a smaller effect on the faecal fat excretion 
and the excretion of bile acids than the organic salts* This 
occurred in spite of the amount of calcium given which was slightly 
greater (by 100 mg/day) and the dietary fat also increased slightly 
(by 0*3 gm/day)o The balance improved in period B compared with 
period A, but it was during period C, on skimmed milk, that the 
balance was most improved* Furthermore, the urinary hydroxyproline 
excretion fell during period B but was lowest during the period of 
skimmed milk supplementation of the diet.
These results are in keeping with the positive calcium 
balance produced by supplementary calcium reported by Owen et al 
(1940); Anderson (l950); Whedon (1959); Harrison and Fraser, 
(1961); Nordin (1962)* However, as the bone mass continues to 
fall while patients were taking calcium supplements (Chapter IX),
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it is clear that the positive balance, the fall in urinary 
hydroxyproline and tne decreased bone resorption rate reported 
in Chapter VI and by the above authors cannot be more than only 
a very temporary one*
There are now several reports in the literature that 
calcium supplementation of the diet interferes with the 
absorption of fat in both experimental animals and in man, 
Bassett, Keutmann, Hyde, van Alstine and Russ (l939) reported 
that faecal fat excretion increased in patients with 
steatorrhoea who were given calcium supplements* Lutwak, 
Laster, Gitelman, Fox, Whedon, Wolfe and Woodson (1964) 
reported this effect in children* Weiner and Lutwak (1963) 
had previously shown a similar effect on young rats* Kane, 
Lovelace and McCay (l949) found that fat absorption was 
decreased in old rats and that absorption, was further depressed 
by the addition of calcium to their diet*
The increased excretion of faecal fat would suggest 
the reason for the decrease in calcium balance. In Chapter II 
and Chapter VIII, it was shoAvn that patients with steatorrhoea 
who had had gastric surgery in the absence of osteomalacia 
showed an increased bone loss when compared with normal subjects 
of their oivn age* The mean rise in faecal fat excretion from
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2*31 gm to 3q69 gm is not large, but over a long period of 
time could be important*
It is evident that a positive balance is only 
possible when the bone formation rate is greater than the 
bone destruction rate, and that a negative balance will 
be associated with a bone destruction rate greater than a 
bone formation rate* The balance could be the primary 
cause in which case decreased calcium absorption or 
increased calcium loss could be the important factor* 
Alternatively, the fault could lie in the bone, the negative 
calcium balance resulting from the bone destruction rate 
being higher than that of the bone formation rate*
The information available would suggest that a 
temporary positive balance can be achieved, but that in time 
the balance must become negative in spite of continued 
supplementation of the diet* The time sequence of events 
would be in keeping with the loss of some nutrient which 
would be responsible for either decreased calcium absorption 
or a relative increase in bone destruction* Furthermore^ 
there is evidence of decreased calcium absorption with age 
(chapter VIl)«
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Vitamin D deficiency of a mild degree could be 
the factor involved, and the results so far available 
would suggest that a trial of vitamin D with or without 
calcium supplements would be worthwhile*
However, it is extremely unlikely that this 
simple explanation will contribute more than a small part 
of the answer to the problem* The important factor here 
is the difference between male and female subjects 
bone loss is a relatively unimportant factor in males, 
though it is unlikely that there is a major difference in 
the environment of male and female subjects* It would 
seem much more likely that the major cause of bone loss 
in women is genetic, and is an expression in some form of 
the X chromosomeo This does not mean that the steady loss 
of bone with age cannot be prevented, but the evidence 
against simple calcium supplementation of the diet as being 
useful is now very strong*
CONCLUSIONS
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CONCLUSIONS
The Conclusions arc considered under the same headings 
that are used to define the problems in the Introduction, 
To summarise:
1) The problems of definition of osteoporosis are 
considered in Chapters I, II and III* The 
factors associated with variations in bone 
mass in the normal male and female population 
are examined in Chapter I* The variations 
from the normal due to pre-disposing pathologi­
cal states are examined in Chapter II* The 
relation between bone mass and fracture 
incidence are considered in Chapter III, The 
quantitative definition of osteoporosis is 
then considered in the light of these 
investigations,
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2) Factors affecting calcium balance are extunined 
in Chapters IV and V# In Chapter IV, the 
isotopic measurement of calcium absorption
is discussed* Chapter V is concerned with 
the control of urinary calcium excretion*
3) Bone formation and destruction rates are 
considered in Chapter VI which is divided into 
two Parts, Part I is concerned with the 
measurement of the bone formation rate and 
the effects of diet and age on bone mass*
Part II is concerned with the measurement of 
bone destruction rate using isotopes, and 
urinary hydroxyproline excretion, and the 
related changes in urinary hydroxyproline 
excretion with age*
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4) In Chapters VII to X, the rolo of the dietary 
intake of calcium, phosphorus, protein and 
vitamin D in relation to bone mass, the 
absorption of calcium, urinary calcium 
excretion and the effects of calcium supple­
mentation of the diet are described*
Chapter VII is concerned with the relation 
between calcium, phosphorus, protein and 
vitamin D intake and bone mass, and the 
variation in these in relation to age and sex* 
Chapter VIII is a study of the changes in the 
calcium and phosphorus intake and excretion 
and their relation to bone mass in patients 
who have undergone gastric surgery* The 
effects of calcium supplementation of the diet 
on the bone mass of women is examined in 
Chapter IX(, In Chapter X, the effects of 
calcium supplementation of the diet on faecal 
bile acids and faecal fat are reported*
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l) The problems of definition
As discussed in Chapter I, the skeletal mass varies throughout 
life in both men and women* The rates of change in bone mass 
depend upon the type of measurement used, the age and sex of 
the population examined* The measurements used in this study 
are the whole bone densities (measured as the standardised 
aluminium equivalent ™ S.A.F*), the cortical density ( .A )ÿ 
the total cortical mineral per unit length (T,CpM*) of the 3rd 
metacarpal, the X-ray indices of the metacarpal (M,!*), 
femoral index (F*!*), Spinal Index (S*I*), and the Relative 
Vertebral Density (R*V*D,), The reason for these differences 
arise because the external and internal diameters of the long 
bones change at different rates throughout life, and because 
of variations in the density of bone as a tissue with time.
The highest rates of change are seen in the S«A*E* (whole bone 
density) and the X-ray indices of the metacarpal and femur*
The whole bone density rises from the age of 5 to 33 years in 
both men and women and falls thereafter, the rate of fall being 
twice as fast in women compared with men between 50 and 60 years 
of age* The X-ray indices (U*I* and F@I*) show a very similar
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pattern of change* The cortical density rises rapidly up 
to the age of 20 years in both men and women. In the male 
it continues to rise slowly throughout life, thereafter*
In the female, there is a slow rise until the age of 40 years 
and a small fall occurs thereafter up to the age of 75 years*
The T,C*M* rises rapidly in men and women up to the age of 21 
and in the males then shows a very slight fall. In women, 
there is a much more pronounced fall after the age of 50,
The Spinal Index falls very slowly with age in women, but not 
significantly in men* The falls slightly in the male,
but to a much greater extent in the female* The rates of change 
in all the measui'ements used, except for the cortical density, 
arc accelerated in women at the time of the menopause* Social 
class does not affect bone mass*
The largest surveys have been carried, out using the densitometric 
measurement of the 3rd metacarpal in normal male and female 
subjects, and the relative rates of change between the sexes 
have been examined in more detail. After 35 years of age, the 
whole bone density shows the greatest fall in both the male and 
female subjects* The relative rates of change, however, are 
greatest in the T.CoM, which shows a rate of change eight times 
greater in the female than in the male. For the 8.A*E, the 
rates of change are only two to one.
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In Chapter II, the bone mass in a variety of pathological 
conditions has been examined* From this study, it is 
clear that if no allowance is made for size, then it is 
impossible to compare the effects of the pathological 
conditions affecting the individual* The. measurements 
which correct for size are the whole bone density,
Metacarpal Index, Femoral Index and Spinal Index* Cortical 
density and Relative Vertebral Density are, of course, 
independent of size* In Chapter II, the effects of the 
pathological states on the and A  are described.
To define the bone status of any individual in relation to 
the normal population, it is also necessary to determine 
the percentile value of the SpAoE, and A and these too 
have been considered*
Female patients referred to a special Bone clinic because 
they were thought to be osteoporotic by the referring 
clinician are found not to differ significantly from the 
normal subjects of their own age in either whole bone density 
or cortical density. Men referred in this way, however, 
were found to be significantly below the mean for their age 
when compared with the normal male population* The reason
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for this is that only a small change in the S*AgE* occurs 
in normal men with age, while a much greater change occurs 
in women* The experienced clinician estimates the bone 
mass in his mind against the idealised picture of the young 
healthy adult* In the male, he will select and refer 
patients who, though within the normal range, will have a 
bone mass below the mean* In the female subject, however, 
he is not able to make allowance for the marked change with 
age, and the patients referred are those over 50 years who 
presented with symptoms, but who otherwise do not differ 
from the normal population*
The whole bone density is lowered in the patient who has had 
gastric surgery, but the cortical density is normal in the 
vast majority* Both the whole bone density and cortical 
density tends to be low in patients with steatorrhoea, 
osteomalacia and hyperparathyroidism.
Female patients with fracture of the femoral neck do not differ 
significantly from the normal population in terms of S*ApE* or A* 
They are merely subjects from the older normal population*
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However, virtually all have an below 28* This
is the 5 percent ile value at age 35 years of the normal 
population when the whole bone density (S*A,E*) is at its 
peak* This is in agreement with the relation between 
whole bone density and spinal biconcavity in women*
Measurement of the Spinal Index shows a significant increase 
in the incidence of spinal biconcavity when the 8,AoEo falls 
below 28* The degree of spinal biconcavity is clearly in 
no way related to the percentile value* This means that the 
development of spinal biconcavity is a function of the total 
bone present, and not a function of the amount of bone in 
relation to that present in normal subjects of the same age.
In Chapter III, the incidence of fracture is seen to increase 
with age in both men and women* The bone mass decreases 
with age in both men and women? when measured either as the 
ApE,, SeA*Eo? T*C»M*, or SoT.C*Mo. Clearly, the rate of 
change of any of those measurements can therefore be corre­
lated with the rate of increase of fracture* However, it 
is only the rate of change in the total cortical mineral 
per mi it length which correlates with the rate of increase of 
fracture incidence in both men and women* The assessment of 
the possibility of any individual patient sustaining a fracture 
requires the T.CoM* to be known*
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Clearly, from the foregoing, the definition of osteoporosis 
quantitatively, requires that several parameters of hone mass 
must be Imown and reported*
These are:
1) The cortical density which is nearly constant between 
20 and 75 years* At lower ages A  is affected by 
the higher proportion of young bone present which 
has a lower density. At the upper end of the age 
range A again tends to fall in women because of 
increased cortical porosity which is characteristic 
of severe osteoporosis* The measurement of A  will 
help to differentiate osteomalacia from osteoporosis*
2) In order to compare individuals, allowance must be made 
for the difference in size in individuals* If this is 
not dong^a large individual will have a higher value 
for bone mass than a small one, even if the former is 
in fact osteoporotic and the latter is normal* The 
values independent of size which have been measured 
are: A  (cortical density), SoA,E* (whole bone density) 
and S,T,C*M* (total cortical mineral divided by the 
square of the external radius). All these measure­
ments refer to the 3rd metacarpal. The X-ray indices 
MçIq, F*I,, S*I,, and the Relative Vertebral Density 
are also independent of size.
3 ) Apart from bone pain, the increased risk of fracture 
is the most important consequence of diminished bone 
mass* In order to determine the risk of fracture 
some measure corresponding to the total cortical 
mineral per unit length of bone (T*CpM*) must be 
determined,
4 ) In order to attribute a value to each of these 
measurements in relation to the normal population, 
the percentile value for each measurement must also 
be known*
Clearly no single measurement will completely define 
osteoporosis which should be considered in relation 
to all the above parameters* If these are determined 
on several occasions, over a sufficient interval of 
time, it is possible to determine quantitatively how 
the bone of any patient is changed in relation to the 
normal population.
Finally, though no single measurement adequately defines 
osteoporosis, it is useful to be able to decide on one 
measurement whether any one patient should be subjected 
to the rigours of further investigation and treatment.
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Since spinal biconcavity increases significantly when 
the SçAçEg falls below 28, this is a useful value 
which can De taken as a practical dividing line below 
which any therapy might be instituted*
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2) Factors affecting calcium balance
In Chapter IV, a double calcium isotope method of 
measuring calcium absorption is compared with the plasma 
value obtained 2 hours after the oral administration of the 
isotope* The reason for this investigation is that the two 
hour plasma value is clearly dependent on a number of different 
factors* It will be affected by the rate of absorption of the 
isotope, the rate of mixing within the rapidly exchanging pool, 
the size of this pool, the rate of loss into bone, the rate of 
loss in the urine and minor losses back into the gut as 
endogenous secretion* By injecting an intravenous tracer at 
the time of the orally administered isotope and comparing the 
integrated specific activities in the plasma of the isotopes 
administered by both routes, rhe rate of transfer of isotope 
from gut to blood can be determined* This technique requires 
only one assumption and that is that the orally administered 
isotope once absorbed into the blood behaves in the same way 
as the intravenously administered isotope* This condition is 
satisfied as discussed in Chapter IV@ The value so obtained
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is 5 of course, quite independent of the rates of loss 
of the isotope from the plasma pool. The two hour 
plasma blood value does correlate with the value 
obtained by the double isotope technique*
The reason why this investigation was carried out was 
to determine if the two hour plasma value was a reasonable 
estimation of calcium absorption in the noimal and 
* osteoporotic^ populations studied, since it is quite 
impracticable to do the more complex procedure in large 
numbers. This investigation justifies the use of the 
two hour plasma level, corrected for body weight, in 
populations in whom very widely differing rates of dis­
appearance of isotope from the plasma pool do not occur - 
e«ge in Paget's disease* The results obtained in the 
populations studied are discussed in Chapter VII*
The calcium balance can also be affected by urinary 
calcium losses* The factors affecting urinary calcium 
losses are examined in Chapter V,
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Calcium intake affects urinary calcium loss* Lmv calcium 
intake leads to a fall in urinary calciiuii excretion, and 
high calcium intake to increased urinary calcium* The 
changes are the result of increased calcium intake causing 
a small hut significant rise in the plasma ultrafilterable 
calcium which in turn causes a rise in the filtered load.
The change in plasma calcium correlates with the urinary 
calcium loss* These small changes in plasma calcium do 
not produce any significant change in the activity of the 
p ar athyr o i d g1ands *
À raised phosphorus intake causes a fall in urinary calcium* 
This is mediated through a fall in plasma ulti'afilterable 
calcium which is in turn associated v/ith a rise in the plasma 
phosphorus* Part of the fall in plasma ultrafilterable 
calcium could be associated with diminished calcium absorption 
due to complexing of the calcium with the additional phosphorus 
in the gut* Unlike the changes in ultrafilterable calcium 
produced by low and high calcium intake, changes in the intake 
of phosphorus clearly affects parathyroid activity. This must 
mean that the fall in plasma calcium induced by high phosphate
feeding causes a fall in the ionic calcium while low 
calcium intakes cause a fall in the coniplexed ultra- 
filterable fraction* Urinary calcium falls during 
high phosphate feeding. This is due partly to the 
fall in the filtered load. However, increased 
parathyroid activity also causes an increase in the 
reabsorption of calcium by the renal tubule (p, 137 ), 
and part of the fall in urinary calcium could be due 
to the parathyroid stimulation due to the high 
phosphate diet* In hypoparathyroidism, the calcium 
reabsorption is diminished (p„ 138 )* Clearly, a
high phosphate diet could affect the bone mass by 
stimulating the parathyroids which affect the rates of 
bone formation and destruction.
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3) Bone formation and destruction rates
The rates of formation and destruction of bone are exjirained 
in Parts I and II of Chapter VI, Before any conclusions 
can be drawn from the measured formation and destruction 
rates using isotopes, an examination of these techniques is 
necessary* From the quantitative auto-and micro-radiographic 
studies of Marshall et al (l959a,b,c,d), Howland (1963), and 
Lloyd (1965)5 it is evident that the isotope is incorporated 
into bone both by active bone formation^when there is net 
accretion of calcium.^and by iso-or heteroionic exchange* 
Exchange5 especially at bone surfaces, occurs rapidly and 
contributes to the fast exchanging calcium pool which has a 
value of about 5 gm of calciiuu* Slower exchange occurs into 
inactive old bone, and the magnitude of this pool cannot be 
measured by the kinetic studies so far used in man* The 
auto-and micro-radiographic studies mentioned above indicate 
that between 10 and 50 percent of isotope may be taken up in 
this way* Much discussion in the past decade has also been 
concerned with the amount of isotope which is lost from bone 
due to bone resorption*
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These problems have been studied by us and are reported 
elsewhere (Shimmins and Smith, 1966; Shimiuins, Allison,
Smith and Speirs, 1967; Smith, Speirs and Shimmins, 1967;
Smith, Speirs and Shimmins, 1968; Shimmins and Smith, 1970; 
Shimmins, Lee, Smith and Lucy, 1970)* These studies are 
concerned with the problem of exchange, the return of isotope 
due to bone resorption, and a comparison of auto-and micro­
radiographic studies in dogs with tetracycline uptake estimation 
of bone formation rate* These studies have shovm:
i) The return of isotope from the skeleton for periods 
up to 100 days in the normal adult and 'osteoporotic® 
subject is almost entirely due to exchange and only
2 to 3 percent of the isotope returns to the plasma 
because of bone resorption*
ii) The most accurate measurement of isotope uptake by 
bone (i,e* both by exchange and due to accretion) 
can be derived from long-term studies up to 100 
days* This is necessary so as to eliminate the 
effects of the rapidly exchanging pool on the 
estimations, which dominate the measurements up
to about 40 days*
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iii) This is done by estimating the true rate of
loss of isotope from bone and allowing for
this in the calculation of true bone uptake*
The reason for this is that the whole body
retention is not a measure of the bone
retention because isotope returning from
bone acts as a fresh injection into the
plasma* Part of the isotope only is lost
from the body, the rest returns into the
bone* The whole body retention measurements
thus underestimates the true rate of loss of
isotope from bone*
iv) Since it is impractical to study whole body
retention over such long periods of time
if a large number of patients are to be
examinedj the correct value so obtained is
used to determine the best time to estimate
the calculation of the isotope uptake by the
method of Bauer, Carlsson and Lindquist (l957)o
The values so obtained indicates that the value
between 5 and 10 days by this method is the
45best time to estimate the bone uptake of Ga 
or and between 7 and 14 days for ^^Sr,
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v) Though the values so obtained with give
a lower value than the values obtained with
k5 47Ca or Ca, the strontium values do
correlate with the values obtained with calcium
(p. 159).
vi) In the dog, a correlation between the values 
obtained by isotopes ox calcium and tetracycline 
labelling was found (Shiminins, Wood, Lee and 
Smith, 1970) Moreover, it was sho^m that 
with age there was a fall in bone formation rate 
which was matched by a corresponding fall in the 
value of the isotope taken up by exchange*
If these results can be extrapolated to man in the normal cind 
^osteoporotic® range, then the rate of bone formation can be 
seen to fall significantly with age in women* However, there 
is a corresponding decline in the bone mass with age which means 
that the rate of bone formation per unit mass of bone remains 
constant*
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The rate of hone destruction falls on calcium supple­
ments measured isotopically* This fall correlates 
inversely with the change in balance, and directly 
with the urinary hydroxyproline excretion*
Furthermore, in Part II of Chapter VI, it is shown 
that the urinary hydroxyproline creatinine excretion 
rises with age* The reason for believing that the 
major part of the urinary hydroxyproline excretion 
comes from bone destruction has been discussed.
These findings are in keeping with the view that the 
bone loss in women is due to an increased rate of 
bone destruction with age* These results are in agree­
ment with those reported by Jowsey (1966) who used a 
quantitative microradiographic technique to determine 
bone formation and destruction rates in normal and 
^osteoporotic* subjects*
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4) The role of dietary intake of calcium, phosphorus, 
protein and vitamin D in relation to bone mass 
and age; the absorption cind urinary excretion of 
calcium; the role of calcium supplementation of 
the diet_______ _________________ ___________ ______,
The dietary intake of calcium, phosphorus, protein and vitamin 
D in the normal male and female population in relation to bone 
mass is reported in Chapter VII* Three groups of subjects 
have been studied* The first was a group consisting of 152 
normal women who were recruited from the relatives and friends 
of patients in the general medical wards of the Western Infirmary, 
Glasgow* The second group was composed of 97 women referred to 
a special Bone clinic because they were thought to be osteoporotic 
by the referring clinician. The third group was composed of 
75 normal male subjects recruited in the same way. Each subject 
had a full dietary history taken. The calculated results
agreed with the results obtained by careful weighing out of the 
diet over one week and are reported elsewhere (Harrison and 
Nordin)*
The X-ray indices of the normal female subjects are compared 
with those of the 97 patients who were considered to be osteoporotic * 
It was found that though the patient group had a low mean X-ray 
score than the normal group, this was because they w^ ere, on average, 
older* When the X-ray indices of the normal and patient groups were
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compared by décades, no significant difference was found 
between the two groups* A higher proportion of the patient 
group had had an artificial menopause and there was a higher 
incidence of backache and fracture in the patient group.
This is not surprising as these were the main reasons for 
the patients being referred to the clinic, apart from the 
appearance of the bone X-rays* The two groups were otherwise 
very similar* The average age of the onset of the menopause 
was virtually identical* They showed the same distribution of 
the site of backache, though backache in neither group corre­
lated with the degree of osteoporosis as judged from the X-ray 
indices* The parity of each group by decades showed no 
difference. They had breast-fed their infants for the same 
length of timOfl The social classes were equally represented 
in both groups* The dietary intake of calcium, phosphorus, 
protein and vitamin D was significantly lower in the patient 
group, but they were older and lighter. When the dietary intake 
was divided by body weight and the two groups were studied by 
decades, no significant difference between them was apparent.
The calcium absorption and urinary calcium excretion again does 
not differ significantly in the patients as compared with the 
normal controls.
293
The striking i’oatnro in fact is the similarity between the 
two groups, even though they were selected in completely 
different ways* It is also evident that age is a major 
factor governing the development of osteoporosis. For 
this reason the two groups were combined and the effects 
of age studied* There is a significant fall in the X-ray 
indices and the Relative Vertebral Density with age. There 
is also a significant fall in the dietary intake of calcium, 
phosphorus, protein and vitcuiiin D with age, the least 
significant change being the fall in calcium intake* There 
is a significant fall in the absorption of calcium with age* 
There is no change in the urinary calcium excretion with age* 
The fall in dietary intake and absorption with age, along 
with the fact that there is no corresponding fall in the 
urinary calcium excretion, is sufficient to account for the 
small negative calcium balance, which would be required to 
produce the measured fall in bone mass with age*
There is a direct relation between the dietary intake of 
calcium, phosphorus, protein and vitamin D and the X-ray 
indices, though the significance is considerably diminished 
when the dietary intake is divided by body weight* Since
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the most important factor is age, this was taken into 
account by comparing the intake of those subjects with 
high and low X-ray indices and Relative Vertebral 
Densities by decades between 30 and 70 years of age*
The results arc illustrated in FigslOO to 111,
The dietary intakes have been considered both corrected 
and uncorrected for body weight* There are some 
significant differences in intake between those with 
high and low intake, but most of these are no longer 
apparent when the intake is divided by body weight* 
However, a significantly lower intake of protein, 
phosphorus and vitamin D persists in those patients 
with a low R*V*D* between 51 and 60 years of age*
There was no significant difference in calcium intake* 
The same patients do not show this difference in the 
Metacarpal, Femoral or Spinal Indices* It is at this 
time of life in women that the rate of bone loss is 
accelerating* These differences do apply in the main 
to the trabecular bone of the spine* However, in view 
of the fact that no differences were found in the other 
measurements or any consistently different intakes at 
any other decade, these results should be interpreted 
with some caution*
29 5
Male subjects show a relatively slight fall in bone mass 
with age* This is especially true of the T*C*M* which 
falls by only k^ 'o between 40 and 70 years* The male 
subjects have a significantly greater amount of bone 
than female subjects as measured by the ToG*M# * However, 
if an allowance for size is made, then the difference 
between them only becomes apparent after 50 years of age 
for the SfiApE*, and after ^0 years for the M*I* *
The male subjects have a higher intake of calcium, 
phosphorus, protein and vitamin D than the female subjects 
The males are heavier than the females, and when the 
dietary intake is divided by the body weight and then 
compared by decades, no significant difference is found 
between the sexes. The male subjects also show a small 
fall in dietary intake with age, but this does not reach 
statistical significance* The male subjects showed no 
fall in calcium absorption with age, and when the two 
hour isotope level indicating calcium absorption was 
corrected for body weight, they have a better calcium 
absorption than the female subjects throughout the age 
range 30'to 70 years* The calcium excretion measured as
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The C c i l c i u m :creatinine ratio showed no significant fall 
with age in the male subjects * The urinary calcium 
excretion in the male was lower than that in the 
female at each decade between the 4th and the ?th 
though it does not reach statistical significance except in 
the 4th and 5th decades.
To summarise, the male subjects do not show the same 
marked fall in bone mass with age which is seen in women. 
Furthermore, calcium absorption is significantly greater 
in the male throughout life, and there is no fall in 
calcium absorption with age* There is a small but not 
significant fall in dietary intake with age* In the female 
the calcium absorption falls with age as does the dietary 
intake* Neither sex shows a significant fall in urinary 
calcium loss with age* It is evident that these differences 
will explain the greater negative balance in women. It is, 
of course, not possible to say whether these differences 
cause the more marked fall in bone mass in the female, or 
are merely the effect of some other change which is responsible 
for both the negative balance and the bone loss*
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In Chapter VIII, the changes in bone mass of patients 
who have undergone gastric surgery are examined* The 
relation of the change to dietary intake of calciian and 
phosphorus, the effects of age cind the type of operation 
are also examined* Two groups are described* One group 
had undergone Polya-gastrectomy, the other vagotomy with 
gastro'-jejunostomy* The two groups were otherwise very 
similar in age, weight and time since operation was 
performed* The intake of calcium and phosphorus did not 
differ significantly between the two groups* However, the 
intake of calcium and phosphorus was higher in the patient 
group than in the normal subjects when considered by 
decades, especially when divided by body weight* The two 
patient groups did not differ significantly in their bone 
mass as measured by X-rays, but there is a greater fall in 
the bone mass with age than was seen in the normal male 
subjects*
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The urinary calcium excretion, as measured by the 
calcium:creatinine ratio, was within the normal range for 
the patients* They tended to have a higher phosphate
excretion than the normal subjects, but this appears to 
be the result of the relatively high phosphate intake*
The phosphate excretion returned to normal in all the patients 
on re-estimation after an overnight fast, except in one 
patient in early renal failure [and in patients with 
osteomalacia* Only two of the patients had convincing 
evidence of osteomalacia, though five further patients with 
slightly abnormal results failed to re-attend for further 
investigation*
The calcium absorption was not tested in these patients, 
but the evidence from the literature (Shiramins et al, 1970; 
Robinson et al, 1964) is that calcium absorption measured 
by isotopic techniques is normal or high in patients who 
had undergone gastric surgery* Only in patients with 
severe steatorrhoea does calcium absorption show evidence 
of diminition following gastric surgery*
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The effect of surgery is not related to the time since 
operation* The fall in hone mass in the older patient 
compared with the normal subjects therefore clearly 
indicates that the older the patient the less able he 
is to adapt to the effects of gastric surgery* Clearly 
the fall in bone mass is not related to removal of part 
of the stomach as both the patients with Polya-gastrectomy 
and vagotomy with gastro-jejunostomy show the sajiie degree 
of bone loss* Unless the older patients represent a 
metabolically different group from the younger patients, 
the diminished bone mass must be the result of the operation, 
The operation must have caused either the diminished 
absorption of some substance other than calcium or it 
must result in some change such as the endocrine factors 
controlling bone formation and destruction* /While the 
latter possibility cannot be excluded, the failure of 
absorption of some other important constituent of the diet 
would appear to be the more likely cause* This is unlikely 
to be dimished phosphate absorption from the evidence that 
urinary phosphate absorption tends to be raised in these
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subjects on their home intakes, and returns to normal on 
fasting* Failure of protein absorption could be a 
contributory factor but the bulk of the evidence would 
favour vitamin D as being equally or more important*
The diminished absorption suggested by the work of 
Thompson et al (l966a,b), and the lowered serum anti­
rachitic activity reported by Smith et £il (1964) suggests 
that a relatively small deficiency of vitamin D may 
contribute to the development of osteoporosis through its 
effects on bone formation and destruction rates. There 
is the further evidence from Chapter VII that calcium 
absorption diminishes with age in women in whom the bone 
mass is also falling* However, Rose (1964) showed that 
vitamin D can also cause a significant rise in urinary 
calcium loss so that little or no benefit in calcium 
balance resuits^ The implications are either that the 
dose of vitamin D is critical or else that age may be the 
dominating factor*
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Although the evidence considered above is not in favour
of calcium deficiency in the diet being a contributory
factor in the development of osteoporosis with age, this
does not exclude the possibility that calcium supplements
might arrest or reverse the process* This has been
examined in Chapter The effects on bone mass
measured as the whole bone density (S*A,E*) or total
cortical mineral per unit length (T*C*M*) are described in
94 patients treated with either calcium glycerophosphate or
calcium in a dose of just over a gram per days The calcium
supplements are additional to their normal dietary calcium
intake* The patients were studied over a period of 18 to
54 months* They did not differ significantly from the
normal subjects of their own age in terms of dietary intake
of calcium, phosphorus, protein or vitamin D, calcium absorption,
urinary calcimn excretion, social class, mean age at the onset
of the menopause, breast-feeding, parity or in their bone
mass measured as the S*A*E« and T*C^M*
The majority of the patients showed a continuing fall in the 
SflAaE* and the ToC*M* while on therapy* Furthermore, when 
the rate of fall was considered in relation to the rate of 
fall in the normal population of the same age, the patient 
group were observed as having a fall in the and the
TpC*M* which occurred significantly faster than was seen in 
the normal subjects* Clearly, though a very few patients 
appear to benefit from calcium supplementation of the diet? 
the majority are adversely affected*
This evidence is at variance with the positive balance 
produced by calcium supplements and reported by a large number 
of researchers over the past decade, and as reported in 
Chapter VI* The effects of calcium supplementation of the 
diet is examined further in Chapter Z* The addition of 
calcium supplements to the diet of 6 patients resulted in a 
significant increase in the faecal excretion of calcium, bile 
acids and fat, the faecal output of these substances increasing 
gradually over 3 to 4 weeks* Increased faecal fat excretion has 
also been reported in patients with steatorrhoea who were given 
additional calcium (Bassett, Keutmann, Hyde, van Alstine and 
Russ, 1939) in children (Lutwak, Laster, Gitelman, Fox, V,he don, 
Wolfe and Woodson, 1964), and (V/erner and Lutwak, 1963) in 
young rats* Kane, Lovelace and M^Cay (l949)
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reported decreased fat absorption in old rats which decreased 
further on the addition of calcium to the diet*
Clearly this may be an important factor in long-term therapy* 
Patients with steatorrhoea and following gastric surgery, 
when the faecal fat excretion is Imown to increase, showed 
an accelerated bone loss* The precise reason for this 
requires further investigation*
The results of these investigations pose many further 
problems, but clearly the accelerated bone loss in v/omen 
compared with men is associated with a small fall in dietary 
intake, a fall in calcium absorption and a higher urinary 
calcium excretion which fails to fall with age* While 
dietary deficiency can be a contributory factor to the 
development of osteoporosis as reported in animals, and 
seen in patients who have diminished absorption due to 
gastric smrgery or steatorrhoea, the evidence against this 
being a significant causal factor in the Western urban 
population is reported in this thesis* The dominant factor 
is the effect of ageing, which plays a more important part 
in the development of osteoporosis in women, who show a much 
greater loss in bone mass with age than is seen in men*
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This difference must arise either from a genetic 
difference affecting the multiplication or function 
of bone cells, or an age change affecting "la fixité 
du milieu intérieur"* The latter could well spring 
from the changes in hormonal secretion related to the 
menopause having a direct effect on the bone cells, or 
on the end effects of diet or hormones on the bone 
cells*
Certainly, there is no reason to believe that these 
factors cannot be controlled* Even though the healing 
of fractures is less efficient in the elderly, there is 
a considerable increase in the rate of bone turnover 
at the site of the fracture which indicates that there 
is no absolute inherent limiting factor within the 
cell preventing effective cell division and function* 
However, the nature of these controlling factors have 
yet to be determined*
S U M M A R Y
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SUMiMARY
The bone mass, as measured by X-ray indices or 
X-ray densitometry, increases up to between 
25 and 40 years of age depending upon the measure­
ment used* All measurements, except cortical 
density in the male, fall with increasing age 
thereafter* The cortical density increases 
throughout life in the male* The X-ray indices, S.A.E, and 
T«C*M« show an accelerated fall after the 
menopause in women*
2 The description of investigations in patients who
are defined as osteoporotic should be accompanied 
by measurements which indicate whole bone density, 
total mineral per unit length of bone, and cortical 
density* Furthermore, these measurements must be 
related to the measurements in the normal population 
of the same age and sex* The best way to quanti­
tate the relation between the patients studied and 
the normal population is to measure and report the 
percentile value of the measurement* This has been 
done in patients with fractures, backache, hyperpara­
thyroidism, hypoparathyroidism, osteomalacia and 
gastric surgery*
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Any bone mass measurement which falls with age 
can be correlated wdth fracture incidence which 
rises with age* However, only the total 
cortical mineral per unit length of bone is 
related to the rate of change in fracture 
incidence in both men and women with age, and is 
the measurement which will correctly define the 
risk of fracture in both male and female subjects* 
There is a very marked increase in the incidence 
rate of fracture after the age of 75 years in 
both men and women* At this time, the rate of 
change in bone mass is in fact decreasing*
Clearly, this increase in fracture incidence 
after 75 years of age must be dominated by 
factors other than the rate of bone mineral loss* 
Spinal biconcavity and fracture is related to 
the amount of bone present and not to the 
percentile value relative to the normal 
population*
307
Though all the above-mentioned measurements 
are required to define the bone status, a 
single measurement can be used to describe 
a patient as being osteoporotic, but this 
measurement must take into account the size 
of the individual* A convenient measurement 
which fulfills this criterion is the whole 
bone density of the 3rd metacarpal (S^A^E*)* 
The value of.the 8oA*E* which gives a useful 
dividing line is 28* There is a considerably 
higher incidence of spinal biconcavity and 
fracture of the femoral neck in women when the 
whole bone density falls below this value*
This value also corresponds with the 5 
percentile value at the age of 35 years, when 
the whole bone density is greatest for both 
men and women*
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All subjects, but especially women, lose bone 
with age* In the absence of any pre­
disposing factors such as gastric surgery 
or steatorrhoea there is evidence that 
there is a specific group of patients in whom 
the rate of bone loss is greater than in the 
normal population* The mean bone mass in 
patients with symptoms, such as backache, 
or fracture, do not differ significantly 
from the normal population* Furthermore, 
while osteoporosis is a major problem in the 
elderly woman, it is of much less significance 
in the male*
The rate of bone mineral transfer in women 
falls with age* The urinary hydroxyproline 
excretion, which correlates with the rate of 
bone destruction, again measured with isotopes, 
rises with age* Though the bone mineral 
transfer rate does not measure the true bone 
formation rate quantitatively, the experimental 
evidence in dogs quoted in Chapter VI is that 
the bone mineral transfer rate correlates with 
the rate of bone formation*
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The evidence therefore is in keeping with a 
fall in the true bone formation rate with 
age and a rise in the bone destruction rate 
in women* However, as the hone mass fails 
with age, the rate of bone formation per unit 
mass does not change significantly*
There is, however, a significant rise in the 
rate of bone resorption with age*
These studies show that the bone loss with 
age in women is associated with decreasing 
dietary intake, diminishing calcium absorption, 
a failure to attain a corresponding fall in 
urinary calcium excretion, a fail in the rate 
of hone formation and a rise in the rate of 
hone destruction with age* Normal male subjects 
also show a slight fall in dietary intake with 
age* They do not, however, show any fall in 
calcium absorption* The calcium absorption 
in male subjects remains significantly better 
than in the females at each decade between the 
4th and 7th* The male subjects also showed 
no significant fall in urinary calcium excretion 
with age, but their urinary calcium:creatinine 
ratios were consistently lower than that of the 
female subjects, though these differences did 
not reach statistical significance att except in 
the 4th and 5th decades.
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These differences between the male and 
female subjects account for the 
differences in the rate of loss of bone 
between the sexes* However, these 
observed effects could be the cause or 
the result of the decreasing bone mass 
with age@
8 The effects of calcium supplementation
of the diet on bone mass in 94 subjects 
was studied from 18 to 54 months*
Four patients showed a significant 
increase in the bone mass over the period 
of the study* Twenty™three patients 
showed a significant fall in bone mass*
The remainder showed no significant change^ 
(There were no features which clearly 
distinguished any group from the normal 
subjects or the remaining patients*
When considered as a group, the fall in 
bone mass over the period of study was 
significantly greater than that observed 
in the normal population of a corresponding
age* The evidence implicates i supplementary calcium 
els the cause of the accelerated bone loss*
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The evidence in 8 above is at variance 
with the reported positive balances in 
patients given calcium supplements, and 
with the evidence in Chapter VI of a fall 
in bone destruction rate which correlated 
inversely with the calcium balance, and 
the fall in urinary hydroxyproline which 
correlated with the fall in bone destruction 
rate* Clearly, either the balance results 
have a consistent error, or else the benefit 
from calcium supplements is only temporary* 
There is an increase in faecal bile acids 
and faecal fat in patients on calcium 
supplements* Malabsorption produced by 
the calcium supplements may therefore 
eventually cause the calcium balance to 
again become negative*
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10 The small fall in vitamin D intake with
age, the accelerated fall in bone mass in 
steatorrhoea and following gastric surgery, 
the fall in calcium absorption with age, 
the reported lower values of senna anti­
rachitic activity in osteoporosis (Smith 
et al, 1964), and the increased faecal
fat output in patients on calcium 
supplements, and increased rate of loss of 
bone when compared with normal subjects 
suggest that the role of vitamin D in the 
development of primary and secondary 
osteoporosis requires further investigation*
11 Ydiile dietary deficiency can be a contributory
factor to the development of osteoporosis in 
experimental animals, there is no evidence 
that it contributes to the development of 
osteoporosis in the Western urban population*
The dominant factor is the effect of ageing 
which affects women more than men. This 
difference must arise from the genetic 
difference between the sexes. The proximal 
cause must be either a change in hormonal 
secretion at the menopause affecting the 
relative rates of bone formation and destruction, 
01' a genetically determined failure of cell 
multiplication or function*
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The bone mass, as measured by X—ray indices or X—ray 
densitometry, increases up to between 25 and 40 years 
of age depending upon the measurement used* All 
measurements, except cortical density in the male, 
fall with increasing age thereafter. The cortical 
density increases throughout life in the male.
The X-ray indices, whole bone density (S,A«E*) and 
the total cortical mineral per unit length of bone 
(T*C*M«) show an accelerated fall after the 
menopause in women.
The description of investigations in patients who 
are defined as osteoporotic should be accompanied by 
measurements which indicate whole bone density, total 
mineral per unit length of bone and cortical density. 
Furthermore, these measurements must be related to the 
measurements in the normal population of the same age 
and sex. The best way to quantitate the relation 
between the patients studied and the normal population 
is to measure and report the percentile value of the 
measurement* This has been done in patients with 
fractures, backache, hyperparathyroidism, hypoparathy­
roidism, osteomalacia and gastric surgery.
Any bone mass measurement which fails with age can 
be correlated with fracture incidence which rises 
with age* However, only the total cortical 
mineral per unit length of bone is related to the 
rate of change in fracture incidence in both men 
and women with age, and is the measurement which 
will correctly define the risk of fracture in both 
male and female subjects* There is a very marked 
increase in the incidence rate of fracture after 
the age of 75 years in both men and women* At 
this time, the rate of change in bone mass is in fact 
decreasing* Clearly, this increase in fracture 
incidence after 75 years of age must be dominated 
by factors other than the rate of bone mineral loss* 
Spinal biconcavity and fracture is related to the 
amount of bone present and not to be percentile 
value relative to the normal population.
Though ali the above-mentioned measurements 
are required to define the bone status, a 
single measurement can be used to describe 
a patient as being osteoporotic, but this 
measurement must take into account the size 
of the individual, A convenient measurement 
which fulfills this criterion is the whole 
bone density of the 3rd metacarpal (S*A,E,), 
The value of the S,A*E, which gives a useful 
dividing line is 28, There is a 
considerably higher incidence of spinal 
biconcavity and fracture of the femoral neck 
in women when the whole bone density falls 
below this value. This value also 
corresponds with the 5 percentile value at 
the age of 35 years, when the whole bone 
density is greatest for both men and women.
All subjects, especially women, lose bone with age.
In the absence of any predisposing factors such as 
gastric surgery or steatorrhoea there is ^  evidence 
that there is a specific group of patients in whom 
the rate of bone loss is greater than in the normal 
population. The mean bone mass in patients with 
symptoms, such as backache, or fracture, do not differ 
significantly from the normal population.
Furthermore, while osteoporosis is a major problem 
in the elderly woman, it is of much less significance 
in the male.
The rate of bone mineral transfer in women falls with 
age. The urinary hydroxyproline excretion, which 
correlates with the rate of bone destruction, again 
measured with isotopes, rises with age. Though the 
bone mineral transfer rate does not measure the true 
bone formation rate quantitatively, the experimental 
evidence in dogs quoted in Chapter VI is that the 
bone mineral transfer rate correlates with the rate 
of bone formation.
The evidence therefore is in keeping with a fall 
in the true bone formation rate with age and a 
rise in the bone destruction rate in women* 
However, as the bone mass falls with age, the 
rate of bone formation per unit mass does not 
change significantly. There is, however, a 
significant rise in the rate of bone resorption 
with age,
7 The dietary intake of calcium, phosphorus,
protein and vitamin D falls significantly with 
age in women. There was a small, but not 
significant, fall in dietary intake with age in 
men. Men have a significantly higher intake of 
calcium, phosphorus, protein and vitamin D than 
women. These differences, however, were no 
longer apparent when age and weight were taken 
into consideration. The dietary intake of 
calcium, phosphorus, protein and vitamin D 
at each decade between the 4th and the 7th was 
examined in women with X-ray indices above and 
below the mean in each group.
Only between 51 and 60 years were small differences 
between the dietary intakes found, and these were 
related only to the Relative Vertebral Density 
(R.V,D,), The evidence therefore shows that some 
factor connected with age and not diet is 
responsible for the loss of bone in women,
8 These studies show further that the bone loss with
age in women is significantly associated with 
decreasing dietary intake, diminishing calcium 
absorption, a failure to attain a corresponding fall 
in urinary calcium excretion, a fall in the rate of 
bone formation and a rise in the rate of bone 
destruction with age* Normal male subjects also 
show a slight fall in dietary intake with age#
They do not, however, show any fall in calcium 
absorption* The calcium absorption in male subjects 
remains significantly better than in the females at 
each decade between the 4th and 7th* The male 
subjects also showed no significant fall in urinary 
calcium excretion with age, but their urinary 
calcium;creatinine ratios were consistently lower
than that of the female subjects, though these 
differences did not reach statistical significance 
except in the 4th and 5th decades.
These differences between the male and female 
subjects account for the differences in the rate of 
loss of bone between the sexes* However, these; 
observed effects could be the cause or the result 
of the decreasing bone mass with age.
9 The effects of calcium supplementation of the diet
on bone mass in 94 subjects was studied from IS to 
54 months# Four patients showed a significant 
increase in the bone mass over the period of the 
study# Twenty-three patients showed a significant 
fall in bone mass* The remainder showed no 
significant change# There were no features which 
clearly distinguished any group from the normal 
subjects or the remaining patients* When 
considered as a group, the fall in bone mass over 
the period of study was significantly greater than 
that observed in the normal population of a 
corresponding age# The evidence implicates 
supplementary calcium as the cause of the 
accelerated bone loss.
810 The evidence in 9 above is at variance with
the reported positive balances in patients 
given calcium supplements, and with the 
evidence in Chapter VI of a fall in bone 
destruction rate which correlated inversely 
with the calcium balance, and the fall in 
urinary hydroxyproline which correlated with 
the fall in bone destruction rate.
Clearly, either the balance results have a 
consistent error, or else the benefit from 
calcium supplements is only temporary.
This was examined further and a significant 
increase in faecal bile acids and faecal fat 
in patients on calcium supplements was found. 
Malabsorption produced by the calcium 
supplements may therefore eventually cause the 
calcium balance to again become negative.
11 The small fall in vitamin D intake with age, the
accelerated fall in bone mass in steatorrhoea 
and following gastric surgery, the fall in 
calcium absorption with age, the reported lower 
values of serum anti-rachitic activity in 
osteoporosis (Smith et al, I964), and the 
increased faecal fat output in patients on 
calcium supplements, and increased rate of loss: 
of bone when compared with normal subjects, 
suggest that the role of vitamin D in the 
development of primary and secondary osteoporosis 
requires further investigation,
12 While dietary deficiency can be a contributory
factor to the development of osteoporosis in 
experimental animals, there is no evidence that 
it contributes to the development of osteoporosis 
in the Western urban population. The dominant 
factor is the effect of ageing which affects women 
more than men. This difference must arise from 
the genetic difference between the sexes. The 
proximal cause must be either a change in hormonal 
secretion at the menopause affecting the relative 
rates of bone formation and destruction, or a 
genetically determined failure of cell multipli­
cation or function.
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TABLE II
Analysis of medical histories in Group I (l52 normal female 
subjects), Group II (75 normal male subjects), Group III 
(317 normal female subjects) and Group IT (312 normal male 
subjects).
History Group I Group II Group III Group IV
Fracture 23 15 54 ,43
Renal stone 4 3 4 13
Persistent nocturia 42 13 58 44
Frequency of 
micturition 16 4 24 25
Dysuria 14 1 14 2
Diarrhoea
(for over 6 months) 5 2 1 1
Chronic bronchitis 10 6 8 24
Gastroenterostomy 1 0 2 4
TABLE III
Regression equations of Metacarpal Index, Femoral Index, 
Spinal Index and Relative Vertebral Density on age in 
Group I (152 normal female volunteers) and Group II 
(75 normal male volunteers).
Regression Correlation
equation coefficient P
i 2 S.E* (r)
Female subjects 
Metacarpal
index y = 0*82—0#005x - 0*15 —0*64 < 0*001
Femoral .
index y » 0*68-0*002x — 0*15 —0*40 < 0*001
Spinal
index y = 0*94—0*001x — 0*10 -0*26 < 0*005
Veitebral ^ “ 3.53-0.06 x 1 2.5 -0.50 < 0.001
Density 
Male subjects
Metacarpal index not significant
Femoral index y = 0*065-0*0017% — 0*17 —0*32 < 0*01
Spine index not significant
Relative
Vertebral Density not significant
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Comparison of S,A*E* in male and female subjects in social classes 
1 + 2  and 4 + 5 in relation to age*
Meani
S.-4A _ L
Age grout) Social class Female Male Female Male
20 -  29 1 + 2 55.57 32.6a  N.S. N.S.
4  + 5 34.85 34.27
30 -  39 1 + 2 32.39 34.11 N.S, N.S,
4 +  5 35,74 36.29
40 -  49 1 + 2 36.94 32.37 N.S. N.S.
4 + 5  33.87 31,72
50 -  59 1 +  2 33.57 30.23 N.S. N.S,
4 + 5  30.54 33.84
6 0 - 6 9  1 + 2 26,63 33.99 N.s; < .01
4 + 5  28,57 29.67
70 + 1 +  2 24.48 28.72 N.S. N.Si
4 + 5 24,36 29.05
Path of X-ray beam
Cross-section
through
metacarpal
A.E. = Absorption equivalent 
in AI of (a+b)
S. A.E. = A.E.
c
\  - Linear attenuation
coefficient of the 
X-radiation in (a+b)
T.C.M. = \*T T (r '-r* )
S.T.C.M. = T.C.M.
Fig 1 The estimation of alnmiiiinin equivalent (A.E# ) and 
the calculation of the Standardised Aluminium 
Equivalent (S.A.E, ), Lambda ( X ) j  Total Cortical 
Mineral per Unit Length of bone (T<>CoM#) and 
Standardised Total Cortical Mineral per unit length 
(S,T*C#M#) of the right 3rd metacarpal#
8FEMALE VOLUNTEERS 
(Age distribution)
35-39
4 0 “ 4 4
4 5 - 4 9
5 0 - 5 4
5 5 - 5 9
6 0 - 6 4
6 5 - 6 9
7 0 - 7 4
l ZJ  T o ta l  (152)
Backaches (52 )
NUMBER
Fig 2 The distribution of normal female subjects (Group l)
in 5 year age groups, showing the incidence of
backache in each age group (l52 subjects)#
normal males
20-1
15—
10-
5—
Total (7 l)  
Backache (lo)
lÜMÏÏÏÏÏÏ
30-34 35-39 40-44145-49 150-54 (55-59 160-64165-691/0-74 1/5-80
AGE-YEARS
Fig 3 The distribution of normal male subjects (Group II)
in 5 year age groups, showing the incidence of
backache in each age group (75 subjects).
Number
NORMAL FEMALES 
Incidence of Backache
40 n
]  Total (317)
I  Backache (49)30 -
20-
10 -
 ____  m m
0-4 5 -9  10-14  15-19 2 0 -2 4  2 5 -2 9  3 0 -3 4  3 5 -3 9  4 0 -4 4  4 5 - 4 9 5 0 -5 4  5 5 -5 9  6 0 -6 4  6 5 -6 9  7 0 -74  7 5 -7 9  0 0 -8 4  8 5 -8 9
Age
Fig 4 The distribution of normal female subjects (Group III)
in 5 year age groups, showing the incidence of
backache in each age group (317 subjects)*
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Number
NORMAL MALES 
Incidence of Backache
40-1
O  Total (312) 
Backache (32)
3 0 -
20-
10-
0 -4  5 -9  10-14 15-19 2 0 -2 4  25-29  30 -34  3 5 -3 9  4 0 -4 4  4 5 -4 9 5 0 -5 4  55 -59  6 0 -6 4  6 5 -69  70-74 75 -79  80-84 85 -89
Age
Fig 5 The distribution of normal male subjects (Group IV)
in 5 year age groups, showing the incidence of
backache in each age group (312 subjects).
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NORMAL WOMEN -  RELATIVE VERTEBRAL DENSITY
Pr«-menopausal Post-menopausalR.V.D.
« 30-
R.V.D. 0  5
-3  0 -
AGE Years since menopause
Fig 6 The relation between Relative Vertebral Density (R,V,D, )
and the menopause in 152 normal female subjects (Group l). 
The R,V,D, and the two 8.E* range for each 5 year age group 
is sho^ra. The age of the subjects is shown in the pre­
menopausal volunteer and the time since the onset of the 
menopause in those who have past the menopause. There is 
an abrupt fall in density 5 years after the onset of the 
menopause.
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NORMAL WOMEN -  METACARPAL INDEX
METACARPAL Pre-menopausal 
INDEX  
80-1 •
##
Post-menopausol
1
4 0  4 5
Years since menopause
Fig 7 The relation between the Metacarpal Index (M*I,)
and the menopause in 152 normal females (Group l). 
The mean and two S .E , range for each 5 year age 
group is shoivn. The age of the volunteers is 
sho-wn in the pre-menopausal subjects and the time 
since the onset of the menopause in those who have 
past the menopause. There is an abrupt fall in the 
M,Xy 10 years after the onset of the menopause.
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NORMAL W OM EN -  FEM O RAL INDEX
FEMORAL Pre-menopausal 
INDEX
Post- menopausal
Years s ince m enopause
Fig 8 The relation between the Femoral Index (P,I.) and the 
menopause in 152 normal female subjects (Group l).
The F,I« of each subject and the two S,E, range for 
each 5 year age group is shotvn. The age of the 
volunteers are shown in the pre-menopausal subjects, 
and the time since the onset of the menopause in those 
who are past the menopause. There is an abrupt fall 
in the F*I, 15 years after the onset of the menopause.
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Standardised  
Alum inium  Equivalent
NORM AL FEMALES
40-
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• • •
10
900 8010 20 40 50 60 7030
AGE (years)
Fig 9 The change in whole hone density (S,A,E,) of the
3rd metacarpal with age in 317 normal female subjects 
(Group III), The mean and two 8,E, range for each 
5 year age group is shoim^
ID
NORMAL FEMALES
Standardised 
Aluminium Equivalent
PRE-MENOPAUSAL POST-MENOPAUSAL
50-1
▲ Artificial Menopause
40-
•A
30-
10
10 20 30
AGE (years)
40 50 10 20 30 40 50
Years since Menopause
Fig 10 The relation between the whole bone density (S,A,E«)
and the menopause in 317 normal female subjects (Group III) 
The S,A*E, of each subject and the 2 8.E, range for each 
5 year age group is shown. The age of the volunteer is 
sho^vn in the pre-menopausal subjects and the time since 
the onset of the menopause in those subjects who have 
past the menopause. There is an abrupt fall in S,A,E,
5 years after the onset of the menopause*
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Standardised 
Aluminium Equivalent 
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• • • • • • •
20
—I—
30
;
' t| *1 * *
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—r- 
60
—r- 
70 80
—r 
90
Fig 11 The relation between whole bone density (S,A,E*) 
and age in 312 normal male subjects (Group IV),
The S,A*E« for each individual and the mean and 
two S,E* range for each 5 year group is indicated.
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S tandardised  
Alum inium  Equivalent
50 — MALES
FEMALES
30-
20-
—r
908060 70500 2010 30 40
AGE (years)
I
Fig 12 The change in whole bone density (S*A.E#) with age
comparing normal male and female subjects (Groups III 
and IV), The data has been analysed in terms of a 
third order polynomial* The mean and the 5 to 
95 percent limits are shown#
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NORMAL FEMALES
A
10-1
8-
m
#6-
• •
4-
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30 60 9010 20 40 GO. 0 70 80
AGE (years)
Fig 13 The relation between cortical density (A) and age 
in 317 normal female volunteers (Group III)*
The cortical density for each individual and the 
mean and 2 S*E* range for each 5 year age group is 
indicated*
%u
NORMAL FEMALES
POST-MENOPAUSALPRE-MENOPAUSAL10-1
A  Artificial Menopause
20 30 40 5050 1030 4020100
AGE (years) YEARS since MENOPAUSE
Fig 14 The cortical density (X) of each female subject 
before the onset of the menopause, and the time 
since the onset of the menopause in the post­
menopausal subjects is shown* (317 normal
female subjects - Group III)* No significant
effect of the menopause on X  detectable#
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A
NORMAL MALES
10-1
6-
2-
908060 7050403010 200
AGE (years)
Fig 15 The change in cortical density ( y\) of the 3rd
metacarpal with age in 312 normal males (volunteers). 
The mean and 2 S,E, range for each 5 year age group 
is shoivn.
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A MALES
10-1
-  FEMALES
8H
6H
44
2H
908070606040302010
AGE (years)
Fig l6 The change in cortical density { \ )  with age
comparing 312 normal male and 317 normal female 
subjects (Groups III and IV)* The data is 
analysed in terms of a third order polynomial#
The mean and the 5 and 95 percent limits are sho^m#
23
4 0 n
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s 'Q>
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o
2
20-
805040
AGE
Fig 17 The change with age in the total cortical mineral 
of the 3rd metacarpal with age in normal male and 
female subjects (Groups III and IV)* The mean 
for each year between 30 and 80 years is shown#
The third order polynomial analysis is illustrated#
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Fig 18 The change in the 8,T,C,M, of the 3rd metacarpal with
age in normal male and female subjects (Groups III and IV). 
The third order polynomial analysis is illustrated.
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Fig 19 Changes in the total width of the 3rd metacarpal 
of normal male and female subjects with age 
(Groups III and IV). The third order polynomial 
analysis is sho^ vn#
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Fie: 20 Changes in the medullary width of the 3rd metacarpal
of normal male and female subjects with age (Groups III 
and IV)* The third order polynomial analysis is shown*
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Fig 21 Changes in the aluminium equivalent of the 3rd
metacarpal in normal male and female subjects with 
age* The data is analysed in terms of a third order 
polynomial*
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Fig 22 Changes in the S,A*E* with age in male and female 
subjects between 25 and 75 years shora as the mean 
values obtained by analysis in terms of a third 
order polynomial*
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NORMAL FEMALES
31 7 Subjects
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Fig 23 The 10, 20, 30, 40 and 50 percentile values 
for the S.A.E* plotted against age derived from 
the 317 normal female subjects of Group III*
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X N O R M A L  FEMALE 317 Subjects
9
7
• * \
’S
©o5
3
8016 48 64320
Age (years)
Fig 24 The percentile values from 5 to 50 between 5
and 80 years derived from the cortical density ( A )  
measured in 317 normal female subjects (Group III)*
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N O R M A L M ALE 312 Subjects
SAE
50-1
40-
e* •
30-
80604020
Age (/ears )
Fig 25 The percentile values between 5 and 50 years 
for the whole bone density (S,A*E*) in normal 
male subjects (Group IV - 512 subjects) against 
age*
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NORMAL MALE
X 312 Subjects
7 -
. »»» 30 ^
# #
03
5 -
4440 56 72248
AGE (Years)
Fig 26 The percentile values for cortical density-
derived from 312 normal male subjects (Group IV) 
plotted against age*
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FEMALE S U B J E C T S - ' o s t e o p o r o s i s '
Spine 
Index 
100
80 -
60-
40
o
(139)
•
I
I
S
I
O
0
0
— I—
<5 10-20
— 1------------r
30-40 >50
S.A.E.( Percentile)
Fig 27 The Spinal Index plotted against the percentile value
for S*A,F# (of the 3rd metacarpal) in female ^osteoporotic 
patients, A Spinal Index below 80 indicates significant 
biconcavity. It is evident that spinal biconcavity may 
be severe even when the patient is above the mean value 
for her age (i.e, above the 50 percentile).
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Spine
Index
100-,
136 Female Subjects
• ?
8 0
e «0 % %  
iP,®c
60
4 0
20 nr
4 12
— 1---------r
20
S.A.E.
28
“I---- 1---- 1
36 44
Fig 28 The Spinal Index plotted against the whole bone
density (S.A.E,) of the same subjects illustrated in 
Fig 25« There is a much higher incidence of spinal 
biconcavity below an S,A,E® of 28 (the 5 percentile value 
at 35 years of age when xhe whole bone density is at its 
greatest in women).
SPINE 
,SH WEIGHT  
(gm/cc)
0-3-1
0 2 -
Y =0 -03 5+ 0-193C 
r  =0-651 (P<0-01)
0-5 1-0
METACARPAL ASH WEIGHT (gm/cc)
Fig 29 The spinal ash weight (gm per cc) plotted against 
metacarpal ash weight (gm per cc). The bone was 
derived from post-mortems on patients who died of 
conditions not associated with metabolic bone
disease*
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CHAPTER III
TABLE X
The ratios of the rates of mineral loss in male 
and female subjects at age 50 years.
àsM.0 S.A.E. T.C.M. S.T.C.M.
Ratio 0,43 0,48 0,12 0,33
Female
43
TABLE XI
Increase in prevalence of bone mineral loss as measured 
by the various parameters in male and female 
subjects between 35 and 75 years.
àÆs> S,A,E. TfCfM,
Male 132 123 26
Percentage
increase 306 257 217
S.T.C.M,
88
268
44
TABLE XII
Categorisation of Fracture Sites
GROUP A
(industrial)
Phalanges (hands 
and feet)
Tarsals and 
metatarsals
Carpals and 
metacarpals
Radius « upper end
GROUP B, 
(Home )
Spine
Pelvis
GROUP C
^Osteoporotic * Uncategorised
Clavicle 
Fibula (malleo­
lus)
Fibula (head and 
shaft) 
Tibia (malleo­
lus)
Tibia (shaft)
Tibia (head)
Patella
Femur (shaft)
Femur (neck)
Femur (trochanter) 
Radius (lower end)
Humerus (upper end) 
Humerus (rest)
Ulna
Ribs
45
50 n
40-
20-
•10%
70 806050
AGE
403020
îx!
Fig 30 This figure illustrates the derivation the increasing
Fl’syalence of whole hone density below the 25 percenti%^^^ 
35 years.. The percentile values hetweeiT 5 and 95 
~in thé female subjects are shown, A line parallel to 
the *x* axis has been arbitrarily drawn from the 
25 percentile value at the age of 35# The rate of change 
of whole bone density can be determined from the intercept 
of this line with the percentile values. The rates of 
change vary with age and are illustrated for each 
X-ray measurement in Fig 31#
4b
90-
S.A.E. T.C.M.
80-
70-
60 -
50-
3 0 -3
i 20-
im 9 0 -
A.E. S.T.C.M.
80-
70 -
50-
4 0-
30-
20-
807030 SO 80 3050 70 40
AGE AGE
Fig 31 The changing prevalence of low hone mass with increasing 
age determined for the A,E», , T,C,M# and S,T.C*M,
(see Fig 30), This prevalence is a function of age, 
sex and the type of X-ray measurement used to determine 
the various parameters of bone mass^
Percentage 
Fracture 
Incidence 
Rate
©Male 
A Female
 Industry
 Home
60"
20-
•-— '
40 60
AGE
Fig 32 The changing percentage fracture incidence rate 
plotted against age for accidents in the home 
and at work for both men and women.
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Radius Upper EndPhalanges • Male 
•^Female
 Feet
 Hands
Breakage
Rate
 Torsals
Metatarsals Carpels
 Metacarpals
60 40 60 80
A G E
Fig 33 The changing fracture incidence with age in
male and female subjects* The graphs do not 
show the absolute changes, but illustrate the 
change in incidence relative to the incidence 
at the age of 40 years* The resemblance to 
fractures sustained in industry are clear*
The fracture sites are those designated as 
Group A (see Table XII and Fig 32)«
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Spine
• Male
A Female
Breakage 1" 
Rate
Pelvis
30-
20-
10-
4 0 8060
AGE
Fig 34 The changing fracture incidence of spine and pelvis 
relative to the incidence at the age of 40 years 
in both male and female subjects* These fractures 
belong to Group B (Table XII) and resemble the changing 
incidence of fractures with age sustained in the 
home (see Fig 32).
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Patella
25i •Male
T.C.M.
*  Female
T.C.M.
15-
Breakoge
Rate
Femur Shaft
80-
40-
40 60
AGE
The changing fracture incidence in the patella and 
femoral shaft in male and female subjects with age.
The changing incidence between 40 and 75 years very 
closely follows the rate of change in the incidence 
of total cortical mineral below the 25 percentile 
in the normal male (o) and female subjects (x ) .  The 
fracture sites belong to Group C (Table XIl), The 
fracture incidence rises markedly for the female subjects 
but shows little change with age in the male subjects. 
Above the age of 75 years the incidence of fracture in 
both the male and female subjects rises sharply and is 
no longer related to the rate of change of T,C,M, 
with age*
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300-1 pemur Trochanfer Radius Lower End•M a le  
*  Female
200- 10-
100-
Breokoge
Rote
Femur Neck 2 ^ 1  Humerus Upper End
800-
25-600-
400- 15-
200-
40 60 40 60
AGE
Fig 36 The pattern of change in fracture incidence of 
fracture in male and female subjects with age 
of the intertrochanteric fractures of femur, lower 
end of radius, femoral neck and upper end of humerus, 
is similar to those in Fig 35» These fractures again 
belong to Group C, and the relative rates of change 
up to 75 years of age are very similar to the changes 
in T,C,M, with age (see Table XIl).
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ClavicleTibia Head
Breakage
Rote
12- Head & ShaftFibulaTibia Shaft
10"
6040 4060 80
AGE
Fig 37 The changing fracture incidence with age relative 
to the incidence at the age of 40 years. Again 
the pattern of change is very similar to the T.C.M, 
as illustrated for the patella and femoral shaft in 
Fig 55, The incidence of fracture changes little 
for male subjects between 40 and 75 years. There 
is a marked rise in the fracture incidence in female 
subjects between 40 and 75 years. Both sexes again 
show the increase in incidence after the age of 75 
to 80 years. These fracture sites are included 
in Group 0 (Table XIl),
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20-1 Humerus RemainderTibta Malleolus
15-
10-
Breakoge
Rate Fibula Malleolus Ulna
406040
AGE
Fig 38 Fracture sites included in Group C (Table XIl)*
Again the relatively small change in bone breakage 
rate in the male subjects below 75 years is in 
contrast to the change in female subjects, resembling 
the changes in T.C.M, with age (Figs 31 and 35).
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4~i
Breakage 
Rate
1 -
Ribs Male
0
40
T
60
AGE
-T-
80
FiK 39 Fractures of the rihs show a change in incidence 
of fracture with age which does not fall into any 
of the patterns A, B or C and is entered separately 
under D (Table XIl)#
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CHAPTER rV
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CALCIUM ABSORPTION
Ca47 Oral
Gut
Ca47
in
Rapidly
Exchanging
Pool
Bone
Kidney
Fig 40 Diagramatic illustration of the pathways followed
by an orally administered isotope of calcium (4?Ca), 
The level of the isotope in the blood at time t 
after administration is a function of the rates of 
transfer in and out of the rapidly exchanging pool 
sho^m in the figure. The isotope is lost permanently 
from the system by passage doira the gut, in the 
faeces and urinary losses.
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CALCIUM ABSORPTION MODEL
GUT
BLOODKa
Kg
Fig 41 This figure shows the fractional transfer rates of 
orally administered isotope which have been 
determined, I(a is the fractional transfer rate 
from the gut xo blood over 6 hours. Kg is the 
fraction of the isotope which passes down the gut.
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CALCIUM ABSORPTION-ANALOGUE MODEL
|k0
3
GUT POOL
---
1
SERUM
POOL
H ^21
Kl2
TK 10
EXCHANGING 
POOL
INITIAL CO NDITIO N  
(Oral Isotope) INITIAL CONDITION  
(i.v. Isotope)
Ka
Kg f Pô P3)K
Fig 42 This figure shows the analogue system set up to
simulate the change in the intravenously administered 
isotope, and the transfer of the isotope from the 
gut to the blood (p, 106),
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A N A L O G U E  C O M P U T E R  CURVE F IT T I N G
10-1
K]2 -  0 *784  
K 21 =  0 * 682  
Kio =  0*345
Ka = 0*611
Kg =  0*3250*8 -
0*6 —
0*4 “
2 31 4 5 6
TIME in HOURS
Fig 43 The curves fitted to the data points of the serum
specific activities of 45Ca (0) administered intravenously, 
and oral 4?Ca administered simultaneously, against time,
I{a is the fractional transfer rate of 4?Ca from the gut 
to blood and Kg the fractional transfer of 4?Ca doTO the 
gut over the 6 hour period of the study.
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2HR PLASMA LEVEL v Ka
10 “  
8 — 
6 “ 
4 “ 
2
2hr PLASMA LEVEL 
BODY W EIG HT
T
0*1 0*3 0*5 0-7 0-9
G U T to SERUM TRANSFER C O EFFIC IE N T Ka H r - '
Fig 44 The two hour plasma 4?Ca levels multiplied by 
body weight is significantly related to the 
fractional transfer rate of the 47Ca from the 
gut to blood (Ka).
61
N E T  C A L C IU M  A B S O R P T IO N  v Ka
g. CALCIUM /  
Week
5 -
3 -
100-80 60-4
Ka h r“
Fig , The net calcium absorption determined from the
measurement of calcium balance is not related 
to  the fractional turnover rate from gut to blood 
estimated by the simultaneous administration of 
47Ca orally and 45Ca intravenously.
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CHAPTER V
TABLE XIII
Plasma calcium on normal and low calcium diets;
63
Mean Plasma 
Number of Number of Calcium
Diet subjects observations (mg/lOO ml) S,E
Normal 27 108 9,46 0,046
Low *
Calcium 27 108 9,29 0,043
* Difference between the means =0,17; t = 2,6; P < 0,01*
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TABLE XIV
24-hour urine calcium on normal and low calcium diets
Number of Nhmber of Mean 24-hour
Diet subjects observations urine calcium S.E.
Normal 2? 2? 198,8* 21,3
Low *
Calcium 2? 27 135.7 13.8
* Difference between means = 63,1; t = 2,3; P < 0,02,
TABLE XV
Urine calcium;creatinine ratio on normal and 
low calcium diets
65
Number of 
Diet subjects
Number of 
observations
Mean urine 
Ca/Cr 8.E.
Normal 27 27
*
0,17 0,016
Low
Calcium 27 27 0,12
*
0,013
* Difference between means = 0,03; t = 2,3; P < 0,02,
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TABLE XVI
The relation between the change in urinary calcium as (i) mg / 24 hrs 
and (ii) Ca/creatinine ratio and the change in plasma calcium.
No,of No, of Regression
Pobservations Subjects equation 2  1',
(i) 40 39 y = 143x - 23 0,46 3,2
(ii) 40 39 y = 14x - 0,025 0.57 4.3
<0,01
<0,001
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TABLE XVII
The effect of a high phosphorus intake on mean 
plasma calcium eCckIinorganic phosphorus concentrations 
in eight subjects with osteoporosis.
Mean plasma Mean plasma
Number of calcium phosphorus
Diet observations (mg/lQO ml) S*E. (mg/lOO ml) 8,E,
Ward 30 9.62 .07 3.51 .18
High
phosphorus 29 9,54 .07 3.92 .10
t- = 1.0 t = 2.83
P > 0.05 P < 0.01
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TABLE XVIII
The effect of a high phosphorus diet on the urinary 
phosphate/creatinine ratio, the phosphate/creatinine 
clearance ratio and the P,E#I. in eight patients with 
osteoporosis.
Number of Mean Mean Mean
Diet observations P/cr ratio S,E. Cp/Ccr 8,E, P*E,I. S.E.
Ward 8; .76 .150 .16 .026 +.05 ,022
High
phosphorus 8 1,25 .125 ,27 .027 +.14 .050
t = 2.57 t = 5.22 t = 3.12
P < 0.05 P < 0,01 P < 0.01
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TABLE XIX
The effect of a calcium infusion on the mean 
urinary phosphate/creatinine ratio, the phosphate 
creatinine clearance ratio and the P.E.I. in 
eight patients with osteoporosis on a high 
phosphorus diet*
Number of Mean p/cr Mean Mean
observations ratio 8«E* Cp/Ccr 8.E# P*E*I* S,E,
Before
infusion 8 1,48 .207 .31 .023 +.17 .024
After
infusion 8 0.65 .210 .11 ,025 -.12 .022
t = 2.99 t = 5.92 t = 9.63
P < 0.01 P < 0,001 P < 0.001
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TABLE XX
The effect of a high phosphorus diet on the 
mean plasma concentrations of calcium and 
inorganic phosphorus in ten subjects.
Mean Mean
Number of plasma calcium plasma phosphorus
Diet observations (mg/lOO ml) (mg/lOO ml) S,E,
Ward 40 9,75 0,071 3.40 0,073
High
phosphorus 40 9.51 0,066 4,l6 0,105
t = 2,6 t = 6,08
P < 0.01 P < 0.001
TABLE XXI
Effect of phosphorus supplements on mean 
concentrations (mg/lOO ml) of total and 
ultrafilterahle calcium in nine normal 
subjects.
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AUT0AMLÏ7ER METHOD;
EDTA mmOD:
Total
calcium
Ultrafilterahle 
calcium
Total Ultrafilterahle 
calcium calcium
Mean Mean Mean 8.E. Mean S*E,
Controls 9.24 0.05 5.10 0,04 9.67 0,06 5.36 0.07
High P 9.01 0.06 4.81 0.04 9,47 0.11 4*88 0,31
t 3.1 3.1 1.4 2,4
P < 0,01 < 0,01 > 0.05 < 0,05
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TABLE XXII
The effect of high phosphorus intake on the 
calcium/creatinine ratio in eight subjects with 
osteoporosis. Three observations were made on 
three successive days before and after starting 
the high phosphorus intake.
Ward Diet High Phosphorus Diet
M,G, .35 .10
.15 .13
.36 _ _ ...12........
J . L, .28 .17
.40 .25
.34 .23
H,L, .35 .15
.24 .17
,26 .18
R.B, .20 .19
.19 .22
.39 .12
I.B, .29 .14
.37 .13
.12 ___________________ _ . . 1 6
H.W. .42 .32
.44 .26
.37 __________..30.........
A. M. .20 .08
.15 .13
.11 .  09 _ _
M.S. .29 .33
.28 .15
.24 .23
Number of
observations 24 24
Mean Ca/Cr .283 .180
t = 4,23 
P < 0,001
TABLE XXIII
Age, sex, weight and creatinine clearance in 8 "osteoporotic" 
subjects, 9 patients with renal stone, 8 patients with 
hyperparathyroidism, and 2 patients with hypoparathyroidism
73
Creatinine
Osteoporosis
Renal stone
Hypoparathyroidism
Patient Age Sex Weight
(Kg)
Clearance
(ml/min)
R.B. 60 F 61 119
C.H. 36 F 45 125
E,T. 61 F 59 88
J.M. 57 M 57 141
A.M. 54 M 55 97
E.B. 61 M 50 97
D.B. 55 F 68 101
A.S. 67 M 60 98
A.C. 51 F 58 100
W.H. 55 M 65 102
J.H. 51 M 71 120
M.S. 68 F 55 110
J.Q. 33 M 67 140
M.M. 53 F 60 80
A.D. 20 M 75 137
T.B. 37 M 81.5 134
S.B. 40 F 64 73
H.C. 46 F 55 97
F.B. 38 M 61 125
J.R. 45 M 58 83
S.M. 48 F 49 94
W.C. 47 F 64 78
D.S. 40 M 63 88
E.S. 37 F 51 140
J.W. 57 M 71 110
S.G. 20 F 45 89
E.B. 43 F 79 102
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TABLE XXIV
Whole bone density and percentile values
in 8 *'osteoporotic" subjects
Patient Age Sex SAE Perceni
R.B. 60 F 27.5 38
C.H. 36 F 32 19
E.T. 61 F 26.6 34
J ,McG. 57 M 31.5 48
A.M. 54 M 27 13
E.B. 6l M 28 27
D.B. 55 F 26 15
W.N. 67 M 25 27
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TABLE XXV
The relation between the calcium/creatinine clearance 
ratio and the plasma ultrafilterable calcium in 
osteoporosis, renal stones, hyperparathyroidism and 
hypoparathyro idisni,______________________ ________________ ___
Diagnostic Regression
group equation r P
Oosteoporosis y = 0,0l6x -0,019 - 0,068 0,47 < 0*0001
Renal stones y = 0,049% *0,l67 - 0*12 0,63 < 0,001
Hyperpara-
tliyroidism y = 0,018% -0,065 - 0,050 0,66 < 0,001
Hypopara-
thyroidism y = 0,052% -0,215 - 0,10 0,87 < 0,001
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URINE Ca 
(mg /2 4 h r )
L O I V  C a  D / E T
11 Normal subjects 
(M E A N  + 2 S.E.)
200-
100
5 73 9- 1
DAYS
Fig 46 The fall in the 24 hour urine calcium output in normal 
subjects when changed from a free to a low calcium 
diet. The significant fall in urinary calcium 
excretion is apparent within 24 hours and no 
significant fall is apparent thereafter. The mean 
and 2 S,E, range of urinary calcium excretion is shown.
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U F Ca 
( mg ®/o )
6* O “I •
5 8 -
5 6 -
5-4
5-2
5 0 -
4 * 8 -
4 • 6
4*4
4 2 -
# o
• 0 9 • e
• o
• 09
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♦ t 
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9IÏ
9 9 9
9 9 0
19 Obs. on 
11 subjects
FR EE
DIET
LOW Ca 
DIET
Fig 47 The ultrafilterable calcium in 11 normal subjects 
on a free and low calcium diet. The fall in
ultrafilterable calcium on a low calcium diet is 
highly significant (P < O.OOl).
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B.N. D.S. CM. I.M. K.T. P.T. B.M. E.C. MB.
Ca.mg %  
60 - 
5 0
4 0 -
20
VJ VJ Ij
6 0 -  
5*0 -
40“ 
2-5 -
VI
6 0  -  
5 0 -
4 0 -
2*5-
\J y
Fig 48 AutoAnalyzer tracing of the calcium concentration
on a free and a low calcium diet. The serum samples 
of the subjects on the two diets were fed in alternately 
and the difference between the two values is apparent 
from the differences in peak height.
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URINE Ca 
m g /2 4 h rs
+ 200-1 r= 0*46
+ 1 6 0 -
+  1 2 0 -
+ 8 0 -
O-
4 0
120-
-  160
—  200 -
— 2 4 0  -
-  2 8 0 -
“  3 2 0 - '
10 —*6 —*4 —*2 O
SERUM Co (m g /1 0 0 m l)
+'2 + 4  +*6 +*S
Fig; 49 The change in 24 hour urinary calcium excretion is
significantly related to the change in plasma calcium 
in patients on low and high calcium diets. The 
continuous line shows the relation between the two values 
The interrupted line shows the change that would be 
expected if the tubular resorption of calcium had 
remained constant.
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H IG H
NO R M A L PHOSPHATE
D IE T D IE T
H IG H
NORM AL PHOSPHATE  
D IET d i e t
H IG H
NO RM A L PHOSPHATE  
D IET d i e t
URINARY
P /C r
ra t io
3-
•4 -
•3 -
Cp/Ccr *2 RE.I .
+  • 1
-.2 -
Fig 50 The effect of high phosphate feeding on the urinary 
phosphate/creatinine ratio, the phosphate/creatinine 
clearance ratio and the Phosphate Excretion Index,
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B E FO R E  A F T E R
3-
2-
U rine_
P/Cr
ra t io
1 -
B E FO R E  AFTER
•5-
• 4 -
CP/Ccr
O-
B E F O R E  AFTER
• 2 -
0 “
Figr 31 The effect of calcium infusions on the ratio of 
phosphate to creatinine in the urine, on the 
phosphate/creatinine clearance ratio and the 
Phosphate Excretion Index, in patients on high 
phosphate feeding.
mLOW
NORMAL CALCIUM  
DIET DIET
NORMAL
DIET
LOW
CALCIUM
DIET
NORMAL
D IET
LOW
CALCIUM
DIET
URINARY 
P /  Cr 
ratio.
3-1
-4-
■3 -
^p/ ^ Cr *2
1 -
0-
3 -1
E.I.
The urinary phosphate/creatinine ratio, 
phosphate/creatinine clearance ratio and 
Phosphate Excretion Index in patients on 
normal and low calcium diet. No significant 
effect on phosphate excretion is evident.
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NORMAL
DIET
5* 8
5*4“
5*0-
4 • 6 *■
Plasma P 
mg ®/o 4 . 2  -
3-6 -
3-4
o • • •
3*0-
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HIGH
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DIET
|::
s.
!.
<• *
NORMAL DIET 
10-7-1 •
HIGH PHOSPHATE DIET
1 0 * 3 -
Plasma Co 
mg •/.
9 • 5 ”
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Fig 33 Changes in plasma phosphate and plasma calcium 
in patients on a normal and a high phosphate 
diet. There is a significant rise in plasma 
phosphorus and a fall in plasma calcium.
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Ca/Cr. ratio
7-1
4 -
2 -
16060 120 140 20040 60 100 180 24020 220
BLOOD UREA (mg Vo)
Fig 54 The change in calcium/creatinine ratio with 
renal failure.
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PATIENTS W IT H  RENAL CALCULI
C A L C f U M - C R E A T J N I N E  
CLEARANCE R A T I O
( ^ Ca/^Cr )
95 % confidence limits 
of “ Hyperparathyroidism "
0 35-1
95 % confidence limits 
of "Osteoporosis"
0 3 0 -
0 2 5 -
0 15-
0 05-
1109 06 0 7 0 1 008-05 0
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Fig; 55 This figure shows the relation of the
calcium/creatinine clearance ratio to plasma 
ultrafilterable calcium in patients with 
"osteoporosis", primary hyperparathyroidism 
and renal stone disease («)*
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56 The relation between the calciiim/creatinine 
clearance ratio and the plasma ultrafilterable
calcium in patients with Ihyperparathyroidism and 
patients with hypoparathyroidism (#), The 95/^  
Confidence limit for the osteoporotic subjects 
is shown.
(—
9 -
8-
C A L C tU M  
REABSORBED 
mg y  100ml 7 -
FILTRATE
87
•  O S T E O P O R O S IS  
O  R E N A L  S T O N E
#
o *
^88 Ù  o°
O .  # % , 0 . # 0  CCD •  o
08?
O o
,.s8 V
• 9 °  o o
o
ULTRAFILTERABLE C A L C IU M  ( m g / l O O m i )
Fig 57 The relation between the calcium reabsorbed 
per 100 ml of glomerular filtrate and the 
plasma ultrafilterable calcium in patients 
with "osteoporosis” and patients with renal 
stone disease.
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Fig 58 The relation between the calcium reabsorbed per 
100 ml of glomerular filtrate and the plasma 
ultrafilterable calcium in patients with "osteoporosis” 
and patients with primary hyperparathyroidism. The 
mean calcium resorption per 100 ml of filtrate is 
significantly higher in the hyperparathyroid patients 
between 6 and 9 mgj^  of ultraf ilterable calcium.
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FÎK 39 The calcittm reabsorbed per 100 ml of filtrate plotted 
against the plasma ultrafilterable calcium in patients 
with hyperparathyroidism and in patients with hypo­
parathyroidism, The fall in the reabsorption of calcium 
is evident in the hypoparathyroid patients above 5»5 
plasma ultrafilterable calcium.
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CHAPTER VI
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TABLE XKVI
Clinical details of patients given isotopes by continuous feeding
Case Age Sex Weight Diagnosis Bone status
(Eg)
Patients given 45Ca and 85Sr:
P,C, 55 M 48 Steatorrhoea Osteoporosis
J*M, 59 M 52 Diarrhoea Normal
B*T, 50 U 72 Osteoporosis Osteoporosis
A#D* 49 M. 52 Steatorrhoea Normal
d^L# 76 F 37 Osteoporosis Osteoporosis
T,a. 64 M 51 Osteoporosis Osteoporosis
F*A. 60 P 57 Osteoporosis. Osteoporosis
E,W, 63 M 57 lUieumatoid arthri­ Osteoporosis
66
tis (steroids)
doL# 63 F Backache Normal
A#M* 54 M 56 Osteoporosis Osteoporosis
F,D, 26 M 56 Osteoporosis Osteoporosis
d,P, 59 F 50 Rheumatoid arthritis Osteoporosis
T*C, 48 M 45 Steatorrhoea Osteomalacia
Patients given 45Cas
6765 F Osteoporosis Osteoporosis
%,8, 53 F 43 Rheumatoid Rheumatoid arthri
62
arthritis (steroids)
I,IC* 43 F Osteoporosis Osteoporosis
A,8, 46 F 62 Osteoporosis Osteoporosis
A,H, 67 F 38 Steatorrhoea Steatorrhoea
F,8. 70 F 46 Renal failure Renal failure
Patients given 85Sr;
A#Mc8# 50 M 47 Steatorrhoea Osteoporosis
43 F 90 Arthritis Normal
d,McNig 58 M 80 Myocard^ infarco Normal
A# Mp 80 F 52 Osteoporosis Osteoporosis
57 F 5S Osteoporosis Osteoporosis
58 F 41 Castroenteritis Osteoporosis
dg If 68 F 61 Osteoporosis Osteoporosis
E,B* 60 F 35 Steatorrhoea Osteomalacia
FpM* 60 F 58 Osteoporosis Osteoporosis
MfMcM* 57 F 46 Osteoporosis Osteoporosis
M*McE* 72 F 43 Osteoporosis Osteoporosis
A*McL# 78 F 48 Osteoporosis Osteoporosis
D.V, 68 F 6l Osteoporosis Osteoporosis
M*McL* 72 F 61 Osteoporosis Osteoporosis
WoYf 60 F 57 Osteoporosis Osteoporosis
F.W, 75 F 40 Renal failure Osteomalacia
c,w. 31 U 82 Calculi Normal-
EfSg 59 F 69 Calculus Osteoporosis
K,C. 34 M 70 Hypertension Normal
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TABLE XXVII
Bonei-mineralization rates (mg/Kg/day) measured by continuous 
feeding of strontium-85 and calcium-45*
Case Bone-mineralization rate Bone-mineralizatign rate
measured by Sr measured by Ca
P.G, 5fO 9,7
J.M, 4,8 10,5
R.T. 0 7,0
A.P. 13,4 13,0
T.B, 33*0 8*0
T.R, 22,0 8*7
F.A. 18,5 7.2
F * A* 12,4 14,0
ReW* 8,3 4,6
R*W, 8*8 3,9
R,W, 7,9 5.3
5,5 4,9
J,L, 0.9 7,2
J.L, 6,6 7,3
A*M* 12,5 7,4
A,M, 3,2 8,4
A,M. 10,5 10,2
F,D, 15,6 4,5
F.D, 22,0 8*0
J*P. 21,0 9*5
d.P* 11,6 8,7
T,C, 13,0 10,0
Mean 11,7 8,1
Standard error 1.7 0,6
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TABLE: XXVIII
Patients given intravenous calcium-45 and strontium-85 
M values are expressed in mg/day
Case Age Weight
(Kg)
Diagnosis 85SrM 45CaM
J.R* 64 50 Osteoporosis 220 234
53 72 Osteoporosis 176 306
A.P, 70 44 Osteoporosis 60 358
P.T* 62 48 Renal failure 105 141
MfMcK 69 46 Osteoporosis 138 153
E,T* 64 54 Osteoporosis 170 181
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TABLE XXIX
Comparison of 858r retention measured by the whole body counter, 
and isotope excretion in Urine and faeces in 3 osteoporotic 
patients,
(WeBoG, is Percent retention estimated on the whole body counter)
Patient (a) Age 6? yrs "patient (b) Age 64 yrs" Patient Age 63 yrs
^ Retention $ Retention $ Retention
)ay W,B,C, Excretion Day W.B.C. Excretion Day W.B.Co Excretion
0 100 100 0 100 100 0 100 100
7 49,4 49,6 5 42 42,1 8 29,6 30.6
14 36,7 33.1 15 22,7 23.4
21 31,1 29.0 22 20,1 20,9
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TABLE XXX
Mineral Transfer Rate (M.T.R.) measured by the 
method of Bauer et al (1957) between 7 and 14 days 
after injection of the isotope*
M*T*R, Metacarpal
Patient Age Weight.(Kg) (mg Ca/day) Index
M.M. 59 53 584 43
E.B. 72 42 261 31
M,J, 64 60 405 28
F.H, 70 50 273 49
E.H. 64 51 135 41
I,W. 46 74 435 39
J.W, 56 43 361 48
C.W, 58 64 134 53
H.M, 82 69 182 48
E.McS. 75 67 266 44
E.McK. 66 57 281 43
M.UoK. 75 - 192
W,McL. 70 59 277 45
J,McL. 79 46 196 21
U.H. 85 70 206 42
A.H. 61 61 301 37
H,Q. 80 57 288 54
I.G. 63 65 211 37
M.G. 31 53 226 48
M,G. 58 69 245
E.B. 66 66 305 59
M.L, 63 68 303 47
M.K, 81 63 111 37
M.K, 65 57 241 49
J.L, 63 65 280 59
M.M, 30 53 227 57
A.M. 80 53 103 46
M.M, 63 44 166 40
M.McI, 84 69 187 44
J, McH. 54 69 79 71
E. McI. 85 63 83 43
M, McE, 67 44 117 33
R.B, 60 61 86 57
H.G, 69 58 122 51
Cont*d,*/
rtient
TABLE XXX Contd, M.T.R,
(mg Ca/day)
Metacarpal
IndexAge Weight (Kg)
c.c. 68 61 131 40
AfH* 78 53 142 36
L,6* 67 60 198 58
J.B. 51 58 198 69
A.Y, 80 55 188 43
M,M 55 63 195 49
E«T, 54 53 196 50
E,L. 75 54 281 43
V.M 68 43 287 43
E,L. 80 61 87 47
J.C. 72 53 39 36
J.G. 58 69 228 54
B.F, 58 69 392 35
E.D. 70 70 39 70
M.8. 52 70 338 50
M,S, 71 325 47
A.8* 48 57 254 58
B,L# 95 48 124 37
G,M. 75 44 153 47
42 65 356 61
N.N. 57 56 553 56
8,0. 74 155 45
J,8. 77 68 242 31
J,a. 64 6l 220 48
H.G. 53 58 176 49
A.P« 70 54 60 40
P.T. 62 56 103 46
M.McK, 69 46 138 50
E,T, 64 51 170 31
E.B, 69 39 220 38
E.McK. 59 40 216 43
+îî
After 2 or 3 weeks equilibration 
Calcium glycerophosphate supplements
Calcium carbonate supplements 
Calcium orthophosphate supplements 
Calcium lactate supplements*
VJl VJl - Vjl
to O  M3 GO
CTn tfJ*OV VI
-vj OV VJl vtr* VjI to  1-*
VJl -vj VI VJl VJlVI 3 OV VJl VO O VO VJl
VJl 3 3 Ov OV CT\ VJl 3 V I -vj -V VJl 0\ OV M to to 3Vj1 OV VJl O  VJl >!>Vjl M  -vj to to to 00
S ’c+Q
«
b>
td
CO * H*CO p O o o o c+ P O o W O P CQP cl- M CO 03 03 03 p h CO CO cl- 03 M Ç+-
o Ô c+- M CH ci- cl- Id M H- cl- P c+- y CD
tsr* 3  4 ^ 3 o 3 <b CD p o Cj* 3 P p P P td* P
P o  R O o O O H* M o o d “ O o CH
o 't J hd O i H* hd hd » p 4
t3* Pj c+- o 4 • « 01 cl- » a a P(0 (0 H* 
'•W' CO
v » x  H ‘ 
CO
O o o o O o o o % o fel OO o 01 03 CO CO CO CO 03 CO o CO CO03 s ci- d- d- d- d- d- d- d- a (4- d-3 3 (+ 3 s  13 3 P 3 P P P 3 p 3 P P 8 p pP P O O o o O o o O p o oo M hd *XJ I-Ü *Td ►cd M Id M 1^lid« * * # » « • « o
it?* v^ to V jl VJl VJl it?* VJl Vjt ft?- to ft?* Vjl it?" VI *v j -vJol Ov VI Vjl to to to
to to M MO M 0> M* @ # • a «
VJl -s) (T\ VO VO 'V
Ï * +t Î Î Î
V I to  to V£> jfc-0 * 9
VO VJl •{» +•+
VI
to ilr*« A 
M  VjI
O
o
S-H*
§opu
o
gHMOP)Hj
o o o« 0 9
O  O  V I 
CO 00 VD 
00 Vol O
o o o• « b
O  O  VO 
VO VO o M M o
o  o  o  o  ob a $ Ob
O  o  ft?* O  tt?* _
VJl VJl o  VJl to VJl VO
it?* VO o  VJl o  ' ■
M  to M M  
-V  (O OV "V OV ft?" • 4> o b o b
psj VI M VI crv VO
to to
V I M  VJl o , «
to
L6
0
1
V_il Vjl to V.>lM Vjl V_il M V^ M M•V Ul VJI ov VO MOOV^ o VO O VjI it?"« e » « A b • b * * « oOv o 9 VJI O ’^tOCX) o Vil o *•0 ot i* -h +
p O o O o o o o o o o o o» « « « * « « * b • • •O Vjl o o o tvdwlO O M o M MI it?" CTv OV CVI 00 VJI O it?* it?* it?*to o O to O O M O O o <J
Vjl to to Lil MVjI te to to M MVI ov VO O to OOM O CO to o VJI VJI« « e <D b b A » • « A • a»vj00 VJI M -U VOitî’M ov itr 00 CJV
VJI VJI VJI it?* V^ it?* VJI V /l -s i Cv *s j CTv ■sj -s i -s i it?VJI 00 *Ss] OV ■sJ VJI <Ov
•v j **vj VO to 00 00 VJI o it?* it?* to OV VJI VJI G\vOtt?"CV o it?" to to 00A b 0 « b 6 A A » b b A o * » A « 4 « b « o A b
CO "v j O o U l «U VJIV>1o to it?* o M to M (JvVOtOVjl M VJI it?* ov VI
o
gfO
<&o
wo
X
C+
toH'
P
1Ui
H-m
CO td M O p P 
C+- fl>s
8 ft?-(M H- O \  O to
crq
I I
CO pbM «
g * to
v-fl
I
HïO
g"
ft?*
o hrj Hs çl-ppj O H'fDO <i O VJl
to H'CD<0 ci-mH
I? MV I to MO  VO 00 OVVJ1 it?" V I  to  M
td td
h co
P >*
I il 1
X—s td td M
to o O
0 0 P
p p Ci
M H*
W M H j H,
P O H*
O W 0 O
P o B
M 0 P P
O d ) d- P
P d - H* d"
M H* O H*
P O 0 <1
d- 0 H*
P 0 d -
p j H
P
P
d -
H) d - P
M P
O o
B
X-s.
d - M
t r
p
H*
eu W
H*
M) O
H? p
P M
l-J Q
P 0
0 M
Ci P
P d-
P
O* p .
p
d -
0
p O
p B
d -
P
d - 0"
13* P
P
pJ
H*
H* H)
P M)
d P
P 0
q i
P p
0
0pj
P
î
H* P
0 P
4
0
0
P
(fl M
P
p 0
Ci O
H* P
Hj
H* P
O 1
P
tdO
d - 0
H* hïj
< *
H*
d -
H*
P
CQ
O
86
O O O O O O O O O C 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0A b O b o o A A A b b b o b b o o b C i o o A a A
O Q M O O M O O O O t O O M O O O M M O V / I O ' C a o OVJï itr- OV if?* iJ?* VI it- i£r* VO VI M ifr VO >1?- OVVIV/1 tO-0*VVj|VJ| OVVO OOVl-slVIOOVI»î?-av*vlVIOCOOtOOOOVD'sOMVJ10ifi"tO
V^ VItOtOV/ltOVJl*sJVIOMtt?'iî?''s/IVJltOtOMtOMVJlVIMM Ob O O b A o  a o a b b b o o A ' b b A A t i b a o  
O Ç r v -s J t^ O O V J1tO v .O G O tO "vJ-sJO VI tO tO V j | vO M Vl i l? ‘ VJiif?-
}-jj™iMMMlOtOVI M M M MVOlOWMVJJOVMVOtOMtOOtO-sJOO-sJtOVO'sjVJlOCOVlVI « A b o b O O A O  b ' a A b A b e O  b b o o s b b  0\VO'sj\jivOK)OVlCiO'vVIOOO'-J-s]0\M'ulO)prCr\VOVOV^
o o o o o o o o o o o o o o o o o o o o o o o oA O o a b & e  b 4 > b O b C o o o o A i o o i > A t > D
O O O O O M O O M O O O O O O O M M O O O O O O  
VI CTi-sJ 00 -V to CT^ -sJ If?- VI VI if?- VJI (lî-ifr-GOVlvO Cn-V VI VI -s] VI •sJVlOOOOVIOOOV^Vltfï^MtOtOtOOOGrvCriVlBV-VOvCO
oi-|r*^]Oil-VIM,i-fe^<|>iri&Vlv^èil:'OOœ^vlilVI«t>bb 0ao.b0.o b : f ) 0 0 b « a « 4 b 4 b c «  
tO tO tO OO-VtO i f r -v JOOMVIOO VJ lv j r i t - iM  OvVJi 00 Ov 00 tO CTv O
VltOVJlVIVlKt-NOM's>ltOVjlMtOMMM's^VI tO tO M  iC tO 
to VO to O O V I O O V J l O O < I V I O O M * s J  C^iVjlOOCrvCVit:-ii?*OOM*VA O A Q b O O O b b C I b O O b A O O o a A Q . A
<3Viî:-VIVJîgM~‘Vlitï-Ov£>V10MMIOOOOVlVlVl\4?-VVlOÛ
M M M  M M
O O D - s J - V - v J .  i f r * V lV I> i? - t f r - s J O O O O O N V O it : *  C W l  tO V I  V./I «vj O  VO 
A « A  o o  O A O 0 4  O O O O 0 - 0  O O  0 0  -0 o o  *K)^(Pit:-VltOVOiv4VOOVOtO"VC)RsjCMOOM-OC}CiOVTV
M M M M  M M  M t O M i —OtOMOVOVOMtOVDMVOvOi|:-fl?-\jlOOdVOMifï’MO»t?*tOO O O O O O O  f o O O O O O  O O O O O O O A O  O
l-îravOdMVOM'sC>tOi{;*VÛUlUlVltOVOOtOCyvvOrfî‘OOOOM"sJ
M M  M  M M  M  M tO M  M
O t O M O O - v J t O t O V O V l ' v J C r \ M V I V I O C T v v X O t O i { ? * M O i l ? ‘ tO o o o  0 0 0 0 0 * 0 0 0  - O O  o o o  o o o  e o o *  
VI Ch Vjl OOVI-vJVj lVJlVIVj iOOVIVOV^it r^^f î '  ©>VO CO 00 00 O  V£>
?
01
p
Ul
P- H) •
o * >w o
p
OR
B >fr-
M o
0 O
P
M
Pr
P
Ch
}i>
o  c j  
«d y
p j H ' H '
O p  <1 d  00 
M OH* P
4
p- Ulo p A 
0) *  
p o
I g
I  f
ifï*
VJl
î - lp ^ «
td  
B  W
h
td
i i r  p j
Je
td
w ' p j  W
VsO
S
m
a
td op Hs 
O
ÿ  p
g -
d -
P
H*(fi O*
d
P  P
: :
og
H ,
0  H* 
y  t j
d -  
d - O
P  w
0
1 g
C7" P  
P  d- 
M P
O W 
t“h d -
 ^& 
P  H* 
P  P  
t>r w
(fl
pm o 
13* o
i l
E'£
O  d*
0 O 
M
1 I
M  O ■ Ip"_ o0
P
î
1 «
99
TABLE XXXII
45
Mean percentage of administered dose of Ca excreted during 
the first 8 weeks in faeces and urine, and mean retention
of isotope.
Week 1 2 3 4 5 6 7 8;
No, of obs. 6 13 18 17 12 12 12 12
Mean
faecal excretion(^) 53«3 55.® 57. ? 62,8. 52.0 63.0 59.8 63.6.
S.E, 7.4 3,5 4.7 4.3 5.5 7.2 6.4 6.5
Mean
urinary excretion(^) 5,6 8,5 9.3 11,1 13.6 10,6 10.3 11.2
S.E. 1.2 2,1 1.7 1.9 3,3 1.9 1.9 1.8
Mean
retention 41,1 35.7 33,0 26.1 34.4 26,4 29.9 25,2
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Fig 60 The two compartment model of showing the determination 
of the rate of return of isotope from bone (y) by long­
term exchange where after 40 days the retention 
(r) = Be"P^ and the rate of return of isotope from bone 
_ loop (Shimmins, Allison, Smith and Speirs, 1967).
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Fis 6l The net absorption of 45Ca and 85Sr at different 
“ levels of stable calcium intake during the
continuous feeding of the isotopes. The mean
and 2 S.E. ranges are shown.
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Fig 62 Urinary excretion of 45Ca and 85Sr at different 
levels of stable calcium intake during the 
continuous feeding of the isotopes. The mean 
and 2 S.E, ranges are shown.
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Correlation coefficient r = 0,92.
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Fig 64 The serum and ultrafilterable 85Sr specific
activity from the same serum samples. The specific 
activity is the same as that in the ultrafiltrate of 
the serum indicating no significant difference in 
the protein-binding of strontium compared with calcium,
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Fig 65 The skeletal retention of 45Ca and 85Sr at 
different levels of stable calcium intake 
during the continuous feeding of the 
isotopes. The mean and 2 S,E. ranges are 
shown.
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Fig: 66 The bone mineral transfer rates in 6 patients in
the present study (o) and 10 patients studied by 
Dow and Stanbury (l9bO) (®), The mineral transfer 
rate is estimated by the method of Bauer et al (l957) 
foi levying the simultaneous intravenous administration 
of 45Ca and 85Sr,
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lia— 62 The bone mineralisation rates in the normal and
osteoporotic subjects estimated from the simultaneous 
intravenous administration of 45Ca and 85Sr. The mean
ana d ranges are sho;vn*
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Fig 68 No significant fall in weight is apparent in the 
65 female patients with age in whom the mineral 
transfer rate has been calculated.
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Fig 69 There is no significant difference in the
Metacarpal Index (m *I.) between the patients 
studied and the normal subjects of Group II 
at any decade.
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Fig 70 The mineral transfer rate plotted against age in
65 female subjects* The mineral transfer rate is 
calculated by the method of Bauer et al (l957) 
between 7 and 14 days after injection of 85Sr.
There is a significant fall in the mineral transfer 
rate with age.
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Fig 71 This figure illustrates the transfer of isotope 
from the E*C,F+ into hone during the phase of 
conversion of freshly deposited matrix to fully 
calcified bone. Initial mineralisation up to 
about 75 percent occurs rapidly and proceeds much 
more slowly thereafter. In order to determine 
the true rate of mineralisation (i,e, the net gain 
of calcium) the magnitude of the exchange into bone 
would have to be Imomi, There is no way of 
estimating this directly using simple isotope 
kinetic data.
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Fig 72 Mean plasma specific activities (as percentages 
of dietary specific activities) during the first 
21 days of continuous feeding of 45Ca (- 1 S.E*),
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Fig; 73 The percentage excretion of 45Ca in faeces and 
urine during the first 8 weeks of continuous 
feeding.
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Fig 74 The excretion of 45Ca in faeces and nrine as 
a function of dietary calcium intake after 
two to three weeks equilibration*
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three weeks equilibration*
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Fig 79 There is a significant inverse correlation 
between calcium balance and urinary hydroxy- 
proline excretion.
120
URINARY —  
HYDROXYPROLINE 
(mg /k g  /  day)
0 9- •57
•027X+-3 O0-8-
0 7 - p . < 0 1
0-3 ” 
0 -2 - '
3 -2  -1 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
RESORPTION RATE (d) (m g /k g /d a y  )
Fig 80 There is a significant direct correlation 
between bone resorption rate measured 
isotopically and urinary hydroxyproline 
output.
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Fig 81 There is no significant difference between 
the Metacarpal Index of the normal and 
•’osteoporotic’* subjects at any decade.
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Fig 82 Twenty-four hour urinary hydroxyproline 
excretion in 106 female subjects on a 
gelatin free diet plotted against age.
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Fig 83 Twenty-four hour urinary hydroxyproline/creatinine 
ratio is directly related to age in women.
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CHAPTER VII
TABIÆ XXXIII
Social Classes
126
Normal
Females
Female 
* Osteoporotic * 
Patients
Class 1 Professional, 6 4*!
etc*
3 3.3#
” 2 Senior
Executive
14 9.8# 9 10.0#
3 Skilled 96 68, 57 63.3#
4 Semi-skilled 18 12.8# 14 15,
5 Unskilled 7 5.0# 7 7,
Not recorded 11
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TABLE XXXV
Site and incidence of backache in normal subjects and in 
•osteoporotic^ patients.
Normals •Osteoporotics•
Site of backache Number percentage Number Percen
Cervical 0 0 2 2,0#
Thoracic 2 1.3# 7 7,3#
Thoraco-lumbar 1 0,7# 6 6,2#
Lumbar 33 21,5# 44 45.0#
Lumbar and legs 10 6,6# 18 18,7#
Sacral 6 3.9# 12 12,4#
Girdle thoracic 0 0 0 0
Girdle lumbar 0 0 0 0
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Group I 
(female)
Group II 
(male)
Group i p  
(female)
Group IV 
(male)
31 -- 40 17 12 18 8
41 -- 50 44 21 25 19
51 -- 60 34 14 19 13
6l -- 70 28 11 12 9
71 -- 80 28 8 10 10
TABLE XXXVI
The percentage of normal male and female subjects 
at each decade with backache.
iju
TABLE XXXVII
The incidence of symptoms other than backache or bone
pain in the normal subjects and •osteoporotic • subjects.
NOimLS •OSTEOPOROTICS»
Number #age Number #age
Diarrhoea 4 2,6 4 4.1
Gastrectomy 0 0 0 0
Short-circuiting
operation 1 0.7 0 0
Renal colic 1 0.7 3 3.1
Single renal stone 2 1.4 2 2,0
Recurrent renal stones 1 0.7 0 0
Frequency of micturition 14 9,2 31 32.0
Nocturia 39 25.6 43 44.0
Dysuria 13 8.6 23 24.0
Hysterectomy 8 5.3 7 7.2
Oophorectomy 2 1.3 13 13.4
TABÏJS XXXVIII
Parity by decades
131
Normal Females •Osteoporotic• Females
21 - 30 1.7 2,0
31 — 40 2*1 1.5
41 - 50 2*3 2.4
51 - 60 2*0 2*2
61 — 70 3.1 2.4
71 - 99 1.9 2.3
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TABLE XLIV
Fall in X-ray indices with age in male and female 
subjects,
MALES No« of subjects r Significance gradient Intercept 
M,I, 75 -0.19 n.s.
F.I. 75 -0.32 P < 0,01 -0.174 65,2
8,1. 75 0,13 n.s.
E.V.D, 71 -0,17 n.s.
FEMALES
M.I. 242 -0,67 P < 0.001 -0.542 83.56
F.I. 242 -0,46 P < 0,001 -0,293 70.31
8.1, 239 -0,30 P < 0,001 -0,202 97.02
a.V.D. 233 -0.55 P < 0.001 -0.608 85.00
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TABLE XLVI
The relation between dietary intake and age in 
normal male subjects.
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Dietary Number of
Constituent subjects r T-value P
Calcium 68 -0,194 -1,606 n.s.
Phosphorus 68 -0,185 -1,531 n.s.
Protein 68 -0.267 -2.249 < 0,05
Vitamin D 68 0,019 0,158 n.s.
Calcium/body weight 66 -0,049 -0.392 n.s.
Phosphorus/ body weight 66 -0,010 -0,078 n.s.
Protein/body weight 66 -0,079 -0,636 n.s.
Vitamin D/body weight 66 0.109 0.880 n.s.
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Zi-E The Metacarpal Index plotted against age in "osteoporotic”
and normal female subjects. At no decade is there any 
significant difference between the two groups. The mean 
and 2 S.E, range in 5 year age groups are shown.
141
CALCIUM
(mg)
900  T
8 0 0 -
7 0 0 -
6 0 0 -*
PROTEIN
(gm)
80-1
7 0 -  
60  - 
5 0 -
Daily Intake (mean ± 2 S.E.)
PHOSPHORUS
(mg)
1200
7^/
Û
P > 0 0 4
U O O -  
1000-
9 0 0  
VITA M IN  D
12^-’
m
m
m
P<0 001
P<0-001
100 -
8 0 -
6 0 - P<0 001
Fig 86 Dietary intake of calciujn, phosphorus, protein and 
vitamin D in normal and "osteoporotic" subjects.
The mean and 2 S.E, range are shoira. The "osteoporotic" 
group has a significantly lower intake of phosphorus, 
protein and vitamin D.
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Fig 87 The frequency distribution of body weight in 
the normal and "osteoporotic" subjects in 5 
year age groups. The "osteoporotic" group is 
significantly lighter than the normal subjects.
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The frequency distribution of age in the 
normal and ’'osteoporotic" subjects in 5 
year age groups. The "osteoporotic" group 
is significantly older than the normal 
group.
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DIETARY INTAKE per kg BODY W EIG H T -v AGE ( m ean± 2 S.E.)
Calcium Phosphorus
m g/kg
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Differences between graphs 
not significant unless specified 
at foot of column.
Fi/y 89 Dietary intake in the normal and ’'osteoporotic" 
subjects divided by body weight and plotted 
against age in 10-year age groups. The mean 
and 2 S,E, range are shown. No significant 
difference between the groups is found.
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Fig 90 Calcium absorption measured with 45Ca in the normal 
and "osteoporotic" subjects. The mean and 2 S,E, 
range in 10 year age groups are plotted against age. 
The two groups do not differ, except between 6l and 
70 years of age.
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Fig 91 The mean and 2 S.E, range of two estimations of
the urinary calcium:creatinine ratio plotted against 
age in 10 year age groups in the normal and 
"osteoporotic" subjects. No significant difference 
between the groups is seen.
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Fig 92 The relation between the Metacarpal Index and the 
dietary intake of calcium, phosphorus, protein and 
vitamin D in women. The mean and 2 S.E, range are 
shmvn, (The significance of the correlations are 
shoTra in Table XLIIl).
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The relation between the Femoral Index and the 
dietary intake of calcium, phosphorus, protein 
and vitamin D in women. The mean and 2 S.E. 
range are shoivn. (The significance of the 
relation between P. I. and age are sho-wn in 
Table XLIIl).
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Fig 94 The relation between the Spinal Index and
dietary intake of calcium, phosphorus, protein 
and vitamin D in women. The mean and 2 S.E, 
range are shomi. (see Table XLIIl),
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Pig 95 The relation between the Relative Vertebral Density 
and dietary intake of calcium, phosphorus, protein 
and vitamin D in women. The mean and 2 S.E. range 
are shoivn (see Table XLIIl).
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F i g  96 The r e l a t i o n  b e tw e e n  th e  M e ta c a r p a l  In d e x  and
d i e t a r y  in t a k e  d iv id e d  b y  b o d y  w e ig h t  i n  women#
The mean an d  2 S ,E ,  ra n g e  a r e  sh o im  (s e e  T a b le  X L I I l ) ,
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Fig 97 The relation between the Femoral Index and dietary 
intake divided by body weight in women. The mean 
and 2 S,E, range are sho™ (see Table XLIIl),
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FiK 98 The relation between the Spinal Index and 
dietary intake divided by body weight in 
women. The mean and 2 S.E. range are 
shoivn (see Table XLIIl).
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Pifï 99 The relation between the Relative Vertebral Density 
and dietary intake, divided by body weight, in women. 
The mean and 2 S.E, range are shoTO (see Table XLIIl).
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Fig 100 The dietary intake in women between 41 and 50 years 
of age with Metacarpal Indices above and below 
the mean value of the index. The mean and 2 S.E, 
range are sho^ vn.
The continuous line shows those below the 
I mean M#I« and the interrupted line shows 
those above the mean M,I*
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Fig 101 The dietary intake in women between 41 and 50 years 
of age with Femoral Indices above and below the 
mean value of the index. The mean and 2 S.E. range 
are shown.
The continuous line shows those below the
mean F*I, and the interrupted line shows
those above the mean F,I,
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Fig 102 The dietary intake in women between 41 and 50 years 
of age with Spinal Indices above and below the mean 
value of the index. The mean and 2 S,E, range 
are shown.
The continuous line shows those below the
mean 8*1* and the interrupted line shows
those above the mean 8,1*
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Fig 103 The dietary intake in women between 41 and 50 years 
of age with Relative Vertebral Densities above and 
below the mean value of the R.V.D. The mean and 
2 S.E. range are shoim.
The continuous line shows those below the
mean R*V,D. and the interrupted line shows
those above the mean E«V.D,
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Fig 104 The dietary intake in women between 51 and 60 years 
of age with Metacarpal Indices above and below the 
mean value of the index. The mean and 2 
range are shown.
The continuous line shows those below the
mean M, I# and the interrupted line shows
those above the mean
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Fig 103 The dietary intake in women between 51 and 60 years 
of age with Femoral Indices above and below the 
mean value of the index. The mean and 2 8,E, 
range are shoim.
The continuous line shows those below the
mean and the interrupted line shows
those above the mean F.I,
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Fig 106 The dietary intake in women between 51 and 60 years 
of age with Spinal Indices above and below the mean 
value of the index. The mean and 2 S,E, range 
are shoim.
The continuous line shows those below the
mean 8#I, and the interrupted line shows
those above the mean S#I.
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Fig 107 The dietary intake in women between 51 and 60 years 
of age with Relative Vertebral Densities above and 
below the mean R.V,D, The mean and 2 S.E, range 
are shoim.
The continuous line shows those below the
mean R#V.D. and the interrupted line shows
those above the mean
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Fig 108 The dietary intake in women between 6l and 70 years 
of age with Metacarpal Indices above and below the 
mean value of the index. The mean and 2 S,E, range 
are shown,
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mean F.I# and the interrupted line shows 
those above the mean F.I#
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of age with Spinal Indices above and below the 
mean value of the index. The mean and 2 S.E, 
range are sho;m.
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Fig 115 A comparison of the change in Femoral Index with 
age in men and women by decades. The mean and 
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The mean and 2 S.E. range are shown.
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Mean value »» Standard Deviation 
Vagotomy with
gas tr o-,i e .j uno s tomy Polyagastrectomy
Number of
subjects 56 51
Height in cms 170*1 Î 6*9 169*0 i 6,5
Weight in Kg 62*9 ^ 7®2 6l,l - 7*6
Months since
operation 102*4 - 17*1 104*7 12,3
(None of the differences approached statistical
significance),
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Pig 131 The serruu calcium, phosphorus and alkaline 
phosphatase in patients who had undergone 
vagotomy with gastro-jejunostomy or Polya- 
gastrectomy 8 to 12 years prior to the 
estimation. The mean and 2 S,E. range by 
decades are shown.
194
VAGOTOMY & 
GASTRO­
JEJUNOSTOMY
POLYA- 
GASTRECTOMY
VAGOTOMY & 
GASTRO­
JEJUNOSTOMY
POLYA- 
GASTRECTOMY
e/00
oe©
Fig 132 The calcium/creatinine ratio and the P,E,I,
(Nordin and Fraser, I960) in patients who had 
undergone vagotomy and gastro-jejunostomy or 
Polya-gastreetomy. The mean and 2 S,E, range
by decades are shown.
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The dietary intake of calcium by decades in 
patients who have undergone vagotomy and gastro­
jejunostomy or Polya-gastrectomy, compared with 
normal male subjects. The mean and 2 S,E, 
range are shoim.
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_ 134 The dietary intake of phosphorus by decades in 
patients who have undergone vagotomy and gastro­
jejunostomy or Polya-gastrectomy, compared with 
normal male subjects. The mean and 2 S,E, 
range are shotvn.
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Fig 135 The dietary intake of calcium, divided hy body 
weight, in patients who have undergone vagotomy 
with gastro-jejunostomy or Polya-gastrectomy, 
compared with normal subjects. The mean and 
2 S,E, range by decades are shown.
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Fig 156 The dietary intake of phosphorus, divided by body
weight, in patients who have undergone vagotomy with 
gastr0“jejunostomy or Polya-gastrectomy, compared with 
normal male subjects. The mean and 2 S.F, range by 
decades are shown.
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Fify 137 The change in Metacarpal Index with age in
the patients who have undergone vagotomy with 
gastro-jejunostomy or Polya-gastrectomy, compared 
with normal male subjects* The mean and 2 S,E, 
range for the normal subjects are shoim as they 
show no significant fall with age (see Table Ll),
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The change in Metacarpal Index with age, hy decades, 
in patients with vagotomy and gastro-jejunostomy 
or Polya-gastrectomy, compared with normal subjects. 
The mean and 2 S,E, range are shoivn (see Table LIl),
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Fig 139- The relation between Femoral Index and age in patients
with vagotomy and gastro-jejunostomy or Polya-gastrectomy, 
compared with normal subjects. The mean and 2 S.E, 
range by decades are shoim (see Table LIX),
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Fig 140 The relation between Spinal Index and age in
patients with vagotomy and gastro-jejunostomy or 
Polya-gastrectomy, compared with normal subjects. 
The mean and 2 S,E, range by decades are shown 
(see Table LIl),
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CHAPTEll IX
204
S.A.E, percentile
V
time on therapy
Gradient Intercept
0.075 55.75 0,039 n.s.
T.C.M. percentile
V - 0,039
time on therapy
32.00 0,020 n,8.
Change in 
S.A.E, percentile
time on therapy
- 0,181 0.81 0.158 < 0.01
Change in 
T.C.M, percentile
V
time on therapy
0.122 0.84 0.150 < 0,01
TilBLE LIII
The relation between the percentile value and the change in the 
percentile value of the S.A.E, and the T.C.M., and the time on 
therapy of 94 patients treated for 18 to 54 months with calcium 
supplements.
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Fig 141 The relation between the initial whole bone 
density (S.A,E*) and age in female patients 
thought to be osteoporotic, compared with the 
normal range* The 3 and 95 percentile values 
for the normal subjects are sho-wn*
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]42 The age distribution of the female patients
—  " treated with calcium supplements.
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Fig 143 The whole bone density (S*A*E.) plotted 
against the time since starting therapy 
in 6-monthly intervals. The mean and 
2 S.E, range are shoira.
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Fig 144 The gradient of the change with time in the S.A.E, 
in patients treated with calcium supplements, 
compared with the rate of change in S.A.E. in the 
normal population with time.
A, • Rate of change of S.A.E, in treated patients. 
■ "Rate of change of S.A.E. in normal subjects.
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Fifï 145 The gradient of the change with time of the
T.C.M. (Total Cortical Mineral per imit length 
of metacarpal) in patients treated with calcium 
supplements, compared with the rate of change in 
T.C.M. in the normal subjects with time.
A  #  Rate of change of T.C.M. in treated patients. 
Rate of change of T.C.M. in normal subjects.
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Fig 146 The initial whole bone density (S.A.E*) in patients 
who showed a significant increase or decrease in 
S,A,E, during the period of calcium therapy, plotted 
against age, compared with the normal population. The 
5 and 95 percentile limits for the normal population 
are shomi.
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The initial whole hone density (SoA*K,) in those 
patients who showed no significant change in S.A.E, 
while on calcium therapy, plotted against age, 
compared with the normal population. The 5 and 95 
percentile limits for the normal population are shovm.
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Fig 148 The initial T.C.M, in those patients who showed a 
significant increase or decrease in T.C.M. during 
the period of calcium therapy, plotted against age, 
compared with the normal population. The 5 and 95 
percentile limits for the normal population are shown.
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Fig 149 The initial T,C,M, in those patients who showed 
no si&niiicant change in T*C,M„ while on calcium 
therapy, plotted against age, compared with the 
normal population. The 5 and 95 percentile limits 
for the normal population are shown.
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Fig 150 The change in percentile value of S.A.E, with
time since starting calcium therapy. The mean 
and 2 S.E, range are sho’tm.
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Fig 151 The change in percentile value of T.C.M.
with time since starting calcium therapy. 
The mean and 2 S.E. range are shown.
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The mean weekly changes (- 1 S,E.) in faecal 
bile acid excretion from the first week of the 
basal period.
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fijL 1 5 3 The mean weekly changes (i 1 S.E,) in faecal 
acid fat; total fat, dry weight and calcium 
from the first week of the basal period.
